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Chapter 1:  
General introduction 
The role of multimodality imaging in the  
selection of patients for aortic valve repair 
 
 
M.V. Regeer, M.I.M. Versteegh, N. Ajmone Marsan, J.J. Bax, V. Delgado 
Expert Rev Cardiovasc Ther. 2016;14:75-86 




Aortic valve sparing surgery for aortic regurgitation and/or aortopathy serves as an alternative 
to aortic valve and root replacement. One of the advantages of aortic valve sparing surgery 
over conventional replacement is that there is no need for life-long anticoagulation, which is 
particularly attractive in young patients who may receive a mechanical prosthesis otherwise.  
However, successful aortic valve repair requires high expertise. At present, reparability is 
determined intraoperatively by direct surgical inspection. Preoperative imaging techniques 
might improve the patient selection for aortic valve repair. The mechanism of aortic 
regurgitation, aortic valve morphology and calcification and aortic root dimensions are all of 
importance when aortic valve repair is considered. The present review focuses on the role of 
imaging techniques in determining aortic valve reparability. 
  




Aortic valve repair for aortic regurgitation and valve-sparing aortic root replacement for aortic 
root and ascending aorta aneurysm or dissection are feasible and safe alternative techniques 
to aortic valve replacement and tubular graft implantation. However, successful and durable 
aortic repair requires high expertise. In contrast to mitral valve repair for mitral valve 
regurgitation, where the pre-procedural and surgical exploration of the valvular pathology and 
the surgical techniques are more standardized,
1
 aortic valve repair techniques are more 
heterogeneous. In addition, since the introduction of the remodeling and reimplantation 
techniques by Drs. Yacoub and David, respectively, several modifications of the techniques 
have been developed according to the experience of the centers.
2-4
 Accurate characterization 
of the underlying pathology and mechanism of aortic regurgitation is crucial for selection of 
patients in who aortic valve repair techniques and valve-sparing aortic root replacement will 
be successful resulting in a durable competent aortic valve.  
The present review article focuses on the role of non-invasive imaging to characterize the 
underlying mechanism of aortic regurgitation and selection of patients who are candidates for 
surgical aortic valve repair/valve-sparing aortic root replacement techniques 
 
Aortic valve and root anatomy  
The aortic root has a complex anatomy consisting of several components as shown in Figure 1. 
The aortoventricular junction, also called the annulus, is described as a virtual basal ring which 
separates the left ventricular outflow tract from the aortic root. It is defined by the 
circumference described by the nadirs of the aortic valve cusp attachments. The sinus of 
Valsalva consists of three bulges of the aortic wall. The coronary arteries arise from two of the 
sinuses, the right coronary sinus and the left coronary sinus. The remaining sinus is termed the 
non-coronary sinus and is spatially related with the interatrial septum. The morphology of the 
sinuses allows the formation of flow vortices during the left ventricular ejection to reduce the 
stress on the aortic valve cusps and support coronary flow.
5
 The sinotubular junction is the 
circumference that supports the peripheral attachments of the aortic cusps and separates the 
aortic root from the ascending aorta.  
The aortic valve consists of three semilunar cusps, commissures and intercusps triangles. The 
aortic cusps are termed according to their corresponding sinus as the left coronary cusp, right 
coronary cusp and non-coronary cusp. They are attached to the aortic root wall in a semilunar 
fashion forming the intercusps triangles. The apices of these triangles demark the 
commissures, defined as the areas where the attachments of the cusps have a parallel course 
for a short distance. In the general population, 1-2% has a bicuspid aortic valve (BAV) defined 
by the presence of two commissures and two equally sized cusps without a raphe or, more 
frequently, three cusps with two of them fused by a raphe.
6,7
 Fusion of the left coronary and  




Figure 1. Anatomy of the aortic valve and root.  
AVJ: aortoventricular junction, LCC: left coronary cusp, NCC: non-coronary cusp, RCC: right coronary cusp, 
SOV: sinus of Valsalva, STJ: sinotubular junction 
 
right coronary cusp or right coronary and non-coronary cusp are the most frequent 
phenotypes.
7
 The posterior aspect of the aortic root is supported by fibrous tissue  
 (membranous part of the membranous septum) in its 50% of the circumference, whereas the 
anterior aspect is surrounded by the left ventricular myocardium.This has important 
implications for aortic valve repair techniques.  
Similarly, successful and durable aortic valve repair requires accurate characterization of the 
specific geometry of the aortic root. The sinotubular junction is usually 10-15% smaller than 
the aortoventricular junction or aortic annulus, whereas at the level of the valve commissures, 
the diameter of the aortic root is comparable to that of the aortic annulus. The height of the 
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aortic cusps (from the apex of the intercusp triangle to the nadir of the cusp) is 12-18 mm. The 
non-coronary sinus and its corresponding cusp are larger than the left and right counterparts. 
These dimensions have been largely studied and formulae to size the tubular graft used in 





Mechanisms of aortic regurgitation  
Aortic regurgitation comprises 10% of all moderate to severe valvular heart diseases, being the 
prevalence of moderate to severe aortic regurgitation in the general population of 0.5%.
13,14
 
Aortic regurgitation is caused by malcoaptation of the aortic valve cusps, which results either 
from intrinsic cusp damage or from aortic root dilation.
15
 Valvular causes of aortic 
regurgitation include aortic valve degeneration, congenital malformation of the aortic valve 
(with BAV being the most common abnormality), rheumatic valvular disease (particularly in 
developing countries) and infective endocarditis.
14,15
 Non-valvular causes of aortic 
regurgitation include aortic root aneurysm (whether or not in the context of connective tissue 
disease such as Marfan syndrome), aortic dissection and aortitis.
15 
Similarly to the classification of mitral regurgitation mechanisms, a repair-oriented 
classification system has been developed to describe the mechanism of aortic regurgitation.
16
 
Based on the motion of the aortic cusps, the underlying mechanism of aortic regurgitation can 
be classified as: type 1 characterized by normal motion of the cusps and malcoaptation due to 
dilatation of the aortic root involving the sinus of Valsalva, type 2 characterized by excessive 
cusp motion causing prolapse an type 3 characterized by restrictive motion of the cusps 
(Figure 2). Some of these mechanisms may coexist. Type 1 aortic regurgitation is frequently 
caused by aortic root aneurysm or aortic dissection, developed due to longstanding 
hypertension, connective tissue disease or in the context of BAV, whereas the underlying 
pathology in type 2 and type 3 aortic regurgitation is valvular dysfunction most often due to 




Aortic valve repair techniques 
To restore the competence of the aortic valve, the several surgical approaches aim at 
correcting the underlying mechanism of aortic regurgitation. In type 1 aortic regurgitation, 
restoration of the normal dimensions of the aortic root is necessary and can be performed 
with one of the valve-sparing aortic root reconstruction techniques. In patients with aortic 
root dilation, either the remodeling technique or the reimplantation technique can be 
performed. In the remodeling technique, the aortic sinuses are resected along the 
commissures and a Dacron graft with neosinuses is implanted.
17
 In the reimplantation 
technique, the entire aortic root until the aortoventricular junction is resected and replaced by 
Chapter 1  
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a Dacron graft and the native aortic valve is reimplanted.
18
 In both the remodeling and 
reimplantation techniques, the coronary arteries are reimplanted in the neo-aortic root. In the 
last decades, several modifications of these techniques have been proposed. The remodeling 
technique can be extended with a subvalvular annuloplasty ring in order to stabilize the 
aortoventricular junction.
3,4
 Another modification of remodeling is the sleeve technique in 






Figure 2. Mechanisms of aortic regurgitation.  
A: aortic regurgitation type 1 due to aortic root dilation. B: aortic regurgitation type 2 due to leaflet 
prolapse. C: aortic regurgitation type 3 due to cusp restriction. 
│ General introduction 
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Moreover, the reimplantation technique uses currently a tailored graft with neosinuses or a 
prefabricated Valsalva-graft (David-V) to provide more physiological hemodyamics.
2
 In 
patients with ascending aorta dilation without aortic root dilation, supracoronary ascending 
aorta replacement using a Dacron graft and remodeling of the sinotubular junction to prevent 
residual aortic regurgitation are commonly performed.
18
 
Type 2 aortic regurgitation, due to excessive cusp motion, can be repaired using different 
leaflet repair techniques. When there is prolapse of one of the leaflets, central cusp plication 
or triangular resection can be performed.
20
. In addition or separately, resuspension of the free 
edge of the leaflet can be performed. A running suture is passed along the cusp free margin. A 
cusp defect or large fenestration can be repaired using a pericardial patch sewn into the 
cusp.
21
 In patients with poorly aligned commissures, a subcommissural annuloplasty using 
three sutures is added.
22
  
Type 3 aortic regurgitation results from aortic valve restriction. Frequently, the aortic cusps 
are thickened and calcified reducing the feasibility of successful and durable repair.
16
 
Therefore, in patients with this type of regurgitation, aortic valve replacement is the surgical 
approach of first choice.  
In experienced centers, aortic valve repair has shown low early mortality rates (1.1-3.6%) and 
a 10-year survival rates ranging between 75% and 95%.
16,23-27
 Freedom from reoperation and 
aortic regurgitation recurrence rates at 10 years are 90% and 80%, respectively.
16,23-28
 The 5-
year survival is better after aortic valve repair (96%) compared to aortic valve replacement 
with biological prosthesis (89%) and mechanical prosthesis (82%; p=0.02). This may be 
explained by the lower operative risks of patients who are referred for aortic valve repair 
compared to that of patients undergoing aortic valve and aortic root replacement.
29
  
Several studies have compared the outcomes between different aortic valve repair 
techniques. David et al. showed that the remodeling technique is marginally associated with a 
three times higher risk of reoperation than the reimplantation technique (p=0.07).
27
  
Additionally, in patients with BAV, connective tissue disease or acute type A aortic dissection, 
freedom from reoperation at follow-up is generally higher after reimplantation approach 
compared with the remodeling technique.
24,30,31
 There is no difference in 8-year freedom from 
reoperation and 5-year freedom from aortic regurgitation recurrence (92% and 89% and 84% 
and 90%, respectively)among patients undergoing isolated valve-sparing root replacement or 
combination of this technique with additional leaflet repair.
32
 However, when leaflet repair is 
applied as an isolated technique, significant worse freedom from reoperation at 10 years 
follow-up  is observed (70%) compared to supracoronary ascending aorta replacement (93%) 
and remodeling technique (89%; p<0.001).
33
 In patients undergoing supracoronary ascending 
aorta replacement in whom additional subcommissural annuloplasty is performed, the 5-year 
Chapter 1  
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freedom survival from aortic regurgitation was better (94%) compared with that of patients in 
whom this procedure was not performed (58%, p=0.02).
34 
 
Multimodality imaging in aortic valve repair 
Imaging of the aortic valve and root plays an important role in decision-making of patients 
with aortic regurgitation who may be candidates for aortic valve repair techniques. Different 
imaging techniques such as 2-dimensional transthoracic and transesophageal 
echocardiography (2DTTE and 2DTEE), 3-dimensional transesophageal echocardiography 
(3DTEE), multi-detector row computed tomography (MDCT) and cardiac magnetic resonance 
(CMR) can be used to assess aortic regurgitation severity, aortic regurgitation mechanism, 
aortic valve reparability and aortic root dimensions (Table 1).  
 
Table 1. Imaging modalities to assess several aspects of aortic regurgitation. 
 2DTTE 2DTEE 3DTEE MDCT CMR 
Aortic regurgitation severity ++ ++ ++ - ++ 
Aortic regurgitation mechanism + + + - +/- 
Aortic root dimensions +/- +/- + ++ ++ 
Aortic valve reparability +/- ++ + + + 
2DTEE: two-dimensional transesophageal echocardiography, 2DTTE: two-dimensional transthoracic 
echocardiography, 3DTEE: three-dimensional transesophageal echocardiography, CMR: cardiac magnetic 
resonance, MDCT: multidetector row computed tomography. 
 
Quantification of aortic regurgitation.  
Echocardiography is the imaging technique of first choice to grade aortic regurgitation. 
Current guidelines recommend a multiparametric approach using multiple views (parasternal 
long axis view and apical views) and several qualitative, semi-quantitative and quantitative 
parameters of regurgitant volume and/or fraction as displayed in table 2.
35,36
 Colour Doppler 
imaging is used to grade aortic regurgitation semi-quantitatively, measuring jet area and jet 
width ratio (ratio between regurgitant jet width and left ventricular outflow tract width). 
However, these methods are not recommended when several aortic regurgitation jets are 
observed.
35
 A more quantitative approach can be followed by measuring the vena contracta 
width, which is defined as the width of the regurgitant jet as it transverses the aortic valve. A 
vena contracta width of <3mm corresponds with mild aortic regurgitation, 3-6 mm with 
moderate and >6mm with severe aortic regurgitation. Using continuous wave Doppler of the 
regurgitant jet, the measurement of a pressure half time <200 ms, indicates the presence of 
severe aortic regurgitation.
35 
In addition, diastolic flow reversal in the descending aorta, 
measured with pulsed wave Doppler is strongly associated with severe aortic regurgitation.  
Moreover, quantitative measurement of the effective regurgitant orifice area and regurgitant 
volume using the proximal isovelocity surface area (PISA) method is highly recommended 
│ General introduction 
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when feasible, especially in patients with intermediate vena contracta values (between 3 and 
6 mm). Aortic regurgitation is considered severe when the effective regurgitation orifice area 
is ≥30mm
2 
or regurgitant volume is ≥60 ml.
37
 However, this method is less feasible when the 
effective orifice area is not circular (prolapse of one of the cusps) or in very eccentric 
regurgitant jets.
38  
With the development of 3-dimensional echocardiographic techniques, newer methods to 
grade aortic regurgitation have been proposed. In particular patients with eccentric jets and 
multiple jets may benefit from three dimensional assessment of the regurgitant jet.  A vena 
contracta area >0.6cm
2
 on 3DTEE indicates the presence severe aortic regurgitation and 
correlates well with aortic regurgitant fraction on CMR.
39,40
 Direct measurement of PISA  
 
Table 2. Echocardiographic parameters to assess severity of aortic regurgitation. 
 Mild Moderate Severe 
Qualitative    
Aortic valve morphology Normal/abnormal Normal/abnormal Abnormal/flail/large 
coaptation defect 
Colour flow aortic 
regurgitation jet width 
Small in central jets Intermediate Large in central jets, 
variable in eccentric 
jets 
Continuous wave signal of 
aortic regurgitation jet 
Incomplete/faint Dense Dense 








Semi-quantitative    
Vena contracta width <3 mm Intermediate  >6 mm 
Pressure half-time >500 ms Intermediate <200 ms 
Quantitative    








Regurgitant volume <30 ml 30-59 ml ≥60 ml 




without geometric assumptions is possible with 3DTEE and seems superior to two-dimensional 
PISA.
41
 In patients with inadequate echocardiographic quality, CMR should be used to assess 
aortic regurgitation severity.
42
 Aortic regurgitant fraction >33% on CMR which is defined as the 
proportion of the regurgitant volume relative to the forward stroke volume identifies patients 
who progressed to symptoms and surgery.
43
 Additionally, effective regurgitant orifice area can 
be measured on gated MDCT in diastolic phase. An aortic regurgitant orifice area of 0.04-0.25 
cm
2
 corresponds with mild aortic regurgitation, 0.37-0.44 cm
2
 with moderate aortic 
regurgitation and 0.81-1.05 cm
2
 with severe aortic regurgitation.
44,45
 Several small studies 
show good correlation between regurgitant orifice area on MDCT and aortic regurgitation 
Chapter 1  
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grade on 2DTTE; however this imaging technique is associated with important radiation dose 
and low temporal resolution and therefore is not an imaging technique of first choice to grade 
aortic regurgitation. 
 
Assessment of aortic regurgitation mechanism and factors associated with reparability.  
At present, aortic valve reparability is assessed intraoperative by direct surgical inspection. 
Aortic regurgitation mechanism is an important factor in determining whether the aortic valve 
is or not reparable.
16
 Besides aortic valve calcification, aortic valve morphology and aortic root 
diameter play an important role in determining reparability. Next to the intraoperative 
inspection, imaging modalities can be used to assess reparability. In Figure 3, the aortic valve 
and root on MDCT and 3DTEE are shown in comparison to direct surgical inspection. 
  
Figure 3 Assessment of the aortic valve and root with multi-detector row computed tomography (A), 3-
dimensional transesophageal echocardiography (B) and surgical view (C: before and after 
reimplantation technique).  
The images are rotated to match the surgical view. R indicates right-coronary cusp.  
│ General introduction 
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An important advantage of imaging techniques over direct surgical inspection is that the cusp 
motion can be observed throughout the cardiac cycle. In addition, preoperative imaging can 
be used at the heart team discussion to decide whether or not aortic valve repair seems 
feasible and which technique is the most appropriate. Table 3 summarizes factors associated 
with reparability and the preferred imaging modality to assess these factors. 
The mechanism of aortic regurgitation can be assessed with 2DTEE. First, the jet direction is 
classified as central or eccentric. Central jets are associated with normal cusp mobility and 
aortic root dilatation whereas eccentric jets are observed in excessive cusp mobility.
46
 
Moreover, a transverse fibrous band in addition to an eccentric jet characteristically identifies 
a prolapsing cusp.
16 
There is a good agreement between identification of the aortic 
regurgitation mechanism by 2DTEE and direct surgical inspection with a kappa of 0.90.
47 
In addition, the tissue characteristics of the aortic cusps have an important impact on the 
durability of the repair. Freedom from recurrent aortic regurgitation grade >2 is significantly 
impaired after repair in type 3 aortic regurgitation, which is characterized by thickened and 
restrictive cusps, in comparison with type 1 and type 2 aortic regurgitation (hazard ratio: 2.6, 
95% confidence interval: 1.1-11.6, p=0.03).
16
 Therefore repair is not recommended in type 3 
aortic regurgitation. 
 
Table 3. Factors associated with aortic valve reparability and the preferred imaging modality 
Factors associated with aortic valve reparability Preferred imaging modality  
Type 1 and 2 aortic regurgitation  2D/3DTEE 
No or only small aortic annular or commissural calcification 2D/3DTEE, MDCT 
Bicuspid aortic valve   
 with commissural orientation >160° 2D/3DTEE, (gated MDCT) 
 with eccentric jet without commissural or cusp thickening 2D/3DTEE 
 with large cusp pliability and small coaptation deficiency 
 index 
2D/3DTEE 
Aortoventricular junction <28 mm MDCT, 3DTEE 
2DTEE: two-dimensional transesophageal echocardiography, 3DTEE: three-dimensional transesophageal 
echocardiography, MDCT: multidetector row computed tomography. 
 
In contrast, preoperative severity of aortic regurgitation is not associated with reparability.
32
 
Patients with aortic regurgitation grade ≥3 need leaflet repair as often as patients with aortic 
regurgitation grade <3 with comparable freedom from reoperation at 8 years (90±7% vs. 
89±11%, respectively; p=0.7).
32 
Calcifications of the aortic valve cusps are also important 
determinants of the success of aortic valve repair. In moderately calcified valves (grade <3), 
when the calcifications are confined to the free margin, repair is considered feasible.
47
 
Calcifications in the body of the cusp or interfering with cusp mobility are considered non-
reparable.
47
  In addition, higher grades of aortic valve commissural and annular calcification, 
assessed with MDCT, are associated with non-reparability.
48 
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In addition, aortic valve morphology has been associated with aortic valve reparability. 
Echocardiography can demonstrate the presence of BAV with precision.
49,50
 The diagnosis of 
BAV is made when there are two leaflets in systole with two commissures framing an ellipsoid 
orifice.
37
 Moreover, ECG-gated contrast enhanced MDCT is highly accurate to differentiate 
between tricuspid aortic valves and BAV.
51
 CMR can also be used to assess aortic valve 
morphology.
52
 Aortic valve repair techniques provide in general good outcomes in BAV-
patients operated by experienced surgeons.
53,54
 BAV-patients with an eccentric regurgitant jet, 
without commissural or cusp thickening on the preoperative 2DTEE are more likely to undergo 
successful aortic valve repair.
55
 Furthermore, greater tissue pliability, defined by tissue 
normality index on 2DTEE ((diastolic cusp area – systolic cusp area) / diastolic cusp area), and 
lower coaptation deficiency index, defined on 2DTEE as the sum of conjoint cusp height and 
reference cusp height relative to diastolic aortic annulus diameter, have been associated with 
higher rates of successful valve repair in patients with incompetent BAV.
21
 On the other hand, 
BAVs are less often reparable when there is a commissural orientation <160° and preoperative 
aortic regurgitation grade ≥3.
56 
Aortic root diameter is also of interest in determining reparability. Patients with an 
aortoventricular junction of >28mm have more often recurrent aortic regurgitation grade >2 
and higher risk of reoperation if no additional surgical techniques are employed to restore the 
dimensions of this aortic root component.
56-58
 Figure 4 describes a flowchart which can be 
used to determine whether or not an incompetent aortic valve is reparable.  
 
Associated aortic root aneurysms.  
Due to increased risk of aortic rupture, the presence of associated aortic root aneurysms of 
>55 mm indicate surgery irrespective of the aortic regurgitation severity.
59
 Lower thresholds of 
50 mm or 45 mm are applied in BAV or connective tissue disease with additional risk factors 
such as positive family history of aortic dissection, fast growth of the ascending aorta (>3 
mm/year), severe aortic regurgitation or desire for pregnancy.
59 
Aortic root dimensions are evaluated on transthoracic echocardiography as part of routine 
cardiac evaluation. The aortic root diameter is measured at 3 predefined levels: 
aortoventricular junction, sinus of Valsalva and sinotubular junction on long axis views during 
end-diastole.
46,60 
Upper normal limits are defined at each level separately for men 
(aortoventricular junction: 31 cm, sinus of Valsalva: 40 cm and sinotubular junction: 36 cm) 








Figure 4 Flowchart to determine aortic valve reparability. 
 
Measurements on 2-dimensional echocardiography significantly underestimate the aortic root 
diameter in comparison to automated measurements on 3DTEE, CMR and MDCT.
61
 Therefore 
3-dimensional imaging modalities are preferred over 2-dimensional modalities in the 
assessment of the aortic root diameter. In 3-dimensional imaging techniques the maximum 
diameter should be measured perpendicular to the centreline of the vessel using multiplanar 
reconstruction.
59,62
 There is no consensus on whether the aortic wall should be included in the 
measurement of the aortic diameter and on whether the measurement should be performed 
in systole or diastole.
59
 Echocardiography uses the leading edge-to-leading edge technique 
whereas MDCT and CMR use the inner edge-to-inner edge technique.
63
 In addition, 
visualization and quantification of dynamic flow patterns with 4-dimensional (4D) flow 
magnetic resonance imaging (MRI) have shown promising in predicting the development of 
aortic disease in patients with aortic valve disease (Figure 5). Vectors plots and particle traces 
(streamlines and pathlines) are the most common approaches to visualize 4D flow data.
64
 
Vector plots represent the actual velocity data at a given moment in time, streamlines connect 
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these vectors with imaginary lines that illustrate the instantaneous flow field and pathlines 
represent blood flow over time and are calculated by releasing imaginary particles intro the 
flow field and tracking their position across the cardiac cycle. 
Quantitative assessment of dynamic flow patterns includes wall shear stress and flow 
displacement. High wall shear stress states and flow displacement have been associated with 




Surgical aortic valve repair demands high experience and surgical skills. In contrast to mitral 
valve repair where the surgical repair techniques are more standardized, surgical aortic valve 
repair is more heterogeneous and requires an advanced knowledge on the anatomy, geometry 
and dynamics of the aortic root. In the evolution of surgical aortic valve repair techniques, 
cardiac imaging has been an important adjuvant to better select the patient in whom this 
treatment will be durable and to modify the techniques in order to attain a more physiological 
function of the replaced aortic root.  
Figure 5. 4D flow MRI of the aortic valve and aorta.  
Comparison of 4D flow MRI streamlines of the aortic flow in a patient with tricuspid aortic valve (TAV) 
and a patient with bicuspid aortic valve (BAV). Reproduced from Meierhofer et al.66 with permission from 
the Oxford University Press.  
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Objective and outline of the thesis 
The primary objective of this thesis is to improve patient selection for valve-sparing aortic root 
reconstructive surgery using imaging techniques. This thesis can be divided into two parts. The 
first part focuses on imaging in patients with aortic regurgitation and/or aortopathy to 
evaluate disease progression and to determine reparability of the aortic valve in surgical 
patients. The second part describes the effect of aortic valve and root surgery on left 
ventricular performance and aortic dilation. 
 
Part I: preoperative evaluation of patients with aortic regurgitation and/or aortopathy 
In Part Ia, the progression of disease in patients with aortic regurgitation and/or aortopathy is 
evaluated. Chapter 2 describes the changes in aortic valve geometry in dilated aortic roots 
evaluated using three-dimensional transesophageal echocardiography. Chapter 3 focuses on 
the effect of aortic regurgitation on mitral valve geometry in relation to the presence of mitral 
regurgitation. Chapter 4 evaluates the effect of statin therapy on aortic root dilation in 
patients with bicuspid aortic valves. Part Ib consists of two chapters discussing different 
preoperative imaging techniques in the selection of patients for valve-sparing root 
replacement techniques. The use of multidetector row computed tomography in determining 
aortic valve reparability is described in Chapter 5. In Chapter 6, the additional value of 
echocardiography in selection of the appropriate graft size in valve-sparing root replacement 
using the reimplantation technique is evaluated.  
 
Part II: postoperative evaluation of patients after aortic valve and root surgery 
In Part IIa, the effects of aortic valve and root surgery on the left ventricle are described. The 
occurrence of postoperative left ventricular reverse remodeling is compared between acute 
aortic regurgitation and chronic aortic regurgitation in chapter 7. In chapter 8, distinction is 
made between left ventricular reverse remodeling after repair and replacement of the aortic 
valve and/or root. Chapter 9 focuses on the changes in left ventricular volumes and function 
after different surgical techniques for acute type A aortic dissection. In chapter 10, the 
prevalence of conduction disturbances and its effect on the left ventricle after aortic valve 
replacement is discussed. Part IIb describes aortic dilation after aortic valve and root surgery. 
Chapter 11 compares aortic root dilation after replacement of a bicuspid and a tricuspid aortic 
valve. Lastly, in chapter 12, dilation of the native descending thoracic aorta after surgery for 
acute type A aortic dissection is evaluated. The final chapters describe a general summary, 
conclusions and future perspectives. 
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Background: It has been hypothesised that in response to dilation of the aortic root, the aortic 
valve cusps may remodel to prevent aortic regurgitation (AR). The aim of the present study 
was to evaluate the association between aortic cusp dimensions and aortic root geometry. 
Methods: Three-dimensional transesophageal echocardiography was performed in 40 patients 
with aortic root dilation (mean age 57±12 years, 75% men, 35% bicuspid aortic valve) and 20 
controls with a normal aortic root (mean age 61±13 years, 65% men). Aortic valve geometry 
was measured and the ratio between closed cusp area and sinotubular junction (STJ) area as a 
measure of the aortic cusp remodeling relative to the aortic root dilation was assessed. 
Results: Patients with aortic root dilation with tricuspid aortic valve (n=26) showed significant 
increase in aortic cusp size. However, the closed cusp area to STJ area ratio was smaller in 
dilated aortic roots (0.88 [95% confidence interval: 0.78-0.98]) compared with normal aortic 
roots (1.22 [95% confidence interval: 1.02-1.41]; p=0.002). In addition, in patients with central 
AR, there was insufficient cusp tissue, as suggested by a closed cusp area to STJ area ratio of 
0.75 (95% confidence interval: 0.67-0.82), compared with relative excess of cusp tissue in 
eccentric AR with a ratio of 1.14 (95% confidence interval: 1.01-1.27; p<0.001). 
Conclusion: Aortic root dilation was associated with significant increase in aortic valve cusp 
size. However, this increase seemed insufficient to match aortic root size, particularly in 
central AR, whereas in eccentric AR, there was relative abundance of cusp tissue resulting in 
relative cusp prolapse. 
  




Aortic root dilation involving particularly the aortic annulus can lead to aortic regurgitation 
(AR) due to malcoaptation of aortic valve cusps.
1
 Idiopathic aortic root dilation is the leading 
cause of valvular insufficiency in about 10-30% of patients with AR.
2,3
 However, not all patients 
with aortic root dilation exhibit AR. It could be hypothesized that in patients with aortic root 
dilation, the aortic valve cusps may be exposed to increased wall stress that triggers their 
remodeling and growth to compensate and preserve valvular competence. Indeed, 
computational models have shown that the aortic valve can adapt in response to aortic root 
dilation.
4
 However, in clinical practice these models are time consuming and require high 
computational costs. In patients who underwent clinically indicated three-dimensional 
transesophageal echocardiography (3DTEE), we evaluated whether the aortic valve cusps 
show remodeling to compensate for the aortic root dilation. The aims of the present study 
were: 1) to assess whether patients with aortic root dilation show remodeling of the aortic 
valve cusps to prevent AR and 2) to investigate whether this remodeling is different in patients 




A total of 40 patients with aortic root dilation (defined as maximum diameter of the sinus of 
Valsalva (SOV) of ≥40 mm in men and ≥36 mm in women or maximum diameter of the 
sinotubular junction (STJ) ≥36 mm in men and ≥32 mm in women
5,6
), who underwent clinically 
indicated 3DTEE, were included. Patients with bicuspid aortic valve were excluded for further 
geometric analyses. Patients with tricuspid aortic valve were divided into two subgroups 
according to presence of AR and according to the presence of a central or eccentric AR jet. 
Patients with more than mild aortic stenosis were excluded. In addition, a control group of 20 
patients who underwent clinically indicated 3DTEE (i.e. evaluation of the mechanism of mitral 
regurgitation, suspected endocarditis, and evaluation of cerebrovascular accident or in the 
context of left atrial appendage closure) and who had normal dimensions of the aortic root 
and normal functioning tricuspid aortic valve was included.  
Clinical characteristics were prospectively collected in the departmental Cardiology 
Information System (EPD-Vision®, Leiden University Medical Center, Leiden, The Netherlands) 
and retrospectively analyzed. 3DTEE data of the aortic valve and root geometry were analyzed 
offline and compared between patients with aortic dilation and controls. In addition, aortic 
valve and root geometry were compared between patients with central and eccentric AR. The 
institutional review board approved this retrospective analysis of clinically acquired data and 
waived the need for patient written informed consent. 
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Two-dimensional transthoracic echocardiography 
Transthoracic echocardiography was performed using commercially available ultrasound 
system (Vivid E9, General Electric Healthcare, Vingmed, Horten, Norway) equipped with M5S 
transducer. Two-dimensional and Doppler data were acquired in the parasternal and apical 
views according to current recommendations.
7,8
 AR grade was assessed using a 
multiparametric approach including the measurement of the jet width relative to the left 
ventricular outflow tract width and the vena contracta in parasternal long-axis and apical 
views. AR was graded as 0 (no), 1 (mild), 2 (mild-moderate), 3 (moderate-severe) or 4 
(severe).
7 
Left ventricular end-diastolic and end-systolic volumes were measured and left 
ventricular ejection fraction was calculated in the apical two- and four-chamber views 
according to the Simpson’s biplane method.
8 
 
Three-dimensional transesophageal echocardiography data acquisition and analysis 
3DTEE was performed using commercially available ultrasound system (Vivid E9, General 
Electric Healthcare, Vingmed, Horten, Norway) equipped with a fully integrated 2D/3D matrix 
transducer (GE 6VT-D, General Electric Healthcare, Vingmed, Horten, Norway). Mid-
esophageal images of the aortic valve and aortic root were obtained in the short-axis at 30-45° 
and in the long-axis at 120-130°. To acquire 3DTEE images, the aortic root was imaged from 
the aortoventricular junction (AVJ) to the STJ in two orthogonal planes. Thereafter, single-beat 
and multi-beat 3DTEE data of the aortic valve and root were acquired to optimize spatial and 
temporal resolution. Attention was paid to avoid stitching artefacts in the multi-beat data 
acquisition. The echocardiographic data were digitally stored in cine-loop format and data 
were retrospectively analyzed using commercially available software (EchoPac 112.0.1, GE 
Medical Systems, Horten, Norway). For 3DTEE data analysis, three orthogonal multiplanar 
reformation planes were reconstructed and aligned the centreline of the aortic root to obtain 
the true short-axis of the aortic valve at the level of cusp coaptation. Figure 1 shows the 
different aortic valve geometric measurements. An end-systolic 3DTEE frame with the aortic 
valve closed was used to measure the cusp height, intercommissural distance and closed cusp 
area. The cusp height was measured from the internal border of the aortic root till the free 
edge of the cusp for each cusp separately and averaged. The intercommissural distance was 
measured between each commissure and also averaged. The cusp area was measured per 
each cusp and then summed to obtain the total closed cusp area. A mid-systolic 3DTEE frame 
was used to measure each cusp area and then summed to obtain the open cusp area. Two 
additional measurements were performed during end-systole: the cusp depth was measured 
per cusp in the cross-sectional image of the middle of the cusp between the deepest point of 
the belly of the cusp and the cross-sectional plane and thereafter averaged whereas the 
central coaptation deficit was measured at the central coaptation point between each pair of  
 




Figure 1. Measurements of aortic valve geometry. 
A: Flexi-slice method was used to obtain a true short-axis of the aortic valve at the level of cusp 
coaptation. B: Cusp height was measured during end-systole from the internal border of the aortic root till 
the free edge of the cusp. C: Intercommissural distance was measured during end-systole between the 
commissures. D: Closed cusp area was measured during end-systole for all cusps. E: Open cusp area was 
measured during mid-systole for all cusps. F: Cusp depth was measured during end-systole per cusp in the 
cross-sectional image of the middle of the cusp between the deepest point of the belly of the cusp and the 
cross-sectional plane. G: Central coaptation deficit was measured during end-systole at the central 
coaptation point between each pair of coapting cusps. 
 
 
Figure 2. Measurements of aortic root geometry. 
Flexi-slice method was used to obtain a true short axis of the aortoventricular junction (A), sinus of 
Valsalva (B) and sinotubular junction (C). Aortic root area, minimum and maximum diameter were 
measured during end-systole in 3DTEE images.  
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coapting cusps and averaged. When there was full coaptation of the cusps in the center, the 
coaptation deficit was defined as 0 mm.In addition, the aortic root measurements were 
performed in the true short-axis of the aortic root at three levels as displayed in figure 2. The 
area, minimum diameter and maximum diameter of the AVJ, SOV and STJ were measured 
during an end-systolic frame on the 3DTEE image. The eccentricity index was calculated per 




All data analyses were performed using the SPSS software (Version 20.0. IBM Corp., Armonk, 
NY, USA). Continuous variables were reported as mean ± standard deviation and compared 
with the Student’s t-test when normally distributed. Median and interquartile range were 
reported for non-normally distributed variables and were compared with the Mann-Whitney 
U-test. Categorical variables were reported as counts and percentages and compared using 
the chi-square test. Differences between controls, patients with dilated aortic root and 
bicuspid aortic valve and patients with dilated aortic root and tricuspid aortic valve were 
reported. Further analyses were performed in subjects with tricuspid aortic valve (patients 
with aortic root dilation vs. controls), to make sure the morphology of the aortic valve wasn’t 
responsible for the differences between patients with aortic root dilation and controls. 
Linear regression analysis without including an intercept was used to assess the ratio between 
the aortic root area at the level of the STJ and the closed cusp area. Subanalysis was 
performed between aortic dilation patients with tricuspid aortic valve with and without AR 
and between aortic dilation patients with tricuspid aortic valve with central AR and eccentric 
AR. The intra-observer and inter-observer variabilities were evaluated in 10 individuals 
randomly selected. The mean difference and 95% confidence interval between two 
measurements for all aortic valve and aortic root measurements were calculated. A p-value 
<0.05 was considered statistically significant. 
Results 
Table 1 outlines the baseline and echocardiographic characteristics of patients with aortic root 
dilation (mean age 57±12 years, 75% men) divided by aortic valve morphology and controls 
(mean age 61±13 years, 65% men). There were no differences in age, gender and body surface 
area. Per definition, controls showed normal anatomy and dimensions of aortic valve and 
aortic root. Left ventricular volumes were significantly larger and left ventricular ejection 
fraction was slightly lower in patients with aortic root dilation compared with controls. 
 
Aortic valve and root geometry in aortic root dilation 
Table 1 shows the aortic valve and root geometric measurements in patients with aortic root 
dilation compared with controls. Per definition, all aortic root measurements were larger in 
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patients with aortic root dilation in comparison to controls. In patients with dilated aortic 
roots, the AVJ was slightly more rounded (eccentricity index: 0.80 [interquartile range: 0.75-
0.89]) compared with normal oval-shaped aortic roots (eccentricity index 0.76 [interquartile 
range: 0.71-0.83]; p=0.052). There was no difference in eccentricity index of the SOV and STJ 
between controls and patients with dilated aortic root. Patients with aortic root dilation 
showed enlarged aortic cusps as displayed by a larger cusp height, closed cusp area and open 
cusp area. In patients with normal dimensions of the aortic root, there was no central 
coaptation deficit, compared with a median central coaptation deficit of 4.0 mm (interquartile 
range: 2.0-6.4 mm; p<0.001) in patients with dilated aortic root. Furthermore, the cusp depth 
was larger in patients with dilated aortic root compared with controls.  
 
Table 1: Baseline and echocardiographic characteristics of patients with normal vs. dilated aortic root 
with tricuspid or bicuspid aortic valve 
 Normal  
aortic root 
(n=20) 




root with BAV 
(n=14) 
p-value 
Age (years) 61±13 59±13 55±11 0.436 
Male gender 13 (65%) 21 (81%) 9 (64%) 0.392 
Body surface area (m
2
) 1.95±0.17 2.04±0.15 1.92±0.22 0.093 
Left ventricular end-diastolic 
volume (ml) 
123±24 151±50 158±69 0.080 
Left ventricular end-systolic 
volume (ml)  
49±18 64±26 72±44 0.070 
Left ventricular ejection 
fraction (%) 
60±10 58±6 57±10 0.364 
Cusp height 15.7 (13.8-16.3) 18.2 (16.3-20.2) 19.5 (18.1-22.1) <0.001 
Intercommissural distance 19.3 (17.8-20.6) 25.8 (22.3-28.3) 24.5 (21.8-27.5) <0.001 
Total closed cusp area (cm
2
) 6.7 (6.0-7.7) 10.1 (8.5-12.5) 10.0 (7.7-11.4) <0.001 
Total open cusp area (cm
2
) 2.5 (2.1-3.4) 5.6 (3.8-6.9) 3.9 (2.6-6.0) <0.001 
Central coaptation deficit 0 (0-0) 2.5 (1.3-4.0) 2.0 (0.8-3.8) <0.001 
Cusp depth  9.0 (7.1-9.3) 10.3 (9.3-12.3) 10.3 (7.4-12.6) 0.003 
AVJ area (cm
2
) 4.2 (3.7-4.4) 5.2 (4.6-6.2) 5.8 (3.7-6.4) 0.002 
AVJ minimum diameter 20 (19-21) 24 (22-26) 24 (21-25) 0.001 
AVJ maximum diameter 26 (25-27) 29 (26-31) 29 (25-31) 0.044 
AVJ eccentricity index 0.76 (0.71-0.83) 0.80 (0.74-0.89) 0.82 (0.77-0.90) 0.127 
SOV area (cm
2
) 7.4 (6.7-8.3) 12.1 (10.4-14.8) 11.2 (9.8-14.6) <0.001 
SOV minimum diameter 27 (25-29) 36 (33-38) 33 (29-37) <0.001 
SOV maximum diameter 34 (31-36) 42 (40-47) 42 (39-45) <0.001 
SOV eccentricity index 0.80 (0.76-0.83) 0.83 (0.79-0.87) 0.80 (0.73-0.84) 0.291 
STJ area (cm
2
) 5.3 (4.9-6.3) 11.4 (8.3-14.4) 9.3 (8.0-13.0) <0.001 
STJ minimum diameter 25 (25-26) 35 (32-40) 34 (29-38) <0.001 
STJ maximum diameter 27 (26-30) 40 (36-44) 38 (33-43) <0.001 
STJ eccentricity index 0.93 (0.85-0.96) 0.91 (0.86-0.95) 0.89 (0.87-0.93) 0.796 
Data are presented as number (percentage), mean ± standard deviation or median (interquartile range). 
Dimensions are displayed in mm unless otherwise specified. AVJ: aortoventricular junction, BAV: bicuspid 
aortic valve, SOV: sinus of Valsalva, STJ: sinotubular junction, TAV: tricuspid aortic valve. 
 





Figure 3. Ratio between sinotubular junction area and closed cusp area in normal vs. dilated aortic 
roots.  
Linear regression analysis through origin was performed to assess the ratio between closed cusp area and 
sinotubular junction area, which was 0.88 in dilated aortic roots and 1.22 in normal controls. 
 
Table 1 shows the aortic valve geometric measurements for patients with dilated root and 
tricuspid aortic valve and for patients with dilated root and bicuspid aortic valve.  
In controls, the closed cusp area was on average 1.22 times the STJ area (95% confidence 
interval: 1.02-1.41), whereas in patients with dilated aortic root with tricuspid aortic valve the 
closed cusp area was only 0.88 times the STJ area (95% confidence interval: 0.78-0.98; 
p=0.002). This indicates that, although aortic root dilation was associated with cusp 
enlargement and increase in closed cusp area, this enlargement was not sufficient when 
compared with normal aortic roots, resulting in more frequent AR (Figure 3). 
 
Aortic valve and root geometry in patients with aortic root dilation and with or without AR 
Among the 26 patients with aortic root dilation and tricuspid aortic valve, 15 patients showed 
AR grade ≥2 (mean age 60±12 years, 87% men)  and the remaining 11 patients showed AR 
grade <2 (mean age 56±14 years, 73% men; Table 2). Patients with AR had significant larger 
left ventricular volumes and slightly lower left ventricular ejection fraction compared with 
patients without AR. In terms of aortic dimensions, both groups of patients were comparable. 




Table 2: Baseline and echocardiographic characteristics of patients with dilated aortic root with 
tricuspid aortic valve with and without aortic regurgitation 
 AR grade <2 
(n=11) 
AR grade ≥2 
(n=15) 
p-value 
Age (years) 56±14 60±12 0.482 
Male gender 8 (73%) 13 (87%) 0.698 
Body surface area (m
2
) 2.02±0.17 2.05±0.14 0.610 
Left ventricular end-diastolic volume (ml) 125±34 170±52 0.019 
Left ventricular end-systolic volume (ml)  48±15 76±26 0.004 
Left ventricular ejection fraction (%) 61±5 55±5 0.004 
Cusp height (mm) 17.3 (16.0-20.0) 18.3 (16.7-20.7) 0.467 
Intercommissural distance (mm) 24.7 (20.0-28.0) 26.3 (23.0-28.3) 0.125 
Total closed cusp area (cm
2
) 10.0 (7.7-11.5) 10.5 (8.6-14.6) 0.406 
Total open cusp area (cm
2
) 4.3 (3.6-6.6) 5.7 (4.1-7.9) 0.392 
Central coaptation deficit (mm) 1.7 (0.7-2.7) 3.3 (2.0-5.0) 0.010 
Cusp depth (mm) 10.7 (9.7-12.3) 10.3 (9.3-12.3) 0.695 
AVJ area (cm
2
) 5.6 (4.8-5.8) 4.7 (4.5-6.3) 0.897 
AVJ minimum diameter (mm) 24 (21-26) 23 (22-26) 0.793 
AVJ maximum diameter (mm) 29 (28-30) 29 (25-31) 0.979 
AVJ eccentricity index 0.77 (0.72-0.80) 0.84 (0.75-0.89) 0.287 
SOV area (cm
2
) 11.5 (9.1-13.4) 12.6 (10.5-16.4) 0.377 
SOV minimum diameter (mm) 34 (32-38) 37 (33-42) 0.152 
SOV maximum diameter (mm) 41 (38-47) 42 (40-53) 0.251 
SOV eccentricity index 0.83 (0.81-0.87) 0.80 (0.78-0.89) 0.795 
STJ area (cm
2
) 9.7 (7.9-12.2) 11.8 (9.7-15.0) 0.232 
STJ minimum diameter (mm) 33 (32-38) 38 (32-41) 0.322 
STJ maximum diameter (mm) 36 (33-41) 43 (37-45) 0.138 
STJ eccentricity index 0.92 (0.90-0.97) 0.90 (0.85-0.95) 0.311 
Data are presented as number (percentage), mean ± standard deviation or median (interquartile range). 
AR: aortic regurgitation, AVJ: aortoventricular junction, SOV: sinus of Valsalva, STJ: sinotubular junction. 
However, there was a difference in the central coaptation deficit, which was only 1.7 mm 
(interquartile range: 0.7-2.7 mm) in patients with AR grade <2, compared with 3.3 mm 
(interquartile range: 2.0-5.0 mm; p=0.010) in patients with AR grade ≥2. The ratio between 
closed cusp area and STJ area was 0.91 (95% confidence interval: 0.73-1.10) in patients 
without AR and 0.86 (95% confidence interval: 0.74-0.98; p=0.660) in patients with AR.  
 
Aortic valve and root geometry in aortic root dilation patients with central and eccentric AR jet 
There were 15 patients with aortic root dilation with tricuspid aortic valve with AR grade ≥2 
who were divided into two subgroups: patients with central AR jet (n=8, mean age 64±13 
years, 75% men) were compared with patients with eccentric AR jet (n=7, mean age 56±12 
years, 100% men).There were no differences in left ventricular volumes and function between 
these subgroups. Table 3 shows the aortic valve and root geometric measurements in patients 
with aortic root dilation with central AR jet and patients with eccentric AR jet. Patients with 
central AR jet were comparable to those with eccentric AR jet regarding aortic cusps size. 
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Furthermore, there were no significant differences in cusp depth and central coaptation 
deficit. Patients with central AR jet had slightly larger STJ area compared with patients with 
eccentric AR jet. Furthermore, the morphology of the aortic root was different between 
patients with central and eccentric AR jet with more oval AVJ in central AR jet compared to 
eccentric AR jet (eccentricity index 0.75 vs. 0.89; p=0.005).  
 
Table 3: Baseline and echocardiographic characteristics of patients with dilated aortic root and 
tricuspid aortic valve with central vs. eccentric aortic regurgitation 





Age (years) 64±13 56±12 0.284 
Male gender 6 (75%) 7 (100%) 0.509 
Body surface area (m
2
) 2.10±0.16 1.99±0.09 0.123 
Left ventricular end-diastolic volume (ml) 160±58 182±47 0.444 
Left ventricular end-systolic volume (ml)  73±30 80±22 0.637 
Left ventricular ejection fraction (%) 54±4 56±5 0.533 
Cusp height (mm) 18.5 (16.5-20.4) 18.0 (16.7-22.3) 0.908 
Intercommissural distance (mm) 26.3 (25.2-28.3) 26.3 (22.3-31.0) 0.601 
Total closed cusp area (cm
2
) 10.7 (8.9-13.7) 9.4 (8.5-17.6) 0.862 
Total open cusp area (cm
2
) 5.7 (3.6-7.6) 5.7 (4.1-8.7) 0.728 
Central coaptation deficit (mm) 3.7 (2.4-5.8) 2.7 (1.3-4.0) 0.201 
Cusp depth (mm) 10.3 (8.1-11.9) 9.7 (9.3-14.0) 0.907 
AVJ area (cm
2
) 4.7 (3.5-6.0) 5.8 (4.6-7.2) 0.245 
AVJ minimum diameter (mm) 22 (19-24) 26 (23-29) 0.016 
AVJ maximum diameter (mm) 28 (26-31) 30 (25-32) 0.642 
AVJ eccentricity index 0.75 (0.70-0.83) 0.89 (0.84-0.96) 0.005 
SOV area (cm
2
) 12.9 (10.7-15.7) 11.1 (10.0-20.2) 0.602 
SOV minimum diameter (mm) 37 (35-41) 34 (32-42) 0.384 
SOV maximum diameter (mm) 44 (40-51) 42 (40-54) 0.770 
SOV eccentricity index 0.87 (0.80-0.90) 0.80 (0.76-0.85) 0.083 
STJ area (cm
2
) 13.0 (11.7-16.3) 9.7 (7.4-13.6) 0.093 
STJ minimum diameter (mm) 40 (35-41) 32 (29-40) 0.093 
STJ maximum diameter (mm) 44 (40-47) 34 (31-45) 0.131 
STJ eccentricity index 0.91 (0.85-0.95) 0.89 (0.84-0.87) 0.908 
Data are presented as number (percentage), mean ± standard deviation or median (interquartile range). 
AR: aortic regurgitation, AVJ: aortoventricular junction, SOV: sinus of Valsalva, STJ: sinotubular junction. 
 
The ratio between the closed cusp area and the STJ area was different between groups (Figure 
4). Patients with central AR jet had a closed cusp area of 0.75 times the STJ area (95% 
confidence interval: 0.67-0.82) indicating that there was not enough cusp tissue in relation to 
the STJ area to cover the aortic orifice. In patients with an eccentric AR jet, the closed cusp 
area was 1.14 times the STJ area (95% confidence interval: 1.01-1.27) indicating that there was 
excess cusp tissue in relation to the STJ area to cover the aortic orifice area resulting in a 
relative prolapse. 
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Intra-observer and inter-observer variabilities 
The variability in measurements within an observer and between observers was evaluated in 
10 controls. The mean and 95% confidence interval of the difference between two 
measurements were displayed in Table 4. 
 
Table 4: Intra-observer and inter-observer variabilities 
 Intra-observer variability Inter-observer variability 
Cusp height (mm) -0.3 (-1.4 to 0.8) 0.4 (-1.0 to 1.8) 
Intercommissural distance (mm) -0.2 (-2.5 to 2.4) 0.6 (-2.7 to 3.8) 
Total closed cusp area (cm
2
) -0.2 (-0.9 to 0.6) 0.4 (-0.8 to 1.6) 
Total open cusp area (cm
2
) -0.7 (-1.6 to 0.2) -0.2 (-1.7 to 3.3) 
Cusp depth (mm) -0.3 (-2.6 to 2.0) -0.7 (-3.3 to 1.9) 
AVJ area (cm
2
) 0.2 (-0.7 to 1.1) 0.0 (-0.8 to 0.9) 
AVJ diameter (mm) 0.7 (-3.5 to 4.8) 0.3 (-5.7 to 6.2) 
SOV area (cm
2
) -0.4 (1.5 to 2.6) 0.0 (-1.3 to 1.4) 
SOV diameter (mm) -0.6 (-2.9 to 1.7) 0.3 (-3.8 to 4.8) 
STJ area (cm
2
) -0.1 (-1.0 to 0.9) 0.3 (-0.8 to 1.5) 
STJ diameter (mm) -0.1 (-4.1 to 3.9) 0.6 (-2.7 to 3.8) 
Data are presented as mean difference between measurements (95% confidence interval). AVJ: 
aortoventricular junction, SOV: sinus of Valsalva, STJ: sinotubular junction. 
 
Discussion 
The present study hypothesized that adaptation of the aortic valve cusps occurs in aortic root 
dilation. The results can be summarized as follows: patients with aortic root dilation show 
significant enlargement of the aortic valve cusps, however this remodeling seems insufficient 
to match the aortic root area resulting in AR. Various types of AR seem to result from different 
remodeling processes. Central AR was associated with cusp tissue deficiency whereas 
eccentric AR was associated with relative abundance of cusp tissue resulting in relative 
prolapse. 
The aortic valve and root form a complex structure in which the valvular function is largely 
dependent on the aortic root dimensions and morphology. In a normal aortic root, the 
dimensions depend on body size and gender and increase during a life time.
5,6
 Computational 
models have shown that an increase in AVJ diameter was associated with a decrease in 
coaptation height and coaptation area.
9
 Furthermore, in patients with STJ dilation, an increase 
in the ratio between STJ and AVJ was associated with a decrease in the coaptation height 
resulting in an incomplete closure of the aortic valve.
10
 In addition, in models with aortic root 
dilation, the aortic cusps are pulled apart resulting in increased stress (defined as force per 
area) and increased strain (defined as percentage extension of cusp tissue) on the aortic 
cusps.
4
 This may lead to aortic cusp remodeling to bear the higher stress posed on the cusps. 
Studies on valvular biomechanical properties showed increased cellular stiffness of valvular 
interstitial cells in left sided heart valves (aortic valve and mitral valve) as opposed to right 
sided heart valves.
11
 This suggests that valvular interstitial cells respond to increased cusp  




Figure 4: Ratio between closed cusp area and sinotubular junction area in patients with tricuspid aortic 
valve with dilated aortic root and central vs. eccentric aortic regurgitation.  
Linear regression analysis through origin was performed to assess the ratio between closed cusp area and 
sinotubular junction area, which was 0.75 in patients with central aortic regurgitation and 1.14 in 
patients with eccentric aortic regurgitation. AR: aortic regurgitation. 
 
stress by altering cellular stiffness.
12
 Aortic valvular interstitial cells are phenotypically plastic 
and can transdifferentiate into myofibroblasts during cusp remodeling.
13
 However, exact 
changes in aortic cusp biomechanics on a microscopic level in aortic root dilation have not 
been described. Recent studies using advanced noninvasive imaging of the aortic valve suggest 
the presence of differences in aortic cusp size between dilated and normal aortic roots.
14,15
 
Measurements of the aortic valve and root geometry with 3DTEE and computed tomography 
have shown good correlations.
14
 Using computed tomography, Kim et al. showed significant 
changes in aortic cusps sizes in patients with aortic root dilation compared with normal aortic 
roots.
15
 Patients with aortic root dilation had significantly larger aortic cusps compared with 
patients with normal aortic roots. Furthermore, the ratio between the closed cusp area and 
aortic root area was reduced in patients with aortic root dilation without AR and even more 
reduced in patients with AR. In this particular subgroup of patients, AR results from a central 
coaptation defect due to larger aortic root area.
15
 Of note, patients with eccentric AR due to 
aortic valve prolapse were excluded. To understand whether remodeling of the aortic cusps 
also occurs in eccentric AR due to prolapse, Sato et al demonstrated that the prolapsing cusp 
was elongated and expanded in comparison with the other cusps on surgical inspection.
16
 The 
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present study shows that in aortic root dilation patients with eccentric AR, there was a relative 
abundance of cusp tissue which may result in relative prolapse. However, the underlying 
mechanism and whether it is indeed an inappropriate adaptation of the cusps to the increased 
stress due to aortic root dilation remains unclear.  
 
Clinical implications 
The present study provides insight into aortic cusp adaptation in patients with aortic root 
dilation. This might impact on the timing and type of aortic valve reconstructive surgery. 
Insufficient coaptation of aortic valve cusps in aortic root dilation may result in AR. Current 
guidelines recommend aortic valve and root surgery in patients with significant aortic root 
dilation, symptomatic AR or asymptomatic AR with left ventricular dilation or dysfunction.
17
 
However, long-lasting increased stress on the cusps may result in thickening of the cusps with 
implications for reparability of the aortic valve. Furthermore, the mechanism of AR is 
important for the selection of the appropriate technique to reconstruct the aortic valve and 
root complex. In central AR, purely caused by aortic root dilation, valve-sparing root 
replacement techniques (remodeling or reimplantation technique) may be sufficient to reduce 
the aortic root diameter in order to match the aortic valve cusp size.
1
 However, in eccentric 
AR, cusp reconstruction with central cusp plication, triangular resection or cusp resuspension 
may be needed.
1
 In addition to the AR mechanism, the ratio between closed cusp area and STJ 
area might help in determining which aortic valve reconstructive technique is most 




The present study was limited by a small sample size. 3DTEE was performed in all patients and 
controls with the same vendor. The measurements were performed manually by the same 
investigator. In future research, automated measurements may be of incremental value for 
which dedicated software is needed. In addition, although the planes were oriented in order 
to obtain the true short-axis and long-axis of the aortic valve and root, the measurements 
were performed in one plane. Therefore, the cusp length over the belly of the cusp could not 
be determined. In addition, the present software was not able to measure curved lengths such 
as the free edge cusp length. In the present study, histological samples were not available. 
Therefore, it cannot be proved that actual cusp remodeling occurred. To obtain more insight 
into the effects of aortic root dilation on the aortic valve cusps, further research including 
histological samples of aortic valve cusps in dilated aortic root is needed. 
 
  




The present study showed an increase in aortic cusp size in patients with aortic root dilation in 
comparison to patients with normal aortic roots. However, the enlargement seemed 
insufficient to match the aortic root area as indicated by a decrease in closed cusp area to STJ 
area ratio in patients with a dilated aortic root. Furthermore, in patients with tricuspid aortic 
valve and central AR, the cusp area in relation to the aortic root area was small, whereas in 
patients with tricuspid aortic valve and eccentric AR, there was relative abundance of cusp 
tissue resulting in relative cusp prolapse. This provides further insight into aortic valve cusp 
remodeling in patients with aortic root dilation. Additionally, the ratio between closed cusp 
area and STJ area may be helpful in the future to determine the timing and type of aortic valve 
reconstructive surgical technique. 
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Background: Changes in mitral valve geometry in patients with significant aortic regurgitation 
(AR) have not been evaluated. The aim of the present study was to assess the prevalence of 
significant secondary mitral regurgitation (MR; grade ≥2) and the geometrical characteristics 
of the mitral valve in patients with moderate and severe AR (grade ≥2) undergoing aortic valve 
and root surgery.  
Methods: One-hundred twenty patients (mean age, 54±15 years; 65% men) with AR grade ≥2 
undergoing aortic valve and root surgery were retrospectively evaluated. The presence of MR 
grade ≥2 and geometry of the mitral valve were assessed on preoperative transthoracic 
echocardiography. Left ventricular (LV) dimensions and mitral valve geometry were compared 
between patients with MR grade ≥2 and patients without.  
Results: MR grade ≥2 was present in 28 (23%) patients. Patients with MR grade ≥2 had higher 
European System for Cardiac Operative Risk Evaluation II scores and more often used β-
blockers and diuretics than their counterparts. Patients with MR grade ≥2 had larger tenting 
areas (mean, 1.59±0.79 vs. 1.25±0.41 cm
2
; p=0.003), larger inter-papillary muscle distances 
(mean, 28.4±9.5 vs. 24.8±5.2 mm; p=0.014), larger left atria (mean, 40.9±13.7 vs. 32.0±12.2 
ml/m
2
; p=0.002) and lower LV ejection fractions (mean, 47.3±12.2 vs. 54.3±9.3%; p=0.002) as 
compared to patients with MR grade <2. However, there were no differences in indexed LV 
volumes. On multivariate logistic regression analysis, LV ejection fraction (odds ratio: 0.94; 
95% confidence interval: 0.89-0.99; p=0.018) and indexed left atrial volume (odds ratio: 1.05; 
95% confidence interval: 1.01-1.10; p=0.019) remained independently associated with MR 
grade ≥2 after correcting for tenting area and inter-papillary muscle distance. 
Conclusion: Among patients with AR grade ≥2 undergoing aortic valve and root surgery, the 
prevalence of MR grade ≥2 was 23%. Lower LV ejection fraction and larger left atrial volume 
were independently associated with MR grade ≥2.  
 




The prevalence of secondary mitral regurgitation (MR) in patients with significant aortic 
regurgitation (AR) ranges between 6 and 45%.
1,2
 The left ventricular (LV) pressure and volume 
overload caused by significant AR leads to LV dilation, with subsequent changes in papillary 
muscle position and tethering of the mitral leaflets, which may cause coaptation failure and 
regurgitation. The prognostic implications of concomitant secondary MR in patients with 
significant AR are not benign and it has been shown that mitral valve surgery in addition to 
aortic valve surgery is associated with better prognosis.
2
 However, it remains unclear why 
some patients with significant AR have concomitant significant secondary MR while other 
patients do not show MR.
1
 
A pioneer study using three-dimensional transthoracic echocardiography suggested that 
patients with significant AR show significantly larger total mitral leaflet area compared with 
patients without AR, which may reflect mitral leaflet remodeling to prevent failure of mitral 
leaflet coaptation.
1
 However, changes in mitral valve geometry, including the subvalvular 
apparatus in patients with significant AR, have not been evaluated. In addition, the effects of 
confounding factors such as concomitant ischemic heart disease on LV remodeling and 
development of secondary MR in this specific subpopulation have not been elucidated. 
Therefore, the aims of the present study were to investigate the prevalence of significant MR, 
evaluate changes in mitral valve geometry, and investigate the associates of MR in patients 




Pre-operative two-dimensional echocardiograms from 166 patients with AR grade ≥2 referred 
for valve-sparing aortic root reconstruction to the Cardio-Thoracic Surgery department of the 
Leiden University Medical Center from 2001 to 2014 were evaluated. Patients with acute 
endocarditis, connective tissue disease, insufficient image quality, organic mitral regurgitation 
or mitral stenosis were excluded (Figure 1). Clinical characteristics were prospectively 
collected in the departmental cardiology information system (EPD-Vision; Leiden University 
Medical Center, Leiden, The Netherlands) and retrospectively analyzed. Mitral valve geometry, 
MR grade, AR grade, and LV volumes and function were analyzed. Mitral valve geometry was 
compared between patients with moderate or severe secondary MR and patients without. The 
institutional review board approved this retrospective analysis of clinically acquired data and 
waived the need for patient written informed consent. 




Figure 1. Flowchart of the patient inclusion. 
 
Two-dimensional transthoracic echocardiography 
Transthoracic echocardiography was performed preoperatively using commercially available 
ultrasound systems (System Five, Vivid 7, and Vivid E9, GE Vingmed Ultrasound AS, Horten, 
Norway) equipped with 3.5-MHz or M5S transducers. Parasternal, apical, subcostal, and 
suprasternal views were obtained at rest with patients in the left decubitus position. Two-
dimensional and Doppler data were acquired according to current recommendations.
3,4 
The 
echocardiographic data were digitally stored in cine-loop format and data were retrospectively 
analyzed using commercially available software (EchoPAC version 112.0.1, Vingmed 
Ultrasound AS, Horten, Norway). 
AR grade was assessed using a multiparametric approach including the measurement of the 
jet width relative to the LV outflow tract (LVOT) width and the vena contracta in the 
parasternal and apical views. AR was graded as grade 2 (mild-moderate; jet width/LVOT width 
of 0.25-0.45 and/or vena contracta of 3.0-4.5 mm), grade 3 (moderate-severe; jet width/LVOT 
width of 0.46-0.64 and/or vena contracta of 4.6-5.9 mm) or grade 4 (severe; jet width/LVOT 
width ≥0.65 and/or vena contracta ≥6.0 mm).
5
 The severity of secondary MR was 
quantitatively determined by proximal isovelocity surface area method or by measuring the 
vena contracta in the parasternal long-axis view, according to current recommendations.
6
 MR 
was graded as absent when there was no regurgitant jet. Among patients with regurgitant jets, 
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proximal isovelocity surface area method could be performed in 45 patients. In the remaining 
33 patients, vena contracta measurement in parasternal long axis view was used to classify 
MR. Secondary MR was defined as mild (regurgitant volume <15 ml or vena contracta of 0.1-
2.9 mm), moderate (regurgitant volume of 15-29 ml or vena contracta 3-6.9 mm) or severe 
(regurgitant volume ≥30 ml or vena contracta ≥7 mm).  
Mitral valve geometry was assessed in the parasternal long-axis view (Figure 2). 
Retrospectively, the images were zoomed in on the mitral valve. The measurements were 
performed by two independent observers, and values were averaged. The length of 
coaptation between the anterior and posterior mitral leaflets (coaptation length), the distance 
between the annular plane and the coaptation point (coaptation height), and the area 
enclosed between the annular line and the mitral leaflets (tenting area) were measured in 
mid-systole. Anterior and posterior mitral leaflet length was measured in mid-diastole. The 
parasternal short-axis view was used to measure the end-diastolic inter-papillary muscle 
distance. The mitral annulus was measured at end-systole in the apical views. The anterior-
posterior diameter and intercommissural diameter were obtained from the apical four- and 
two-chamber views, respectively. 
Left atrial volume, LV end-diastolic volume and LV end-systolic volume were measured in the 
apical two- and four-chamber views and indexed to body surface area (LAVi, LVEDVi and 
LVESVi). Sphericity index was calculated by dividing the length by the width of the left ventricle 
in the apical four-chamber view, as previously described.
6
 LV ejection fraction (LVEF) was 





After median sternotomy, cardiopulmonary bypass was set through cannulation of the distal 
ascending aorta or the subclavian or femoral artery (in patients with ascending aorta 
pathology). The aorta was incised at the level of the pulmonary artery and resected until the 
sinotubular junction.  
Intraoperatively, the surgeon decided whether a valve-sparing aortic root reconstruction was 
feasible. In these patients, either the sinotubular junction was restored using a vascular graft 
or the native sinuses of Valsalva were resected, a graft was implanted using the reimplantation 
technique (modified David procedure), or the remodeling technique (Yacoub procedure) and 
the coronary buttons were reimplanted.
7,8
 Otherwise, aortic valve and root replacement using 
the Medtronic Freestyle stentless bioprosthesis (Medtronic, Minneapolis, MN) was performed. 
In these patients, the coronary buttons were mobilized, and the aortic root and valve were 
completely excised. The bioprosthesis was then implanted, usually with a 120° clockwise 
rotation, with interrupted sutures at one plane at the level of the nadir of the sinus. 
Thereafter, the coronary buttons were reattached to the bioprosthesis.
9 




Figure 2. Measurements of mitral valve geometry. 
During mid-diastole: mitral valve leaflet length (A) of the anterior mitral leaflet (AML) and the posterior 
mitral leaflet (PML). At mid-systole: coaptation length (B), coaptation height (C) and tenting area (D). 
 
If secondary MR was present, concomitant mitral valve surgery was performed at the 
discretion of the surgeon. In all patients in whom concomitant mitral valve surgery was 
performed, a restrictive ring annuloplasty was used to repair the mitral valve. No mitral valve 




All data analyses were performed using SPSS version 20.0 (IBM, Armonk, NY). Continuous 
variables are reported as mean ± standard deviation or medians and interquartile ranges, as 
appropriate. Categorical variables are reported as counts and percentages. Patients with no or 
mild MR (grade <2) were compared with patients with moderate or severe MR (grade ≥2). 
Continuous and categorical variables were compared by the Student’s t-test (or the Mann 
Whitney U test for variables non-normally distributed) and chi-square test, respectively. Mitral 
valve geometric changes were compared between patients with normal left ventricles (LVESVi 
<31 ml/m
2
) and patients with dilated left ventricles (LVESVi ≥31 ml/m
2
). Multivariate logistic 
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regression analysis was performed to investigate the independent associates of significant 
(moderate or severe) secondary MR. All echocardiographic variables with p-values <0.05 on 
univariate logistic regression analysis were included in the multivariate model. The odds ratio 
and 95% confidence interval were calculated. All statistical tests were two-sided. A p-value 
<0.05 was considered statistically significant. Interobserver and intraobserver variability of 
mitral valve geometric measurements was evaluated using Bland-Altman analysis in 40 
randomly selected patients. Furthermore the coefficients of variation were calculated for 
coaptation length, coaptation height and tenting area. 
 
Results 
A total of 120 patients (mean age, 54±15 years; 65% men) were included in the present 
analysis. AR was grade 2 in 52 patients (43%), grade 3 in 43 patients (36%), and grade 4 in 25 
patients (21%). Forty-two patients (35%) did not have MR. Mild, moderate and severe MR 
were observed in 50 (42%), 25 (21%) and 3 (2%) patients, respectively. The prevalence of 
significant secondary MR (moderate and severe) was 23%. Patients were divided into two 
groups according to the presence and severity of the secondary MR: patients without 
significant secondary MR (n=92) were compared with those with moderate or severe 
secondary MR (n=28). Table 1 shows the differences in baseline clinical characteristics 
between groups.  
Patients were comparable regarding age, gender, and comorbidities. Patients with significant 
secondary MR had a higher frequency of prior myocardial infarction than patients without MR; 
however this difference was not statistically significant. In addition, the presence of 
cardiovascular risk factors and the need for coronary artery bypass grafting was not different 
between patients with and without MR. However, β-blockers and diuretics were more 
frequently used among patients with MR grade ≥2 as compared to their counterparts.  
 
Surgical characteristics 
Patients with moderate or severe secondary MR had a higher European System for Cardiac 
Operative Risk Evaluation II scores (median, 3.6% [interquartile range: 2.5-7.8%] vs. median, 
2.4% [interquartile range: 1.6-4.5%]; p=0.003) compared with their counterparts. Seventy-
three patients (61%) underwent valve-sparing aortic root reconstruction. The  
remaining 47 patients (39%) were considered ineligible for repair during surgery and 
underwent aortic valve and root replacement using the Medtronic Freestyle stentless 
bioprosthesis. Concomitant coronary artery bypass grafting was performed in 25 patients 
(21%). Concomitant mitral valve surgery with restrictive ring mitral annuloplasty was 
performed in 13 patients (11%).  Concomitant tricuspid valve surgery (annuloplasty) was 
performed in 10 patients (8%).  
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Table 1. Baseline characteristics  
Continuous data are presented as mean ± standard deviation or median (interquartile range). Categorical 
data are presented as number (percentage). ACE = Angiotensin converting enzyme, CABG = Coronary 
Artery Bypass Grafting, EuroSCORE: European System for Cardiac Operative Risk Evaluation, MR = Mitral 
Regurgitation, NYHA = New York Heart Association.  
 
Echocardiographic measurements associated with preoperative secondary MR 
The preoperative echocardiographic data are presented in Table 2. LV volumes and mitral 
valve geometric measurements in the parasternal long-axis view were available in all 120 
patients, whereas inter-papillary muscle distance and LAVi were available in 108 patients and 
119 patients, respectively. Coaptation length, coaptation height and lengths of the anterior 
and posterior leaflets were comparable in both groups. Patients with moderate or severe 
secondary MR had larger tenting areas (1.59±0.79 vs. 1.25±0.41 cm
2
; p=0.003) and larger 
inter-papillary muscle distances (28.4±9.5 vs. 24.8±5.2 mm; p=0.014) compared with those 








Age (years) 53.3±15.2 57.7±13.7 0.174 
Male 58 (63%) 20 (71%) 0.556 
Smoking 25 (27%) 7 (25%) 0.989 
Diabetes 3 (3%) 2 (7%) 0.719 
Hypertension 45 (49%) 18 (64%) 0.226 
Dyslipidaemia 20 (22%) 3 (11%) 0.252 
NYHA functional class   1 
 I – II 70 (76%) 21 (75%)  
 III – IV 22 (24%) 7 (25%)  
Creatinine clearance (ml/min) 103±37 85±29 0.023 
Coronary artery disease 16 (17%) 6 (21%) 0.838 
Previous myocardial infarction   0.435 
 Anterior 1 (1%) 1 (4%)  
 Non-anterior 3 (3%) 2 (7%)  
ACE-inhibitor or Angiotensin 
Receptor Blocker 
45 (49%) 19 (68%) 0.123 
Beta-blocker 31 (34%) 18 (64%) 0.008 
Calcium channel antagonist 17 (19%) 2 (7%) 0.253 
Diuretics 25 (27%) 15 (54%) 0.018 
Aortic regurgitation   0.312 
 Grade 2 39 (42%) 13 (46%)  
 Grade 3 36 (39%) 7 (25%)  
 Grade 4 17 (19%) 8 (29%)  
EuroSCORE II (%) 2.4 (1.6-4.5) 3.6 (2.5-7.8) 0.003 
Aortic valve/root technique   0.048 
 repair 51 (55%) 22 (79%)  
 replacement 41 (45%) 6 (21%)  
CABG 19 (21%) 6 (21%) 1 
Mitral valve repair 2 (2%) 11 (39%) <0.001 
Tricuspid valve repair 1 (1%) 9 (32%) <0.001 
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diameters among patients with MR grade ≥2. LVEDVi was comparable between patients with 
and without secondary MR whereas LVESVi was slightly larger (nonsignificant) in patients with 
moderate or severe secondary MR. Consequently, the LVEF was significantly lower in patients 
with moderate or severe secondary MR (47.3±12.2 vs. 54.3±9.3%; p=0.002). 
 











Anterior leaflet length (mm) 24.6±4.1 24.6±4.1 0.970 
Posterior leaflet length (mm) 18.3±3.2 18.9±3.6 0.383 
Coaptation  length  (mm) 7.8±1.7 7.3±1.9 0.273 
Coaptation  height (mm) 8.0±2.3 8.5±2.6 0.287 
Tenting area (cm
2
) 1.25±0.41 1.59±0.79 0.003 
Interpapillary muscle distance (mm) 24.8±5.2 28.4±9.5 0.014 
Mitral annulus AP diameter (mm) 31.0±4.9 33.1±6.0 0.068 
Mitral annulus intercommissural diameter (mm) 31.4±5.2 33.5±5.6 0.068 
LAVi (ml/m
2
) 32.0±12.2 40.9±13.7 0.002 
LVEDVi (ml/m
2
) 77.4±27.9 79.6±28.9 0.715 
LVESVi (ml/m
2
) 36.1±17.5 42.8±23.9 0.104 
Sphericity index 1.59±0.27 1.59±0.25 0.949 
LVEF (%) 54.3±9.3 47.3±12.2 0.002 
Data are presented as mean ± standard deviation. AP = Anterior-Posterior, LAVi = Left Atrial Volume 
indexed for body surface area, LVEDVi = Left Ventricular End Diastolic Volume indexed for body surface 
area, LVEF = Left Ventricular Ejection Fraction, LVESVi = Left Ventricular End Systolic Volume indexed for 
body surface area, MR = Mitral Regurgitation. 
 
Subgroup analysis was performed to assess the effect of LV dilation on the mitral valve 
geometry. LVESVi ≥31ml/m
2
 was defined as abnormal according to current recommendations.
3
 
The left ventricle was dilated in 68 patients (57%), with a mean LVESVi of 49.4±17.6 ml. In the 
remaining 52 patients, the mean LVESVi was 22.2±5.6 ml. In the group of patients with dilated 
left ventricles, larger inter-papillary muscle distances (26.9±7.5 vs. 24.3±5.3 mm; p=0.047), 
larger mitral valve annuli (anteroposterior diameter, 32.7±5.4 vs. 30.0±4.6 mm; p=0.005 and 
intercommissural diameter, 33.6±4.8 vs. 29.7±5.2 mm; p<0.001) and larger left atria (LAVi: 
37.0±12.1 vs. 30.2±13.3 ml/m
2
; p=0.004) were observed. Furthermore, the sphericity index 
and LVEF were significantly lower in patients with dilated left ventricles (1.51±0.20 vs. 
1.69±0.29; p<0.001 and 48.5±10.0 vs. 58.1±8.5%; p<0.001, respectively). Mitral leaflet 
tethering was more pronounced in patients with dilated left ventricles as indicated by larger 
coaptation heights and larger tenting areas (9.0±2.4 vs. 6.9±1.8 mm; p<0.001 and 1.51±0.60 
vs. 1.10±0.34 cm
2
; p<0.001, respectively). Probably as a compensatory mechanism, patients 
with a dilated left ventricles had significant larger mitral leaflets compared with those without 
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dilated left ventricles (anterior leaflet length, 25.9±4.2 vs. 23.0±3.4 mm; p<0.001 and posterior 
leaflet length, 19.4±3.0 vs. 17.2±3.3 mm; p<0.001). This resulted in slightly larger coaptation 
length (7.9±1.8 vs. 7.4±1.6 mm; p=0.151). 
 
Correlates of significant secondary MR in patients with significant AR 
Table 3 presents the results of the logistic regression analysis to assess correlates of significant 
secondary MR in patients with AR. Tenting area, inter-papillary muscle distance, LAVi, and 
LVEF were included as independent variables in the multivariate analysis. However, only LVEF 
(odds ratio, 0.94; 95% confidence interval: 0.89-0.99; p=0.018) and LAVi (odds ratio, 1.05; 95% 
confidence interval: 1.01-1.10; p=0.019) remained independently associated with MR grade ≥2 
after adjusting for the other echocardiographic parameters in the model. 
 
Table 3. Correlates of significant MR in patients with significant AR 
 Univariate analysis Multivariate analysis 
 OR 95% CI p-value OR 95% CI p-value 
Anterior leaflet length (mm) 1.00 0.90-1.11 0.969    
Posterior leaflet length (mm) 1.06 0.93-1.20 0.380    
Coaptation length (mm) 0.87 0.68-1.12 0.272    
Coaptation height (mm) 1.10 0.92-1.31 0.286    
Tenting area (cm
2
) 3.26 1.30-8.17 0.012 1.30 0.43-3.98 0.641 
Interpapillary muscle distance (mm) 1.08 1.01-1.17 0.028 1.05 0.97-1.15 0.230 
Mitral annulus AP diameter (mm) 1.08 0.99-1.17 0.072    
Mitral annulus inter-commissural 
diameter (mm) 
1.08 0.99-1.18 0.071    
LAVi (ml/m
2
) 1.05 1.02-1.09 0.003 1.05 1.01-1.10 0.019 
LVEDVi (ml/m
2
) 1.00 0.99-1.02 0.712    
LVESVi (ml/m
2
) 1.02 1.00-1.04 0.111    
Sphericity index 0.95 0.19-4.86 0.948    
LVEF (%) 0.94 0.90-0.98 0.003 0.94 0.89-0.99 0.018 
Data are presented from univariate and multivariate logistic regression analysis. AP = Anterior-Posterior, 
CI = Confidence Interval, LAVi = Left Atrial Volume indexed for body surface area, LVEDVi = Left 
Ventricular End Diastolic Volume indexed for body surface area, LVEF = Left Ventricular Ejection Fraction, 
LVESVi = Left Ventricular End Systolic Volume indexed for body surface area, OR = Odds Ratio.  
 
Interobserver and intraobserver variability 
Reproducibility of the mitral valve geometric measurements was assessed in 40 randomly 
selected patients. Figure 3 shows the Bland Altman analysis which indicated fair interobserver 
and intraobserver agreement for the measurement of the coaptation length, coaptation 
height, and tenting area. The interobserver and intraobserver coefficients of variation were 
11.3% and 11.9% for coaptation length, 28.0% and 11.2% for coaptation height and 9.4% and 
11.4% for tenting area, respectively. 
 




Figure 3. Interobserver and intraobserver agreement. 
Bland Altman plots for interobserver and intraobserver agreement of the measurement of the coaptation 
length, coaptation height and tenting area 
 
Discussion 
The present evaluation shows that in selected patients with AR undergoing aortic valve and 
aortic root surgery, the presence of significant secondary MR was frequent (23%). Lower LVEF 
and larger LAVi were independently associated with significant secondary MR. 
 
Prevalence of significant secondary MR in patients with significant AR 
The previously reported prevalence of significant MR in patients with significant AR differs 
significantly across the studies (from 6% to 45%).
1,2,10
 These differences are probably due to 
different methodologies to grade MR and different selection of patients. Although some 
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studies included less load-dependent measures to grade MR, such as vena contracta 
diameter,
1,2
 in other studies, MR was graded on the basis of regurgitant jet area.
10
 In terms of 
patients characteristics, Beaudoin et al.
1
 performed a retrospective analysis of an institutional 
echocardiographic database and included all patients with moderate or severe AR without LV 
systolic dysfunction (LVEF>40%), associated degenerative mitral valve disease, or connective 
tissue pathologies (Marfan syndrome), leading to a prevalence of concomitant significant MR 
of 5.6%. In contrast, Pai and Varadarajan
2
 performed a retrospective analysis of patients with 
severe AR with less strict inclusion and exclusion criteria and reported a prevalence of 
significant MR of 45%. The present study included a selected cohort of patients undergoing 
aortic valve and root surgery and further evaluated the differences in mitral valve geometry 
between patients with concomitant significant secondary MR and patients without. The 
prevalence of significant MR was 23%. The inclusion of patients undergoing surgical aortic 
valve replacement may lead to an increased prevalence of significant MR because the 
presence of combined valvular heart disease prompts the treating physician to refer the 
patient for surgical repair or replacement. In contrast, the series described by Beaudoin et al. a 
larger population of patients with moderate or severe AR independently of therapeutic 
management, which may explain the lower prevalence of concomitant significant MR. The 
disparate prevalence rates of the present study and the study by Pai and Varadarajan may be 
attributed to the different methodologies used to grade MR: whereas we used the proximal 
isovelocity surface area method and vena contracta width to grade MR, Pai and Varadarajan 




Mechanisms underlying significant secondary MR in patients with significant AR 
In significant AR, LV volume and pressure overload results in an increase in LV dimensions to 
maintain LVEF. If compensatory LV remodeling fails, LV function deteriorates.
11
 Reduced 
systolic LV function leads to a decrease in closing forces of the mitral valve and MR.
12 
Furthermore, LV dilation results in tethering of the mitral leaflets.
13
 The imbalance between 
decreased closing forces and increased tethering forces may lead to secondary MR.
14
 The 
present evaluation confirmed that in LV dilation due to AR, there is a reduction in LV systolic 
function and more mitral leaflet tethering. Lower LVEF was independently associated with 
significant MR in patients with AR indicating that the main mechanism of MR in these patients 
is the reduction in closing forces. 
Annular dilation is another contributing factor in developing secondary MR in patients with 
significant AR.
14
 However, MR secondary to isolated annular dilation remains controversial, 
and a previous surgical study did not show an association between secondary MR and the 
annular diameter.
15
 Also, in our patient population, although annular diameters increased in 
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patients with dilated left ventricles, there was no significant difference in annular diameters 
between patients with and without significant secondary MR.  
Lastly, it has been shown in both necropsy and echocardiography studies that in patients with 
AR, compensatory mitral valve enlargement occurs and could prevent MR.
1,16
 When this 
compensatory mechanism fails, MR may appear worsening the LV remodeling process and 
causing more severe MR. In our cohort of patients with AR and dilated left ventricles, the 
mitral leaflets were longer, probably in order to increase the coaptation length in an attempt 
to compensate the leaflet tethering. However, there were no significant differences in mitral 
leaflet length between patients with and without significant secondary MR. 
 
Clinical implications 
The present study shows that secondary MR in patients with AR results mainly from an 
imbalance in closing forces and tethering forces. Aortic valve surgery in these patients resolves 
the pressure and volume overload in the left ventricle, which leads to LV reverse remodeling.
17 
In theory, this may result in a decrease in tethering of the mitral valve and subsequently a 
decrease in MR grade. It was recently shown that secondary MR improves after aortic valve 
surgery for AR in the majority of patients.
10
 However, it remains unclear whether this 
improvement is related to restoration of normal mitral valve geometry postoperatively. 
Further research is needed to elucidate the mechanisms of decrease in MR grade after aortic 
valve surgery to determine when additional mitral valve repair is indicated in this specific 
patient population. Prospective randomized trials comparing aortic valve surgery with and 
without additional mitral valve repair would provide the evidence to this unmet clinical need.  
 
Limitations 
The present study was limited by its retrospective nature. The duration of significant AR 
before surgery was not recorded. This may have resulted in a more dilated left ventricle and 
therefore have an effect on the MR grade. Data were acquired over a long period of time and 
the images were not always zoomed on the mitral valve, which may have hampered the 
accuracy of the mitral valve geometric measurements. Patients were followed up at the 
discretion of the treating cardiologist. Changes in MR after aortic valve surgery were not 
evaluated, because systematic echocardiographic follow-up was not available in all patients. 
Furthermore, the cohort consisted of patients referred for valve sparing aortic root 
replacement. The underlying pathology of AR was thus aortic root dilation and/or cusp 
prolapse, because valve sparing surgery is often feasible in these AR mechanisms. There were 
no patients with endocarditis or cusp restriction so results cannot be extrapolated to those 
patients. Also, the present results may not be applicable in a nonsurgical AR cohort. Evaluation 
of mitral regurgitant volume and fraction using proximal isovelocity surface area method was 
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feasible in 58% of patients with a regurgitant jet. In the remaining patients, vena contracta 
was used to grade MR. Measurements of the mitral valve geometry using three-dimensional 
echocardiography may have been more accurate; however three-dimensional 
echocardiography was not available in this cohort.  
 
Conclusion 
Significant secondary MR was present in 23% of patients with significant AR undergoing aortic 
valve and aortic root surgery. Multivariate logistic regression analysis identified lower LVEF 
and larger LAVi as independent associates of significant MR.  
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Background: Bicuspid aortic valve (BAV) anatomy is associated with increased growth rate of 
the aortic root compared to tricuspid aortic valves. Statins decrease the growth rate of 
abdominal aneurysms; however their effect on the aortic root growth rate has not been 
elucidated. The present study evaluated the association between use of statins and aortic root 
growth in patients with BAV. 
Methods: A total of 199 patients (43±15 years, 69% male) with BAV who underwent ≥2 
echocardiographic measurements of the aortic root ≥1 year apart were included in this 
retrospective observational study. Median follow-up duration was 4.7 years (interquartile 
range: 2.7-8.3 years). Growth rate (mm/year) of the aortic root was compared between statin 
users (n=41) and non-users (n=158).  
Results: Statin users were significantly older and had more cardiovascular risk factors than 
their counterparts. Ascending aorta diameter was significantly smaller at baseline and at 
follow-up in statin users compared with non-users when adjusted for coronary artery disease, 
age and medication. The average annual growth rate was 0.08 mm/year (95% confidence 
interval: 0.03-0.13) for the aortoventricular junction, 0.16 mm/year (0.11-0.21) for the sinus of 
Valsalva, 0.12 mm/year (0.07-0.17) for the sinotubular junction and 0.45 mm/year (0.37-0.53) 
for the ascending aorta. The dilation rate of the aortic segments was not different between 
statin users and non-users.  
Conclusion: In patients with bicuspid aortic valve, although the use of statins was associated 
with smaller ascending aorta, the annual dilation rate of the aortic root was not influenced by 
the use of statins.  
 
 




Patients with bicuspid aortic valve (BAV) anatomy have shown larger aortic root diameters and 
faster growth rate of the ascending aorta compared with patients with tricuspid aortic valve 
(TAV) anatomy leading to an excess risk of dissection and rupture in the former patients.
1
 The 
average growth rate of the ascending aorta in patients with BAV is 0.77 mm/year, 5-fold 
higher than that of age-matched TAV patients.
2
 Pathophysiological factors associated with the 
increased prevalence of ascending aorta dilation and faster growth rate among BAV patients 
include abnormal wall stress distribution (particularly in patients with dysfunctional aortic 
valves), altered aortic wall structure and/or an underlying genetic substrate.
3
 Specifically, 
increased activity and expression of metalloproteinases have been demonstrated in 
histological samples of ascending aorta aneurysms of patients with BAV.
4
 The pleiotropic 
effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) reduce the 
expression of metalloproteinases
5,6
 and have been demonstrated to limit the growth rate of 
abdominal aneurysms and to improve the thoracic and abdominal aortic aneurysm rupture 
and dissection–free survival.
7-11
 In patients with BAV, the use of statins has been associated 
with smaller aortic root and ascending aorta diameters in cross-sectional studies.
12
 However, 
the effect of statins on the aortic root and ascending aorta growth rate of these patients 
remains unclear. Accordingly, we evaluated the effect of statins on the aortic root and 




The present retrospective study included patients aged ≥18 years with BAV who underwent 
transthoracic echocardiography surveillance from 1995 to 2014 for at least 1 year. If patients 
underwent aortic valve and/or aortic root surgery during follow-up, the last transthoracic 
echocardiography before surgery was selected for analysis. Patients with complex congenital 
heart disease, connective tissue disease and subvalvular aortic stenosis were not included. In 
total 262 patients were eligible for inclusion. From this group, 48 patients with coarctation of 
the aorta and 15 patients with an ascending aorta of ≥45mm at baseline were excluded. The 
final cohort consisted of 199 patients (Figure 1).  
Demographic and clinical characteristics were collected in the departmental Cardiology 
Information System (EPD-Vision®, Leiden University Medical Center, Leiden, The Netherlands) 
and retrospectively analyzed. Medication use (statins, angiotensin converting enzyme-
inhibitors / angiotensin receptor blockers and beta-blockers) were obtained from chart review. 
Patients were divided into two groups: patients treated with statins for at least 50% of the 
follow-up time (statin users) and patients not treated with statins (non-users). 




Figure 1. Flowchart of patient inclusion 
 
Aortic root diameters were measured at 4 levels and annual growth rate in mm/year was 
compared between the two groups. The institutional review board approved this retrospective 
analysis of clinically acquired data and waived the need for patient written informed consent. 
 
Two-dimensional transthoracic echocardiography 
Transthoracic echocardiography was performed using commercially available ultrasound 
systems (System Five, Vivid 7, and E9, General Electric Healthcare, Vingmed, Horten, Norway) 
equipped with 3.5-MHz or M5S transducers. Parasternal and apical views were obtained at 
rest with patients in the left decubitus position while subcostal and supra-sternal views were 
obtained with patients in supine position. Two-dimensional, M-mode and Doppler data were 
acquired according to current recommendations.
13
 The echocardiographic data were digitally 
stored in cine-loop format and data were retrospectively analysed off-line using commercially 
available software (EchoPac 112.0.1, GE Medical Systems, Horten, Norway). Left ventricular 
(LV) end-diastolic and end-systolic diameters were measured in the M-mode parasternal long-
axis view recordings. LV end-diastolic and end-systolic volumes were measured in the apical 2- 
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BAV was diagnosed on the parasternal short-axis view of the aortic valve by the presence of 
two commissures in systole.
14
 BAV was typical when the commissures were oriented at 4-10, 
5-11 or 3-9 o’clock and atypical when the commissures were oriented at 1-7 or 12-6 o’clock. 
The presence of a raphe was noted.
14
 Aortic valve function was evaluated using colour-
Doppler, continuous- and pulsed-wave Doppler. Valvular dysfunction was defined as pure 
aortic regurgitation when ≥ grade 2 and less then mild aortic stenosis, pure aortic stenosis 
when ≥ moderate and aortic regurgitation ≤ grade 1 or mixed aortic aortic valve disease.
15,16
  
Aortic root dimensions were measured using the leading edge-to-leading edge technique 
during end-diastole in the parasternal long-axis view perpendicular to the long-axis of the 
aorta at 4 predefined levels: (1) the aortoventricular junction (AVJ) defined as the hinge points 
of the aortic leaflets, (2) the sinuses of Valsalva (SOV), (3) the sinotubular junction (STJ) and (4) 





Continuous variables were reported as mean ± standard deviation or median and interquartile 
range when appropriate. Categorical variables were reported as numbers and percentages. 
Continuous and categorical variables were compared with the Student’s t-test (or Mann 
Whitney U test in non-normally distributed variables) and Chi-square test, respectively.  
Differences in aortic root diameters at baseline and follow-up between groups were assessed 
with ANOVA test for repeated measures. Statin use was incorporated in the model as factor 
together with coronary artery disease, use of beta-blockers and the use of angiotensin 
converting enzyme-inhibitors or angiotensin receptor blockers. Age at baseline was 
incorporated in the model as covariate. Estimated marginal means ± standard error of the 
mean for the aortic root diameters were reported for statin users and non-users at baseline 
and during follow-up.  Regression analysis was used to assess the difference in aortic root 
growth rate in mm/year between statin users and non-users following the previously 
described instrumental variables approach.
19
 Assuming that the aortic root growth is linear, 
the estimate of the association between aortic root growth and the follow-up was obtained by 
linear regression analysis without including an intercept. Next statin use multiplied by follow-
up duration in years was introduced to assess the additive value of statin use on the growth of 
the aortic root in mm/year. Intra-observer variability was assessed using Bland-Altman 
method measuring 20 echocardiograms repeatedly by one observer. Similarly, inter-observer 
variability was assessed by performing the measurements by two independent observers at 
least 1 week apart. All statistical tests were two-sided. A p-value<0.05 was considered 
statistically significant. Data analyses were performed using the SPSS software (Version 20.0. 
Armonk, NY: IBM Corp). 
  




A total of 199 patients (mean age 43±15 years, 69% men) were included in the present 
analysis. There were 41 (21%) statin users and 158 (79%) non-users. Baseline characteristics 
are presented in Table 1. Among statin users, the median duration of the treatment was 3.5 
years (interquartile range: 2.4-5.4 years). The types and doses of statins varied over time and 
were adjusted to patient’s tolerance. The majority of patients received simvastatin (usually 20 
mg or 40 mg daily) or rosuvastatin (usually 10 mg daily). Other types of statins used were 
atorvastatin and pravastatin (usually 20 mg or 40 mg daily).  
 
Table 1. Baseline characteristics  





Age (years)  40±14 55±10 <0.001 
Male   106 (67%) 31 (76%) 0.389 
Body surface area (m
2
) 1.93±0.23 1.98±0.21 0.189 
Smoking  29 (18%) 12 (29%) 0.186 
Diabetes  4 (3%) 3 (7%) 0.314 
Hypertension  26 (16%) 14 (34%) 0.021 
NYHA Functional Class   <0.001 
 I 145 (91%) 27 (66%)  
 II 9 (6%) 12 (29%)  
 III 4 (3%) 2 (5%)  
 IV 0 (0%) 0 (0%)  
Previous cardiac surgery 4 (3%) 4 (10%) 0.098 
Coronary artery disease 1 (1%) 15 (37%) <0.001 
ACE-inhibitor or ARB 32 (20%) 25 (61%) <0.001 
Beta-blocker 32 (20%) 24 (59%) <0.001 
Total cholesterol (mg/dl) 195±36 198±47 0.690 
LDL cholesterol (mg/dl) 120±32 136±46 0.071 
Triglycerides (mg/dl) 128±63 154±85 0.081 
HDL cholesterol (mg/dl) 57±17 49±14 0.028 
LV end-diastolic diameter (mm) 50±6 49±6 0.160 
LV end-systolic diameter (mm) 31±6 31±7 0.994 
LV end-diastolic volume (ml) 131±39 120±27 0.089 
LV end-systolic volume (ml) 62±24 59±17 0.450 
LV ejection fraction (%) 53±7 51±7 0.054 
Atypical bicuspid aortic valve 45 (28%) 11 (27%) 0.988 
Raphe 135 (85%) 37 (90%) 0.586 
Valvular dysfunction    0.274 
 None 99 (63%) 27 (66%)  
 Pure aortic regurgitation 27 (17%) 6 (15%)  
 Pure aortic stenosis 21 (13%) 8 (19%)  
 Mixed aortic disease 11 (7%) 0 (0%)  
Data are presented as mean ± SD or as number (percentage). ACE: Angiotensin converting enzyme. ARB: 
Angiotensin Receptor Blocker. HDL: high density lipoprotein. LDL: low density lipoprotein. LV: left 
ventricular. NYHA: New York Heart Association.  
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Figure 2. Comparison of aortic diameters at baseline and at follow-up between statin users and non-
users. 
Data are presented as estimated marginal means ± standard error of the mean calculated for mean age 
at baseline of 43 years and corrected for the presence of coronary artery disease and the use of 
angiotensin converting enzyme-inhibitors or angiotensin receptor blockers and beta-blockers. 
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Statin users were significantly older, with greater incidence of coronary artery disease, 
hypertension and New York Heart Association II-III functional class heart failure symptoms. 
Furthermore, statin users received more frequently angiotensin converting enzyme-inhibitors 
/ angiotensin receptor blockers and beta-blockers. There was no significant difference 
between groups in total cholesterol levels at baseline. However, in statin users there was a 
tendency towards higher LDL-cholesterol and higher triglycerides. Furthermore the HDL-
cholesterol was significantly lower in statin users compared to their counterparts. There was 
no significant difference in LV end-diastolic and end-systolic dimensions. Statin users had 
slightly lower LV ejection fraction compared to non-users (51±7% vs. 53±7%; p=0.054). The 
presence of a raphe, type of bicuspid aortic valve and aortic valvular dysfunction was not 
significantly different between statin-users and non-users. 
Echocardiographic follow-up was complete with a median follow-up duration of 5.1 years 
(interquartile range: 2.7-8.8 years) in non-users and 3.9 years (interquartile range: 2.6-5.5 
years) in statin users (p=0.052).  
Figure 2 shows the differences in aortic root diameters at baseline and during follow-up 
between the groups, using the ANOVA test for repeated measurements adjusted for age at 
baseline, the presence of coronary artery disease and the use of angiotensin converting 
enzyme-inhibitors or angiotensin receptor blockers and beta-blockers. The aortic root 
diameter at the level of the AVJ was not significantly different between statin users and non-
users. Aortic root diameter at the level of the SOV was comparable at baseline and at follow-
up in statin users (32.7±0.8 mm and 33.5±0.9 mm) compared to non-users (34.3±0.8 mm and 
35.2±0.9 mm). At the level of the STJ, the diameter was significantly smaller in statin users 
compared to non-users at baseline (27.8±0.8 mm vs. 30.3±0.8 mm; p=0.013). However, there 
was no significant difference in STJ diameter at follow-up. The AAo was significantly smaller in 
statin users compared to non-users at baseline (30.8±0.9 mm vs. 34.7±0.9 mm; p=0.001) and 
at follow-up (33.2±1.0 mm vs. 36.3±1.0 mm; p=0.014). The average annual aortic growth rate 
was 0.08 mm/year (95% confidence interval: 0.03-0.13) for the AVJ, 0.16 mm/year (0.11-0.21) 
for the SOV, 0.12 mm/year (0.07-0.17) for the STJ and 0.45 mm/year (0.37-0.53) for the AAo. 
There was no significant additive value of statin use on the annual growth rate of the aortic 
segments as presented in Table 2.   
The intra-observer variability, displayed as 1.96 times the standard deviation of the difference 
between the two measurements was 1.6 mm for the AVJ, 3.2 mm for the SOV, 4.2 mm for the 
STJ and 5.1 mm for the AAo. The inter-observer variability was 2.6 mm for the AVJ, 3.9 mm for 
the SOV, 4.3 mm for the STJ and 4.4 mm for the AAo.   
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Table 2. Average annual growth rates in mm/year per aortic segment with the additive effect of the 
use of statins on the annual growth rate 
 Annual growth rate Additive effect of the use of 
statins on annual growth rate 
 B (95% CI) p-value B (95% CI) p-value 
Aortoventricular junction 0.08 (0.03 – 0.13) 0.001 -0.03 (-0.16 – 0.11) 0.687 
Sinus of Valsalva 0.16 (0.11 – 0.21) <0.001 -0.06 (-0.20 – 0.08) 0.413 
Sinotubular junction 0.12 (0.07 – 0.17) <0.001 0.13 (-0.02 – 0.28) 0.079 
Ascending aorta 0.45 (0.37 – 0.53) <0.001 -0.05 (-0.27 – 0.17) 0.671 
Data are presented as regression coefficient (B) and 95% confidence interval (95% CI) indicating annual 
growth rates in mm/year.  
 
Discussion 
The main results of the present observational study can be summarized as follows: among 
patients with BAV, those treated with statins had smaller STJ at baseline and smaller AAo at 
baseline and at follow-up compared with patients non-treated with statins after correcting for 
age, presence of coronary artery disease and the use of angiotensin converting enzyme-
inhibitors or angiotensin receptor blockers and beta-blockers. However, there was no 
significant effect of statins on the annual aortic growth rate since this was comparable 
between both subgroups of patients. 
Bicuspid aortic valve is the most frequent congenital heart disease with an estimated 
prevalence of 1.3% in the general population.
20 
In addition, BAV anatomy is associated with 
aortopathy and increased prevalence of aneurysms of the ascending aorta which occur at a 
younger age than in TAV.
2,21
 Specific genotypes, histological and inmunohistochemical factors 
and changes in hemodynamics with increased shear stress on the aortic wall have been 
associated with increased risk of ascending aortic dilation in patients with BAV.
21-23
 Indeed, in 
patients with BAV the growth rate of the aortic root and ascending aorta ranges between 0.2 
and 0.9 mm/year,
9,24
 a growth rate relatively similar to that observed in patients with Marfan 
syndrome but significantly different from that of patients with TAV and degenerative 
aortopathy.
24
 In a recent study involving 353 patients with BAV who were compared with 51 
patients with degenerative aortopathy and 50 patients with Marfan syndrome, Detaint et al. 
showed that in patients with BAV the maximal dilation rate was 0.42±0.6 mm/year while in 
patients with Marfan syndrome and in patients with degenerative aortopathy the maximal 
dilation rate was 0.49±0.5 mm/year and 0.20±0.3 mm/year, respectively (p=0.02).
24
 
Interestingly, the growth rate was largest at the ascending aorta in patients with BAV 
(0.42±0.6 mm/year) while in patients with Marfan syndrome, the sinuses of Valsalva showed 
the largest growth rate (0.49±0.5 mm/year). The present study shows similar growth rates for 
each level of the aortic root and ascending aorta to those reported by Detaint et al. with the 
ascending aorta as the segment with the largest growth rate. However, Detaint et al. did not 
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find an independent association between aortic growth rate and the use of angiotensin 
converting enzyme inhibitors, angiotensin receptor blockers or beta-blockers.
24 
The present 
study also did not find an association between the use of angiotensin converting enzyme-
inhibitors / angiotensin receptor blockers and beta-blockers and the aortic root diameters at 
baseline and during follow-up. In contrast, the present study provides information on the 
association between statin use and the aortic growth rate of these patients.    
The pathogenesis of ascending aorta dilation in patients with BAV is multifactorial and, in 
contrast to abdominal aortic aneurysms, ascending aorta aneurysms do not result in 
atherosclerosis.
25
 However, in patients with BAV, there is an increased expression and activity 
of metalloproteinases that degrade the type IV collagen, elastin and fibrillar collagens.
4
 Statins, 
clinically used as lipid lowering drugs, have various anti-inflammatory and pleiotropic effects.
6
 
Therefore it has been hypothesized that statins may have an inhibitory effect on aneurysm 
formation. For example, in experimental models statins have shown to inhibit the progression 
of abdominal aortic aneurysms independently of the total serum cholesterol levels lowering 
effect.
5,6
 Inhibition of macrophage infiltration into the aorta and preservation of aortic wall 




Clinical experiences have shown that patients with BAV who receive statin therapy have 
smaller ascending aorta diameters compared to non-users.
12
 In 147 patients with BAV 
undergoing aortic valve replacement with or without aortic root replacement, Goel et al. 
showed that patients treated with statins had significantly smaller ascending aorta diameters 
than patients not receiving statins (3.6±0.7 cm vs. 3.9±0.6 cm, p<0.001) and the use of statins 
was independently associated with a 0.33 cm reduction in aortic size.
12
 Furthermore, Jovin et 
al. showed that in patients with thoracic aneurysms (without specifying the prevalence of 
BAV), the annual growth rate of the thoracic aortic aneurysm in patients treated with statins 
(n=46) was comparable to that of patients not treated with statins (n=169) (0.8 mm/year vs. 
0.9 mm/year, p=0.7).
9
 Angeloni et al. recently published a large propensity score matched 
cohort study that showed a significantly smaller ascending aorta dilation rate of 0.95 mm/year 
in statin users compared to 1.27 mm/year in non-users.
11
 The reported dilation rates were 
both larger than those reported in the present study, which might be explained by the 
inclusion of larger ascending aortic aneurysms at baseline in the study by Angeloni et al.
11
 
However, it should be emphasized that the anatomy of the aortic valve was not specified and 
that the age of the population was older than that of the patients included in our study and 
therefore, the results reported by Angeloni and coworkers may not be extrapolated to a 
younger BAV patient cohort.  
 
  




Ascending aorta dilation is the second most common morbidity in patients with BAV.
1
 Due to 
the associated risk of aneurysm rupture, identification of pathophysiological determinants and 
potential therapeutic targets to reduce the risk of aortic dilation is a cardiovascular research 
priority. Besides advances in multimodality imaging that permit accurate diagnosis and 
characterization of BAV and its hemodynamics; genetic- and biomarker-based risk 
stratification may help to identify those patients at increased risk of aortic dilation. In addition, 
prospective studies evaluating the effect of specific therapies such as statins that may reduce 
the expression and activity of metalloproteinases or angiotensin converting enzymes inhibitors 
that may favourably affect the shear strain of the aortic wall are needed.  
 
Limitations 
The present study, taking into consideration all the limitations of an observational 
retrospective design, shows that the use of statins is associated with smaller aortic root and 
ascending aorta dimensions in patients with BAV but does not influence the growth rate. 
Therefore, it cannot be concluded that BAV patients without an indication for statins, should 
use a statin as primary prevention for aortic dilation. The relatively small number of patients 
treated with statins is also another limitation. In addition, patients using statins were different 
from non-users regarding age, presence of coronary artery disease and the use of angiotensin 
converting enzyme-inhibitors, angiotensin receptor blockers and beta-blockers. We corrected 
the statistical analysis for these important confounding factors. However, the influence of 
potential other unknown confounding factors could not be taken into account. Prospective 
trials with appropriate sample sizes randomizing patients to statin treatment or placebo are 
needed to assess the isolated effect of statins on aortic root dilation excluding potential 
confounding factors (such as cardiovascular risk factors and other drugs used). Other 
limitations of the present study include the evaluation of a selected cohort of patients with at 
least 2 echocardiographic studies ≥1 year of follow-up. This may have introduced selection 
bias, since patients with large or rapid growing aneurysms will be referred immediately for 
surgery. Furthermore, compared with other imaging techniques that provide higher spatial 
resolution data, transthoracic echocardiography may provide less accurate measurements of 
the aortic root and ascending aorta diameters. However, in this study we used linear 
regression analysis to assess the dilation rate following the previously described instrumental 
variables approach which mitigates problems associated with random errors such as 
measurement variability.
19
 There was a wide variety in the type and doses of drugs taken by 
the patients included in the present study. Also within patients, the type and dose of drug 
could change during follow-up. Therefore a more precise analysis per type and dose of statins 
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was not feasible. Future studies may provide further insight into the differences between 
types of statins and their effects on the aortic root dilation rate. 
 
Conclusion 
In conclusion, in patients with BAV, the use of statins is associated with smaller STJ and AAo 
diameters when corrected for confounding factors. However, the annual growth rate of the 
aortic root and ascending aorta was not influenced by the use of statins.  
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Background: The underlying mechanism of aortic regurgitation, aortic valve and root 
characteristics have been associated with the durability of surgical repair. We investigated 
whether multidetector CT (MDCT) identifies the characteristics of the aortic valve and root 
that may be associated with the ability to perform successful surgical repair.  
Methods: Sixty-one patients with aortic regurgitation and/or aortic root pathology who were 
evaluated for aortic valve or root repair and underwent clinically indicated gated or non-gated 
MDCT of the aortic valve and aortic root were included in the present analysis. Patients with 
endocarditis were excluded. MDCT data of aortic valve anatomy and calcification and thoracic 
aorta dimensions were analyzed.  
Results: The aortic valve and root was successfully repaired in 36 patients (55±13 years; 61% 
male; median EuroSCORE II, 3.8%) whereas in 25 patients (56±15 years; 52% male; median 
EuroSCORE II, 2.5%) repair was not attempted (n=20) or valve repair was converted to aortic 
valve replacement during surgery (n=5). In patients in whom repair was considered not 
possible or failed, there was a higher percentage of bicuspid aortic valves (48% vs. 17%; 
p=0.019), more severe commissural calcification, and more severe annular calcification.  
Conclusion: The degree of commissural and annular calcification of the aortic valve 
determined by MDCT is inversely related to the ability to perform surgical valve repair instead 
of replacement. Similarly, bicuspid valve anatomy predicts failure to perform repair. 




Valve-sparing aortic root replacement techniques are successfully performed in selected 
patients with aortic regurgitation (AR) and/or aortic root pathology.
1-4
 The underlying 
mechanism of the AR and several morphological characteristics of the aortic valve and root 
have been associated with durable aortic valve repair.
5 
Based on direct surgical inspection, a 
classification of AR mechanisms has been developed to guide the decision and feasibility of 
surgical aortic valve repair.
6
 In AR type 1 (functional aortic annulus dilation) and AR type 2 
(cusp prolapse), different aortic root and valve repair techniques may be applied unless the 
valve is heavily calcified. In contrast, in AR type 3 (cusp restriction), repair techniques are not 
recommended as the risk of failed repair and recurrent significant AR is high.
6
 In addition, wide 
preoperative aortoventricular junction (AVJ) is associated with recurrence of AR after aortic 
valve repair.
7 
Two-dimensional transesophageal echocardiography (TEE) has been applied: (1) to identify the 
underlying mechanism of AR, (2) to characterize the anatomy and morphology of the aortic 
valve, (3) to assess geometry of the aortic root, and (4) to predict surgical reparability.
5
 
However, 2-dimensional TEE underestimates the diameters of the functional aortic annulus as 
compared with multidetector CT (MDCT).
8,9
 MDCT provides high-spatial resolution data of the 
aortic valve and root characteristics and permits qualitative (morphology of aortic valve and 
root, extent of annulus, cusps and commissural calcification) and quantitative (dimensions) 
evaluation of the aortic valve and root that may be relevant for decision making.
10
 The aim of 
the present study was to investigate whether MDCT provides preoperative insight into 
characteristics of the aortic valve and root that may be associated with feasible and successful 




The institutional ethical committee approved this retrospective evaluation of clinically 
acquired data and waived the need for individual written patient consent. A total of 168 
patients with AR and/or aortic root pathology were evaluated for surgical valve-sparing aortic 
root repair at the Leiden University Medical Center between 2003 and 2013. Patients with 
available preoperative MDCT data of the aortic valve and root were considered eligible for the 
present study. Patients with endocarditis were excluded. The study population consisted of 61 
patients with AR and/or aortic root pathology. MDCT data of aortic valve anatomy and 
calcification and aortic root dimensions were analyzed and compared between patients who 
underwent successful valve-sparing aortic root repair (defined as postoperative AR <grade 2) 
and patients in whom repair was not successful or not feasible and who eventually underwent 
aortic root replacement using the Freestyle stentless bioprosthesis (Medtronic; Minneapolis, 
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MN). Clinical and surgical data were collected in the departmental cardiology information 
system (EPD-Vision; Leiden University Medical Center, Leiden, the Netherlands) and 
retrospectively analyzed.  
 
Multi-detector row computed tomography 
MDCT studies were performed to evaluate the presence and extent of aortic root pathology 
within the Leiden University Medical Center in 40 patients with a 320-slice, 64-slice or 16-slice 
MDCT scanner (Aquilion; Toshiba Medical Systems, Tokyo, Japan). In the remaining 21 
patients, the MDCT studies were performed at the referral hospitals. MDCT angiography data 
acquisition extended from above the aortic arch to the diaphragm, including the entire 
thoracic aorta. MDCT data were acquired during breathhold in deep inspiration, with tube 
potential of 100 or 120 kV and tube current adapted to body habitus, with intravenous 
contrast enhancement and no electrocardiographic triggering in 77% of patients. In 14 (23%) 
patients, the scans were electrocardiographically triggered at 45% or 75% of the R-R interval. 
Data were reconstructed with a slice thickness of 0.5 to 5 mm. All the MDCT datasets were 
loaded for off-line analysis to a dedicated remote workstation (Vitrea FX 1.0; Vital Images, 
Minnetonka, MN). MDCT angiography was not performed in patients with chronic kidney 
disease stage 4 or 5. Chronic kidney disease stage 3 (estimated glomerular filtration rate: 30-
59 ml/min) was present in 8 patients. These patients were hydrated orally or intravenously 
before and after MDCT to prevent contrast-induced nephropathy. 
Data analysis was performed by 2 experienced observers blinded to the reparability of the 
valve. Anatomy of the aortic valve (tricuspid or bicuspid), the degree of calcification of aortic 
valve, and AVJ
10,11
 and the diameter of thoracic aorta at 10 different levels were evaluated.
12,13
   
Three orthogonal multiplanar reformation (MPR) planes were oriented to obtain the cross 
sectional plane parallel to the AVJ, just below the hinge points of the coronary cusps.
11
 
By orienting the reconstructed single-oblique sagittal and coronal views across the aortic 
annulus, the true short-axis of the AVJ was displayed on the reconstructed double-oblique 
transverse view.
11
 On this view, the anatomy of aortic valve (tricuspid or bicuspid) was 
identified, and the grade of commissural calcification was qualitatively assessed based on a 
scale from 0 to 3 (0= no calcification, 1= small calcium spots <5mm, 2= several calcium lesions 
>5mm and 3= heavy calcification of all cusps; Figure 1).
10,11
 In addition, annular calcification 
was also visually assessed on a scale from 0 to 3 (0= no calcification, 1= 1 or multiple spots 
<5mm or one spot >5mm, 2= 2-3 spots >5mm and 3= >3 spots of >5mm diameter; Figure 1).
10
 
From the double-oblique view the centerline was determined and on the orthogonal coronal 
and the single-oblique sagittal views, the coronal, and sagittal AVJ diameters were measured
11
 
(Figure 2) and the average diameter was calculated.  
 




Figure 1. Classification of commissural and annular aortic valve calcification.  
Commissural calcification was classified as grade 0 when there was no calcification, grade 1 when there 
were small calcium spots <5mm (A) or grade 2 when there were several calcium lesions >5mm (B). 
Annular calcification was considered grade 0 when there was no calcification, grade 1 when there were 
one or multiple spots <5mm or one spot >5mm (C) or grade 2 when there were 2-3 spots >5mm (D). Scans 
were acquired at 45 or 75% of R-R interval on 320-slice MDCT-scanner with tube potential of 100 or 120 
kV and tube current adapted to body habitus. 
 
The AVJ shape was evaluated by calculating the eccentricity index =1-(sagittal/coronal 
diameter); when the result of the equation was ≥0.1 the aortic annulus was considered 
ellipsoid.
14
 Next, the diameter of the sinus of Valsalva (SOV) and sinotubular junction (STJ) at 
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Figure 2. Measurement of aortoventricular junction on MDCT.  
The 3 orthogonal multiplanar reformation planes (green, red and blue lines) were oriented on the single 
oblique sagittal (A) and coronal view (B) to visualize on the reconstructed double oblique transverse view 
(C) the true cross sectional plane of aortoventricular junction, just below the hinge points of the coronary 
cusps. The sagittal and coronal aortoventricular junction diameters, pointed by the blue arrows, were 
measured at the corresponding view (A and B respectively). In this example, the scan was acquired not 
electrocardiographically triggered on 16-slice MDCT-scanner with tube potential of 100 kV and tube 
current adapted to body habitus. 
 
The diameters of the different levels of the thoracic aorta (at the level of the tubular ascending 
aorta, proximal and distal to the innominate trunk, proximal and distal to the left subclavian 
artery, proximal descending aorta and at the level of the diaphragm) were measured using the 
standard 3 MPR planes; the single-oblique and the coronal view were adjusted at each level to 
visualize the true cross-sectional view of each level at the double-oblique transverse view 





Figure 3. Measurement of thoracic aorta at the level of descending aorta on MDCT. 
By using the standard orthogonal 3 multiplanar reconstruction planes (green, red and blue lines); the 
single oblique sagittal view (A) and the coronal view (B) were adjusted at descending aorta level to 
visualize the true cross sectional view at the double oblique transverse view (C). Then, the aortic diameter 
of descending aorta was measured (blue arrow) at the single oblique sagittal view (A). In this example, 
the scan was acquired not electrocardiographically triggered on 16-slice MDCT-scanner with tube 
potential of 100 kV and tube current adapted to body habitus. 
 
  




After median sternotomy, cardiopulmonary bypass was set through cannulation of the 
proximal part of the aortic arch or through femoral or preferably subclavian arterial route in 
patients with ascending aorta dissection or dilation. The aorta was transected at 2 cm above 
the ostium of the right coronary artery. The aortic root and valve were inspected by the 
surgeon and based on the AR mechanism, classified as type 1 (AR due to aortic root dilation), 
type 2 (AR due to cusp prolapse) or type 3 (AR due to cusp restriction).
6 
Valve-sparing aortic 
root reconstruction was considered a feasible option in most type 1 and type 2 ARs unless 
heavy calcification of the aortic valve. If feasible, a vascular graft was implanted using either 
the reimplantation technique (modified David procedure) or the remodeling technique 
(Yacoub procedure) as previously described, with reimplantation of the coronary buttons.
15,16
 
In some cases, only the STJ was restored using a vascular graft.
17
 Concomitant cusp repair 
techniques such as triangular resection, central cusp plication, resuspension, or shaving of the 
cusps were performed if needed.
18
  
In patients with aortic valve and root considered non-reparable, aortic root replacement was 
performed using the Freestyle stentless bioprosthesis. The SOV and the aortic valve were 
excised. The bioprosthesis was then implanted with a 120° clockwise rotation with interrupted 








All data analyses were performed using the SPSS 20.0 (SPSS, Chicago, IL). Categorical variables 
were reported as frequencies and percentages. Continuous variables were displayed as mean 
± standard deviation if normally distributed and as median and interquartile range if non-
normally distributed. Differences between patients who underwent surgical valve-sparing 
aortic root reconstruction and patients who underwent aortic valve replacement were 
analyzed using the chi-square test, the unpaired Student t-test or Mann-Whitney U test as 




The clinical characteristics of the patient population (mean age 56±14 years; 57% men) are 
listed in Table 1. Aortic valve and root repair was performed successfully in 36 patients (59%), 
with postoperative <grade 2 AR. The David reimplantation technique was performed in 24 
patients (67%). The Yacoub remodeling technique was performed in 2 patients (6%). In the 
remaining 10 patients (28%), restoration of the STJ was performed. Additional subcommissural 
annuloplasty (so called Cosgrove stitches) was executed in 3 patients to diminish the AVJ 
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dimension. Various cusp repair techniques were performed in 9 patients (25%). Furthermore, 
in 25 patients (41%) aortic valve repair techniques were considered not feasible or 
unsuccessful. In 5 of these 25 patients, repair of the aortic valve and root was initially 
attempted but the residual postoperative AR grade was >2 and were converted to aortic root 
replacement using the Freestyle stentless bioprosthesis. The clinical characteristics of both 
groups of patients (aortic valve or root repair group and nonreparable group) were similar 
(Table 1). 
 
Table 1. Baseline characteristics. 
 Nonreparable (n=25) Reparable (n=36) p-value 
Age (years)  56.3±14.6 55.4±13.2 0.796 
Male   13 (52%) 22 (61%) 0.657 
Smoking  7 (28%) 6 (17%) 0.438 
Diabetes  2 (8%) 1 (3%) 0.745 
Hypertension  9 (36%) 15 (42%) 0.858 
Dyslipidemia  5 (20%) 5 (14%) 0.661 
NYHA functional class    0.665 
 I 13 (52%) 17 (47%)  
 II 7 (28%) 14 (39%)  
 III 3 (12%) 3 (8%)  
 IV 2 (8%) 1 (3%)  
Creatinin clearance (ml/min) 108.4±44.3 96.6±33.5 0.238 
Chronic Kidney Disease   0.195 
 Stage 1 16 (64%) 17 (47%)  
 Stage 2 5 (20%) 15 (42%)  
 Stage 3 4 (16%) 4 (11%)  
EuroSCORE II (%) 3.8 (1.6-6.2) 2.5 (1.8-4.3) 0.747 
Setting of surgery   0.754 
 Emergency  6 (24%) 11 (31%)  
 Urgent   5 (20%) 5 (14%)  
 Elective 14 (56%) 20 (56%)  
Mitral valve surgery 1 (4%) 4 (11%) 0.602 
Tricuspid valve surgery 0 (0%) 4 (11%) 0.231 
CABG 5 (20%) 6 (17%) 1.000 
Data are presented as number (percentage), as mean ± standard deviation or as median (interquartile 
range). CABG: Coronary Artery Bypass Grafting; EuroSCORE II: European System for Cardiac Operative 
Risk Evaluation II; NYHA: New York Heart Association. 
 
MDCT characteristics associated with reparable aortic root and valve 
Among the various MDCT variables evaluated, 3 characteristics were more frequently 
associated with nonreparability: bicuspid anatomy, severe commissural calcification and 
annular calcification. The prevalence of bicuspid aortic valve (BAV) was significantly higher in 
the nonreparable group compared with the aortic valve or root repair group (48% vs. 17%; 
p=0.019). The degree of calcification of the commissures and the aortic annulus is displayed in 
Figure 4. The valve commissures were more calcified in the nonreparable group than in the 
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aortic valve or root repair group (grade 1, 14% vs. 14%; grade 2: 29% vs. 0%, respectively; 
p=0.003). The annulus calcification grade was also higher in the nonreparable group than in 




Figure 4. Grade of calcification. 
Displayed in percentages per group for commissural calcification and annular calcification. 
 
The eccentricity index of the AVJ was 0.24 in the nonreparable group, compared to 0.26 in the 
reparable group (p=0.696). The diameters of the aortic root and thoracic aorta were measured 
at 10 levels (Figure 5). Patients with a reparable valve tended to have a wider SOV compared 
with the patients in the nonreparable group (48.3±9.3 mm vs. 44.6±7.1 mm, respectively; 
p=0.103); however, this difference was not statistically significant. All other diameters were 
comparable between the 2 groups. 
 
Discussion 
The present analysis identified anatomic features of the aortic valve and root assessed on 
preoperative MDCT that may be associated with feasible and successful surgical repair of the 
aortic valve. Tricuspid anatomy and less commissural and annular calcification were associated 
with feasible and successful valve repair.  
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Figure 5. Diameters of the aortic root and thoracic aorta at 10 levels.  
Data are displayed as mean and standard error of the mean (SEM).  
 
Aortic valve morphology and geometry and aortic root dimensions are parameters associated 
with feasibility of surgical aortic valve repair. So far, most studies have evaluated these aspects 
with TEE.
5 
However, MDCT may be frequently requested in AR associated with aortic root 
pathology. MDCT is highly accurate to differentiate between bicuspid and tricuspid anatomy 
(particularly in the presence of calcifications) and provides accurate measurements of aortic 
root and thoracic aorta.
9,20 
Valve-sparing aortic root replacement techniques provide good 
outcomes in patients with BAV who are operated in highly experienced centers.
 21,22
 However, 
some valve characteristics have been associated with increased rates of reoperation (up to 
20%).
23,24
 For example, a commissural orientation of <160º (which indicates asymmetrical size 
cusps) has been suggested as a risk factor for reoperation in BAV.
1
 In contrast, eccentric 
regurgitant jets and absence of cusp and commissural thickening or calcification have been 
associated with successful repair in patients with BAV.
25
 In the present study, 67% of BAVs 
were considered nonreparable and importantly 36% had commissural calcification grade ≥2.  
Calcification extent is also an important characteristic associated with reparability in tricuspid 
anatomy of the aortic valve.
5
 The present analysis demonstrated that higher grades of 
commissural and annular calcification (grade ≥2) were associated with higher probability of 
performing eventually an aortic valve replacement rather than aortic valve repair. Using 2-
│ CT in aortic valve repair 
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dimensional TEE, le Polain de Waroux et al. showed that severe calcification of the aortic valve 
was associated with high recurrence rate of significant AR after surgical repair.
5
 MDCT permits 
accurate assessment, quantification and location of aortic valve calcification and is considered 
the method of reference.
10
  
In addition, several studies have shown less successful repair in patients with a wide annulus, 
that is, AVJ of >28 mm.
1,7,26
 In the present series, the diameter of the AVJ was not different 
between patients in whom repair was feasible and patients who underwent valve 
replacement. However, there was a tendency towards a wider SOV in patients who underwent 
successful aortic valve and root repair. This may be attributed to different pathophysiologic 
types of aortic regurgitation.
27
 Measurement of the aortic root and ascending aorta 
dimensions is accurately assessed with MDCT since this 3-dimensional imaging technique 
permits alignment of the MPR across the aortic root and ascending aorta, defining a centerline 
to avoid off-axis measurements.  Therefore, MDCT, frequently requested before valve-sparing 
aortic root replacement techniques to assess concomitant aortic pathology, provides several 
important data (morphological and quantitative) that may help to identify the patients in 
whom AR repair may be successfully performed.  
 
Clinical perspective 
MDCT forms a part of the preoperative assessment of patients with AR associated with aortic 
root pathology. Dimensions of the aortic root and ascending aorta are accurately obtained 
with MDCT and are paramount to decide the surgical approach.
7,9
 However, it is important to 
note that MDCT data can also provide useful information on the aortic valve anatomy and 
morphology that can indicate whether aortic valve repair may be successful or not. 
Furthermore, current advances on computational fluid dynamics have provided insightful data 
on the pathophysiology of aortic diseases.
28,29 
These novel algorithms permit quantification of 
wall shear stress of the aorta and dynamic pressures of the aortic flow as well as qualitative 
evaluation of the streamlines that may refine the underling mechanism of AR and predict the 
feasibility and durability of repair. 
However, there are subgroups of patients with contraindications for MDCT in whom these 
aspects may be analyzed with other imaging techniques. For example, in patients with 
concomitant stage 4 to 5 chronic kidney disease, MDCT may be contraindicated.
30 
In this group 
of patients, magnetic resonance imaging may be a valuable 3-dimensional imaging technique 
to assess some of the aforementioned variables. However, calcification of the aortic valve may 
be difficult to assess with MRI. Currently, TEE is the most frequent technique to assess the 
grade and mechanism of AR. However, this technique is semi-invasive and does not provide 
information on the aortic arch at the level of the brachiocephalic and left common carotid 
arteries. Integration of information obtained with TEE and MDCT may accurately predict which 
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patients may be suitable for aortic valve-sparing surgical techniques and which type of 
technique may be the most appropriate. This may result in adequate referral of suitable 
patients to high-volume centers performing durable aortic valve repair techniques. Additional 
studies evaluating the impact of a systematic assessment of the aortic valve or root with TEE 
and MDCT on the outcomes of surgical aortic valve repair techniques would establish the role 
of these imaging techniques in the clinical management of patients with aortic root pathology 
associated or not with AR.  
 
Limitations 
The present analysis is limited by its retrospective observational nature. Although the surgical 
repair technique performed by the surgeon was not influenced by the preoperative MDCT 
data, the relatively small number of patients precluded us to perform statistical analysis to 
investigate the independent determinants or predictors of successful aortic valve repair. 
Furthermore, transesophageal echocardiographic assessment to identify the patients in whom 
aortic valve repair may be feasible was not systematically available. Therefore, the 
incremental value of MDCT assessment combined with transesophageal echocardiographic 
evaluation to predict aortic valve reparability could not be investigated. Quantification of 
aortic valve and root calcification using the Agatston score was not possible because non-
contrast enhanced MDCT data were not systematically available. MDCT was performed on a 
320-, 64- or 16-slice scanner which may have induced heterogeneity in the MDCT data. MDCT 
data acquisition was not electrocardiographic triggered in the majority of patients which may 
have resulted in artifacts particularly in the aortic root and ascending aorta that may hamper 
the reproducibility of the measurements. However, in our series there were no patients 
excluded because of non-analyzable MDCT data. Moreover, MDCT data were not consistently 
acquired in diastole or systole which may introduce an important bias. In 21 patients, MDCT 
was performed at the referral hospital and information on MDCT data acquisition was not 
systematically available. Lastly, MDCT angiography is not the imaging technique of first choice 
in patients with severe chronic kidney disease (stage 4 or 5),
30 
and therefore, the results of the 
present study may not be generalizable to this subgroup of patients.  
 
Conclusion 
Tricuspid valve anatomy and less commissural and annular calcification are significantly 
associated with feasible and successful aortic valve and root repair. The information provided 
by MDCT regarding valve morphology and calcification might be helpful in determining the 
surgical strategy in patients with aortic root pathology, associated or not with AR. 
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Background: Selection of tubular graft size during David reimplantation technique for aortic 
root dilation is based on perioperative leaflet height measurements. The present study 
evaluated whether transthoracic echocardiography (TTE)-based algorithms may help in 
selecting the graft size preoperatively. 
Methods: Thirty patients (52±11 years old, 73% men) who underwent David reimplantation 
technique were evaluated. The implanted graft size was based on the David’s formula. Leaflet 
height (diameter = 1.1 • ((2 • 2/3 • leaflet height) + 2)), leaflet length (diameter = ((2 • 2/3 • 
leaflet length) + 2)) and leaflet area (diameter = 0.8 • ((2 • √(total leaflet area / π)) + 2)) TTE-
derived formulas were retrospectively developed. The percentage of under- or oversized 
implanted grafts was calculated and the association between the adequacy of graft sizing 
using TTE-derived formulas and the incidence of residual aortic regurgitation (AR) was 
evaluated retrospectively.  
Results: The incidence of postoperative mild residual AR was 23%. The actually implanted graft 
diameter was oversized based on leaflet height in 15 (50%) patients, based on leaflet length in 
13 (43%) patients and based on leaflet area TTE-derived formula in 11 (37%) patients. The 
incidence of mild AR was significantly lower in undersized grafts compared with oversized 
grafts based on leaflet length TTE-derived formula (6% vs. 46%, p=0.032) and leaflet area TTE-
derived formula (5% vs. 55%, p=0.009).  
Conclusion: In patients undergoing David reimplantation technique, grafts considered 
undersized according to the leaflet length or leaflet area TTE-derived formula were associated 
with less incidence of residual AR than patients with oversized grafts.   




The David reimplantation technique is a feasible and effective surgical valve-sparing aortic 
root replacement for patients with aortic regurgitation (AR) due to dilation of the aortic root.
1
 
The incidence of recurrent significant AR (AR ≥ grade 3) during follow-up ranges between 4 
and 22%.
2,3
 The presence of residual AR after the surgery has been associated with a 5-fold 
higher risk of recurrent AR during follow-up.
2
 To prevent residual AR, adequate sizing of the 
tubular graft is pivotal.
4 
Leaflet coaptation may be insufficient if the graft is too large 
(oversized), whereas leaflet prolapse and cusp abrasion may occur if the graft is too small 
(undersized). In current practice, the tubular graft size is based on intraoperative 
measurement of the average leaflet height using the David’s formula (diameter = 2 • 2/3 • 
hleaflet + (2 • Aowall)) where hleaflet is the leaflet height measured with surgical callipers and Aowall 
is the thickness of the aortic wall.
5
 We hypothesized that preoperative transthoracic 
echocardiography (TTE) may be helpful in determining the appropriate graft size in David 
reimplantation technique. Therefore the aims of the present study were first to develop TTE-
derived formulas to calculate the recommended graft size and second to assess whether there 
was an association between graft sizing using the TTE-derived formulas and the presence of 




Thirty patients with aortic root pathology who underwent surgical valve-sparing aortic root 
replacement using the David reimplantation technique at the Leiden University Medical Center 
between 2001 and 2014 with sufficient echocardiographic data were included in the present 
study. Patients who underwent additional aortic leaflet repair were excluded. Patients who 
underwent concomitant mitral valve or tricuspid valve surgery were not excluded. Clinical and 
surgical data were collected at the departmental Cardiology Information System (EPD-Vision, 
Leiden University Medical Center, Leiden, Netherlands) and retrospectively analysed.  
AR grade and aortic valve geometry were assessed retrospectively with preoperative two-
dimensional (2D) TTE. Three TTE-derived formulas were developed to select the graft size for 
the David reimplantation technique, based on leaflet height, leaflet length and leaflet area 
(see below). The implanted graft was sized using the David’s formula based on surgically 
measured leaflet height.
5
 Transesophageal echocardiography (TEE) was used to assess residual 
AR directly after the surgery. The percentage of under- or oversized implanted grafts was 
reported and the association between the adequacy of graft sizing using the TTE-derived 
formulas and the incidence of residual AR was evaluated. The institutional review board 
approved this retrospective analysis of clinically acquired data and waived the need for patient 
written informed consent. 
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Two-dimensional transthoracic echocardiography 
Preoperative TTE was performed at rest using commercially available ultrasound systems 
(System Five, Vivid 7 and E9, General Electric Healthcare, Vingmed, Horten, Norway) equipped 
with 3.5-MHz or M5S transducers. 2D and Doppler echocardiographic data were acquired at 
the parasternal and apical views according to current recommendations.
6
 The 
echocardiographic data were digitally stored in cine-loop format and were retrospectively 
analysed using EchoPac (112.0.1, GE Medical Systems, Horten, Norway). 
AR grade was assessed using colour, pulsed and continuous wave Doppler recordings and 
using a multiparametric approach that includes the measurement of the jet width relative to 
the LV outflow tract diameter, vena contracta and the pressure half time of the regurgitant 
flow (if feasible) according to current recommendations.
7
 AR was graded as 0 (absent), 1 
(mild), 2 (mild-moderate), 3 (moderate-severe) or 4 (severe). The AR jet was classified as 
central or eccentric. 
Aortic valve geometry was measured during end-diastole (just before opening of the aortic 
valve) in the parasternal short-axis and long-axis view. The image was zoomed on the aortic 
valve. The leaflet height was measured in the parasternal short-axis view from the internal 
border of the aortic root to the free edge of the leaflet and was averaged per patient (Figure 
1). The leaflet depth was measured in the parasternal long-axis view as the distance between 
the line from the leaflet insertion to the leaflet tip and the most convex point of the leaflet.  
 
Figure 1. Leaflet height on 
transthoracic echocardiography. 
Leaflet height was measured 
during end diastole in 
parasternal short-axis view from 
the internal aortic root border to 












Figure 2. Leaflet length on 
transthoracic echocardiography. 
The leaflet length over the belly of 
the leaflet was subsequently 
calculated as the half perimeter of 
the ellipse described by the 
average leaflet height as major 
axis and twice the leaflet depth as 
minor axis. The leaflet height was 
measured in the parasternal 
short-axis view from the internal 
border of the aortic root to the 
free edge of the leaflet. The leaflet 
depth was measured in the 
parasternal long-axis view as the 
distance between the line from 
the leaflet insertion to the leaflet 
tip and the most convex point of 
the leaflet. 
 
The leaflet length over the belly of the leaflet was subsequently calculated as the half peri-
meter of the ellipse described by the average leaflet height as major axis and twice the leaflet 
depth as minor axis (Figure 2).The leaflet area was measured in the parasternal short-axis view 
per leaflet and was then summed per patient to obtain the total leaflet area (Figure 3). 
 
Figure 3. Leaflet area on 
transthoracic echocardiography. 
Leaflet area was measured 













After median sternotomy, cardiopulmonary bypass was set through cannulation of the distal 
ascending aorta or proximal aortic arch. In patients with aortic dissection or dilation of the 
distal ascending aorta, cannulation via the sub-clavian or femoral arterial route was 
performed. The aorta was incised 2 cm above the ostium of the right coronary artery and 
resected until the aortoventricular junction (AVJ).  
The height of all leaflets was measured using surgical callipers from the nadir of the leaflet 
insertion on the AVJ to the free margin of each leaflet and then averaged. The size of the graft 
at the level of the AVJ was determined using the David’s formula: (diameter = (hleaflet • 2 • 2/3) 
+ (2 • Aowall)), where hleaflet was the average leaflet height measured with surgical calipers.
5
 The 
thickness of the aortic wall (Aowall) was estimated as 1 mm. David I procedure was performed 
in 6 patients (20%) as previously described.
5
 A modified David V procedure was performed in 
24 patients (80%), resizing the ventricular rim of the graft according to the calculated size of 
the AVJ following the David’s formula.
8
 In both David I and modified David V techniques, the 
coronary buttons were reimplanted into the respective neosinuses. Directly after the 
procedure, the presence of residual AR was assessed using TEE. Residual AR was graded as 
none, trace or mild based on the TEE report. There was no more than mild AR after the 
procedures. Furthermore, the coaptation length of the aortic valve was measured on TEE 
during diastole when the valve was closed. 
 
Statistical analysis 
Analyses were performed using the SPSS software version 20 (SPSS, Chicago, IL, USA). 
Continuous variables were displayed as mean ± standard deviation if normally distributed and 
as median and interquartile range if non-normally distributed. TTE-derived formulas based on 
leaflet height, leaflet length and leaflet area were retrospectively developed using linear 
regression analysis without including an intercept. Per patient, the recommended graft 
diameter was calculated for each TTE-derived formula and rounded to whole millimetres. 
Patients with an implanted graft smaller than or equal to that recommended by TTE-derived 
formulas (undersized) were compared with patients with an implanted graft larger than 
recommended by TTE-derived formulas (oversized) using the chi-square test. All statistical 
tests were two-sided. A p-value<0.05 was considered statistically significant. 
 
Results 
Development of transthoracic echocardiography-derived formulas 
A total of 30 patients (mean age 52 ± 11 years, 73% men) who underwent the David 
reimplantation technique because of aortic root pathology were evaluated. The clinical, 
echocardiographic and surgical characteristics are presented in Table 1. 
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Table 1: Baseline clinical, echocardiographic and surgical characteristics.  
 All patients (n=30) 
Clinical characteristics:  
Age (years)  52 ± 11 
Male  22 (73%) 
Body surface area (m
2
) 2.02 ± 0.16 
Smoking 8 (27%) 
Diabetes 0 (0%) 
Hypertension 7 (23%) 
Dyslipidaemia 5 (17%) 
NYHA functional class   
 I 17 (57%) 
 II 6 (20%) 
 III 7 (23%) 
 IV 0 (0%) 
Echocardiographic characteristics:  
Aortic regurgitation  
 Grade 0 5 (17%) 
 Grade 1 4 (13%) 
 Grade 2 12 (40%) 
 Grade 3 5 (17%) 
 Grade 4 4 (13%) 
Aortic regurgitation jet direction  
 No jet 5 (17%) 
 Central jet 15 (50%) 
 Eccentric jet 10 (33%) 
Average leaflet height (cm) 1.9 ± 0.3 
Total leaflet area (cm
2
) 10.9 ± 3.0 
Surgical characteristics:  
Bicuspid aortic valve 3 (10%) 
EuroSCORE II (%) 1.9 (1.2 – 2.6) 
Reimplantation technique  
 David I 6 (20%) 
 David V 24 (80%) 
Graft diameter at level of AVJ (mm) 30 ± 3 
Data are presented as number (percentage), as mean ± standard deviation or as median (interquartile 
range). AVJ = Aortoventricular Junction. EuroSCORE = European System for Cardiac Operative Risk 
Evaluation. NYHA = New York Heart Association.  
 
The ratio between the surgically measured leaflet height and echocardiographic measured 
leaflet height was on average 1.1±0.2, indicating that TTE underestimated the leaflet height. 
This correction factor was taken into account when the TTE-derived formula based on leaflet 
height was developed similar to the David’s formula. Linear regression analysis was performed 
to compare the calculated diameter based on TTE-measured leaflet height and the diameter 
based on surgically measured leaflet height (both: diameter = (2 • 2/3 • hleaflet) + 2) (Figure 4). 
The slope was 1.1 (95% confidence interval: 1.0-1.2; p<0.001) indicating that the diameter 
obtained by TTE-derived formula based on the leaflet height had to be multiplied by factor 1.1 
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to obtain the recommended diameter. Therefore the TTE-derived formula based on leaflet 
height was: diameter = 1.1 • ((2 • 2/3 • height) + 2).   
Secondly, the leaflet length TTE-derived formula was developed. Linear regression analysis was 
performed to compare the calculated diameter based on leaflet length and the diameter of 
the actually implanted graft (Figure 4). The slope was 1.0 (95% confidence interval: 0.9-1.0; 
p<0.001); therefore, no correction factor is needed resulting in the TTE-derived formula based 
on leaflet length: diameter = ((2 • 2/3 • length) + 2). 
Lastly, the TTE-derived formula based on leaflet area was developed. As area equals π times 
the squared radius, the diameter was calculated as diameter = (2 • √(total leaflet area / π)) + 2. 
Linear regression analysis was performed to obtain a correction factor for converting the 
diameter based on TTE measurements to a surgically applicable diameter (Figure 4). The slope 
was 0.8 (95% confidence interval: 0.7-0.8; p<0.001) indicating that the diameter obtained by 
TTE-derived formula based on leaflet area had to be multiplied by factor 0.8 for the 
recommended diameter. The TTE-derived formula based on leaflet area was: diameter = 0.8 • 
((2 • √(total leaflet area / π)) + 2). 
 
Relation between oversizing and residual aortic regurgitation 
The implanted graft diameter was considered oversized based on leaflet height TTE-derived 
formula in 15 (50%) patients, based on leaflet length TTE-derived formula in 13 (43%) patients 
and based on leaflet area TTE-derived formula in 11 (37%) patients. For the overall population, 
mild residual AR, assessed with intraoperative TEE, was present in 7 (23%) patients whereas 
the remaining 23 (77%) patients did not have AR.  
Chi-square test was performed to assess whether an oversized graft according to TTE-derived 
formulas was associated with higher rates of residual AR. The results are presented in Figure 5. 
Residual AR was present in 5 (33%) patients with oversized graft according to the leaflet height 
TTE-derived formula, and in 2 (13%) patients with an undersized graft (p=0.388). According to 
the leaflet length TTE-derived formula, residual AR was more often present in patients who 
received an oversized graft (6 (46%) patients) compared with patients who received an 
undersized graft (1 (6%) patients; p=0.032). In patients who received an oversized graft 
according to leaflet area TTE-derived formula, the prevalence of residual AR was 55%. In 
patients who received an undersized graft, there was only 1 (5%) patient with residual AR 
(p=0.009). The coaptation length of the aortic valve after surgery was at least 6 mm in all 
patients and on average 7.6 ± 1.3 mm.  
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Figure 4. Linear regression analysis for the development of TTE-derived formulas 
(A) Linear regression analysis in the development of the leaflet height-based TTE-derived formula. The 
correction factor of 1.1 should be applied in the general formula. 
(B) Linear regression analysis in the development of the leaflet length-based TTE-derived formula. No 
correction factor is necessary in the general formula. 
(C) Linear regression analysis in the development of the leaflet area-based TTE-derived formula. The 
correction factor of 0.8 should be applied in the general formula. AVJ: aortoventricular junction; TTE: 
transthoracic echocardiography  
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Figure 5. Residual aortic regurgitation in patients with an undersized graft compared to patients with 
an oversized graft.  
AR: aortic regurgitation 
 
Discussion 
The David aortic valve reimplantation technique has shown favourable mid- and long-term 
results in patients with aortic root or ascending aorta aneurysms.
9-11
 Accurate sizing of the 
tubular Dacron graft where the valve is inserted into is pivotal to ensure durable repair. After 
the first description of the surgical technique by Drs David and Feindel, where the size of the 
tubular graft was selected upon perioperative measurement of the average leaflet height,
5
 
several modifications have been developed, including the creation of neosinuses of Valsalva by 
achieving an area of the Dacron fabric contained within two commissures larger than the 
anatomical area.
12 
However, selection of the appropriate size of the tubular graft remains 
challenging and several investigational groups have proposed alternative methods for graft 
sizing. For example, Svensson et al. proposed the implantation of a 28- or 30-mm graft for men 
and 26- or 28-mm for women and the use of a Hegar’s dilator of a size equivalent to the 
patient’s expected normal LV outflow tract size.
13
 The proximal end of the graft is sutured and 
crimped down to the Hegar’s dilator size creating neosinuses of Valsalva where the graft is 7-9 
mm larger than the LV outflow tract. After sewing the aortic valve in position, the anchoring 
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sutures at the level of the commissures are placed 4 mm apart narrowing the graft at the level 
of the neosinotubular junction. One of the advantages of this technique is its reproducibility.
13
 
Alternatively, de Kerchove et al. proposed a method to select the tubular graft size based on 
the hypothesis of preserved height of the aortic commissures in aortic root aneurysms.
14,15
 
Usually measured from the base of the interleaflet triangle to the top of the non-
coronary/left-coronary commissure, the height corresponds to the size of the graft and 
theoretically to the size of the sinotubular junction in normally functioning aortic valves. 
Eventually, if the height does not correspond to the available labelled graft sizes, the next 
larger size is selected. This methodology tested in 27 consecutive patients undergoing aortic 
valve-sparing surgery using the reimplantation technique (59% bicuspid valve, 53% with severe 
preoperative AR) showed acute favourable results with no (54%) or mild AR (46%) at discharge 
TTE.
14 
However, all the aforementioned series based the sizing of the graft on surgical inspection and 
direct intraoperative measurements. Ex-vivo studies have demonstrated that the aortic valve 
leaflet length is influenced by the pressure on the aortic leaflets
16
 and the distensibility of the 





echocardiography could overcome these limitations as 
measurements are performed in diastole under physiological pressures.  
This hypothesis-generating study evaluated the prevalence of under- or oversized tubular graft 
using a TTE-derived formula and its association with residual mild AR after aortic valve-sparing 
surgery using the reimplantation technique. The incidence of mild AR was 23% and was 
significantly higher among patients who received an oversized tubular graft according to the 
leaflet length and leaflet area TTE-derived formula. The reported incidences of mild AR after 
aortic valve-sparing surgery using the reimplantation technique range between 24 and 
46%.
14,18,19
 Leaflet height was easily measured on TTE, however there was a factor 1.1 
difference between the TTE-measured and surgically measured leaflet height; therefore a 
correction factor had to be applied into the leaflet height TTE-derived formula. In addition, 
there was no significant difference in residual AR in oversized and undersized grafts based on 
the TTE leaflet height formula. In addition, using the leaflet length formula, oversizing was 
associated significantly with more residual AR. The leaflet area was easily measured and also 
resulted in a significant association between oversizing based on the leaflet area formula and 
more residual AR.  
Awaiting prospective evaluation of the performance of these proposed TTE-derived formulas, 
the present results suggest that the graft size should not be larger than calculated by the 
leaflet length and leaflet area formula. The leaflet area is easier to measure on TTE in 
comparison with leaflet length. In our series, the leaflet area TTE-based formula performed 
best in demonstrating residual AR in relation to oversizing, hence this formula seems to be the 
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most promising when using TTE in determining the appropriate graft size. Eventually, 
additional manoeuvres to tailor the size of the graft at the levels of the aortoventricular and 
sinotubular junctions would be required to achieve good leaflet coaptation while avoiding 





The present study was limited by the relatively small number of patients with a heterogeneous 
cohort including aortic valve reimplantation using the David I technique as well as the David V 
modified technique.  The formulas were retrospectively developed and evaluated. Therefore it 
remains unknown whether the clinical course of the patients would be different if a graft size 
based on echocardiography would have been implanted. Nevertheless, the TTE-derived 
formulas may be helpful to assist the surgeon in decision-making and to prevent oversizing. 
The present study is a first step in the use of echocardiography to standardize the selection of 
the graft size in David reimplantation technique. Firstly, retrospective validation of the 
formulas in a larger cohort and secondly, prospective application of the formulas is needed 
before introduction into routine clinical practice. In addition, the use of a 2D imaging 
technique may be limited by the use of off-axis images that may underestimate the leaflet 
size. The aortic root size probably influences the measurements of the leaflet size on 
echocardiography since the leaflet height was taken from the internal border of the aortic root 
to the free edge of the leaflet. The small number of patients hampered subanalysis of 
performance of the formulas in small and large aortic roots. This topic might be of interest in 
further clinical research. 3D echocardiography may refine the geometric assessment of the 
aortic valve and root and should be used in future studies. Automated software for 3D 




The present study shows that undersizing based on the leaflet length and leaflet area TTE-
derived formula is better in preventing residual AR compared with oversizing; however, 
prolapse or direct contact between the leaflet and the graft should be avoided. Therefore, the 




In patients undergoing David reimplantation technique, grafts considered undersized 
according to leaflet length and leaflet area TTE-derived formulas are associated with less AR 
than patients with oversized grafts. This study provides a proof-of-concept on the use of 
echocardiography to standardize the selection of the appropriate graft size in David 
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reimplantation technique. However, future studies are needed to validate the formulas and 
make them applicable in routine clinical practice.  
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Background: Extent of left ventricular (LV) reverse remodeling after aortic valve repair or 
replacement (AVR) may differ between patients operated for acute aortic regurgitation (AR) 
and chronic AR. The aim of this study was to compare changes in LV volumes and function 
between patients with acute and chronic AR who underwent AVR.  
Methods: A total of 98 patients (54±15 years, 61% men) with acute (n=21) or chronic AR 
(n=77) were included in the present retrospective evaluation. LV volumes, LV ejection fraction 
and global longitudinal strain indexed for LV end-diastolic volume (GLSi) were assessed 
preoperatively and after a median follow-up of 28 months (interquartile range: 17-66 months). 
Results: Patients with acute AR tended to have smaller preoperative LV end-diastolic volume 
compared to chronic AR (156±15 vs. 183±6 ml; p=0.070). Both in patients with acute and 
chronic AR, significant LV reverse remodeling with sustained reduction in LV volumes occurred 
during follow-up with a significant smaller LV end-diastolic volume in acute AR compared to 
chronic AR (106±8 vs. 128±5 ml; p=0.032). Preoperative and postoperative LV ejection 
fractions were not significantly different between groups. In contrast, GLSi was better in 
patients with acute AR compared to chronic AR before AVR (-1.34±0.20 vs. -0.96±0.07 %/10 
ml; p=0.042) and during follow-up (-1.65±0.16 vs. -1.29±0.07 %/10 ml; p=0.017).  
Conclusion: After AVR, LV reverse remodeling occurs both in patients with acute and chronic 
AR. However, LV end-diastolic volume was more reduced and GLSi was more preserved during 
follow-up in acute AR than in chronic AR.  
  




The prevalence of aortic regurgitation (AR) in the general population is 10% and is often 
mild.
1,2
 Severe chronic AR results in a combination of left ventricular (LV) volume overload 
(due to the regurgitant volume) and LV pressure overload (due to systolic hypertension as a 
result from an increase in total aortic stroke volume).
3
 In early stages of the disease, the LV 
adapts to the volume overload with eccentric LV hypertrophy to preserve LV systolic function.
4
 
Progressive LV dilation and systolic hypertension increase LV wall stress leading to 
ultrastructural myocardial changes that may not reverse after aortic valve repair or 
replacement (AVR).
5-7
 In severe acute AR, these changes may not take place and therefore the 
remodeling process after emergent AVR may be different to that observed in patients with 
chronic AR.  
The studies evaluating the presence and clinical implications of LV reverse remodeling after 
AVR have focused on patients with severe chronic AR.
8-11
 However, little is known about the LV 
reverse remodeling process in patients with severe acute AR. Accordingly, the aim of the 
current study was to characterize changes in LV volumes and function after AVR in patients 




The present retrospective study included adult patients who underwent aortic valve and root 
surgery for AR or aortic root pathology from 1998 to 2013 at the Leiden University Medical 
Center, The Netherlands. Patients with moderate to severe and severe AR and 
no more than mild aortic stenosis were selected from a large echocardiographic database. 
Patients with available echocardiograms at baseline (before surgery) and at least 6 months 
after aortic valve replacement were included. If patients underwent reoperation on the aortic 
valve and/or aortic root during follow-up, the last transthoracic echocardiography before 
reoperation was considered in the analysis. Concomitant mitral or tricuspid valve disease was 
not an exclusion criterion.  
Baseline clinical characteristics, EuroSCORE II and surgical procedures were recorded. In 
addition, LV volumes and function and valvular hemodynamics were assessed with 2-
dimensional transthoracic echocardiography preoperatively and at 6 months or longer follow-
up. All data were prospectively collected in the departmental Cardiology Information System 
(EPD-Vision, Leiden University Medical Center, Leiden, The  Netherlands) and retrospectively 
analyzed. Patients were divided into two groups: patients with acute AR developed ≤6 weeks 
before AVR and patients with chronic AR lasting for >6 weeks before AVR. 
The institutional ethical committee approved the retrospective analysis of clinical and 
echocardiographic data and waived the need for patient written informed consent for patients 
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followed-up at the Leiden University Medical Center, The Netherlands. For retrospective 
analysis of postoperative echocardiographic data of patients followed-up in referral centers, 
written informed consent was obtained. 
 
Two-dimensional transthoracic echocardiography 
Transthoracic echocardiography was performed at rest with patients in the left decubitus 
position using commercially available ultrasound systems (System 5, Vivid 7 and E9, General 
Electric Healthcare, Vingmed, Horten, Norway) equipped with 3.5-MHz or M5S transducers. 
Two-dimensional and Doppler data were acquired at the parasternal, apical, subcostal and 
supra-sternal views according to current recommendations.
12
 The echocardiographic data 
were digitally stored in cine-loop format and data analysis was retrospectively performed 
using EchoPac (112.0.1, GE Medical Systems, Horten, Norway). LV end-diastolic (LVEDV) and 
end-systolic (LVESV) volumes were quantified in the apical two- and four-chamber views using 
the Simpson’s biplane method and LV ejection fraction (LVEF) was calculated.
12
 Further 
evaluation of LV systolic function was performed with two-dimensional speckle-tracking 
longitudinal strain analysis. LV longitudinal strain was measured from apical two-, three- and 
four-chamber views and averaged to obtain LV global longitudinal strain (GLS). To take into 
consideration changes in LV volumes over time after AVR, GLS was corrected for LVEDV and 
expressed as percentage of deformation per 10 ml of LVEDV (GLSi).  
Aortic valve function was evaluated using color, continuous- and pulsed-wave Doppler. AR 
grade was assessed using a multiparametric approach including the measurement of the jet 
width relative to the LV outflow tract width and the vena contracta width in the parasternal 
long-axis view and apical three- or five-chamber views and the measurement of the pressure 
half time (if feasible) with continuous wave Doppler on the apical three- or five-chamber 
views. AR was graded as 0 (absent), 1 (mild), 2 (mild-moderate), 3 (moderate-severe) or 4 
(severe).
13
 Aortic stenosis grade was assessed measuring the aortic jet velocity and transaortic 
mean pressure gradient on continuous-wave Doppler recordings of the valve obtained in the 
apical three- or five-chamber views. Left ventricular outflow tract velocity was measured using 
the pulsed-wave Doppler in the apical three- or five-chamber views with the sample volume 
placed 5 mm below the aortic annulus plane into the left ventricle. Aortic valve area was 
calculated using the continuity equation. Patients with more than mild aortic stenosis were 
excluded as per inclusion and exclusion criteria of the study. 
 
Surgery 
After median sternotomy, arterial cannulation was performed of the distal ascending aorta (in 
elective non-dissected aortic pathology and in the absence of dilatation of the distal part of 
the ascending aorta) or the subclavian or femoral artery (in patients with ascending aorta 
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dissection or dilatation). Patients underwent aortic valve and root replacement or valve-
sparing aortic root reconstruction. In aortic valve and root replacement techniques, the 
coronary buttons were mobilized and the sinuses of Valsalva and the aortic valve were 
excised. A mechanical or biological prosthesis was then implanted. Thereafter the coronary 
buttons were reattached.
14,15
 For valve-sparing aortic root reconstruction, either a 
supracoronary ascending aorta replacement was performed with restoration of the 
sinotubular junction or the native sinuses of Valsalva were resected and a graft was implanted 
using the reimplantation technique (modified David procedure) or the remodeling technique 
(Yacoub technique), as previously described.
16-18
 Leaflet repair procedures (leaflet triangular 
resection, leaflet resuspension and plication of the free edge of the leaflet) were performed if 
needed. In addition, concomitant aortic arch replacement was performed if the luminal 
diameter at this level was >45 mm or – in cases of dissection – a (re)entry tear was present in 
the arch.  
 
Follow-up 
Patients underwent two-dimensional transthoracic echocardiography during follow-up at the 
discretion of the treating cardiologist. The median follow-up duration was 28 months 
(interquartile range: 17-66 months). 
 
Statistical analysis 
All data analyses were performed using the SPSS software version 20 (SPSS, Chicago, IL, USA). 
Categorical variables are reported as numbers and percentages. Continuous variables are 
reported as mean ± standard deviation or median and interquartile range. Differences 
between acute and chronic AR were analysed using the chi-square test (for categorical 
variables) and the unpaired Student’s t-test or Mann-Whitney U test (for normally or non-
normally distributed continuous variables, respectively). Linear mixed model analysis was used 
to assess the differences in change in LV dimensions and function over time between the two 
groups. Onset of AR (acute or chronic) and time of transthoracic echocardiography 
(preoperative or follow-up) were incorporated in the model as fixed variables. An unstructured 
covariance matrix was applied. The estimated marginal mean ± standard error of the mean 




A total of 98 patients (mean age 54±15 years, 61% men) were evaluated: acute AR was present 
in 21 (21%) patients and chronic AR in 77 (79%) patients. Acute AR was classified as moderate-
severe in 6 (29%) patients and severe in 15 (71%) patients and the etiology was endocarditis in 
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14 (66%) patients, acute type A aortic dissection in 5 (24%) and acute pulmonary edema 
associated with aortic root dilation in the remaining 2 (10%) patients. Chronic AR was 
classified as moderate-severe in 49 (64%) patients and severe in 28 (36%) patients. The clinical 
and surgical characteristics of both groups are displayed in Table 1. Cardiovascular risk factors 
were comparable between groups. However, the creatinine clearance was significantly lower 
and New York Heart Association class IV heart failure symptoms were more frequently 
reported in patients with acute AR compared with chronic AR. Patients with acute AR had 
higher EuroSCORE II compared with patients with chronic AR. Among patients with acute AR, 6 
(29%) patients underwent emergent surgery and 15 (71%) patients underwent urgent surgery. 
In the entire cohort, the aortic valve and root were replaced by a biological prosthesis in 60 
(61%) patients and by a mechanical prosthesis in 10 (10%) patients. 
 
Table 1. Baseline and surgical characteristics.  





Age (years)  56 ± 14 53 ± 15 0.380 
Male   10 (48%) 50 (65%) 0.234 
Body surface area (m
2
) 1.85 ± 0.18 2.03 ± 0.41 0.059 
Smoking  5 (24%) 18 (23%) 1 
Diabetes mellitus  3 (14%) 2 (3%) 0.110 
Hypertension  8 (38%) 29 (38%) 1 
Dyslipidaemia  2 (10%) 7 (9%) 1 
NYHA functional class    0.002 
 I 11 (52%) 29 (38%)  
 II 3 (14%) 26 (33%)  
 III 2 (10%) 20 (26%)  
 IV 5 (24%) 2 (3%)  
Creatinine clearance (ml/min) 78 ± 36 104 ± 37 0.008 
EuroSCORE II (%) 7.3 (3.3 – 22.4) 2.5 (1.6 – 4.2) <0.001 
Bicuspid aortic valve 2 (10%) 27 (35%) 0.042 
Aortic valve and root technique   0.414 
 Replacement 17 (81%) 53 (69%)  
 Valve-sparing restoration 4 (19%) 24 (31%)  
Mitral valve surgery 6 (29%) 15 (19%) 0.549 
Tricuspid valve surgery 4 (19%) 10 (13%) 0.725 
CABG 2 (10%) 6 (8%) 1 
Data are presented as mean ± standard deviation, as median (interquartile range) or as number 
(percentage). AR: aortic regurgitation. CABG: coronary artery by-pass grafting. EuroSCORE: European 
System for Cardiac Operative Risk Evaluation. NYHA: New York Heart Association. 
 
In the remaining 28 (29%) patients, a valve sparing procedure was performed with isolated 
aortic valve repair in 3 patients, supracoronary ascending aorta replacement with restoration 
of the sinotubular junction in 6 patients, reimplantation technique of David in 17 patients and 
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the remodeling technique of Yacoub in 2 patients. There were no differences in the number 
and type of concomitant surgeries performed in both groups.  
 
LV reverse remodeling after AVR for acute versus chronic AR 
The median echocardiographic follow-up duration was 34 months (interquartile range: 18-66 
months) in patients with acute AR and 26 months (interquartile range: 16-64 months) in 
patients with chronic AR (p=0.491). Recurrence of moderate-severe or severe AR at follow-up 
was present in 5 (5%) patients, all in chronic AR patients. At follow-up, the mean aortic valve 
gradient was similar between patients with acute and patients with chronic AR (9.3±10.3 vs. 
7.3±5.3 mmHg; p=0.236). 
Figure 1 shows the LV volumes preoperatively and at follow-up. The preoperative LVEDV was 
slightly smaller in patients with acute AR compared with chronic AR (156±15 vs. 183±6 ml, 
p=0.070). The preoperative LVESV was comparable between acute and chronic AR (73±10 vs. 
85±4 ml; p=0.162). At follow-up, in both groups, LV reverse remodeling occurred with a 
significant reduction in LVEDV and LVESV. However, the LVEDV was significantly smaller at 
follow-up in patients with acute AR than in patients with chronic AR (106±8 vs. 128±5 ml; 
p=0.032).  
The change in LV function is displayed in figure 2. The preoperative LVEF was similar in 
patients with acute AR and chronic AR (55±2 vs. 54±1%; p=0.595) and increased during follow-
up with no difference between groups (acute AR: 57±2% vs. chronic AR: 59±1%; p=0.444). In 
patients with acute AR, GLS was −15.8±1.3% before and −15.5±0.9% aler surgery (p=0.874). In 
patients with chronic AR, GLS was −15.0±0.8% before and −14.3±0.4% aler surgery (p=0.373). 
Because GLS represents shortening of the LV, which is dependent on the size of the LV, GLS 
was indexed for LVEDV. The GLSi was significantly better in patients with acute AR compared 
with chronic AR at baseline (−1.34±0.20 vs −0.96±0.07%/10 mL; P=.042) as well as during 
follow-up (−1.65±0.16 vs −1.29±0.07; p=0.017). 
 
Discussion 
The main findings of the present study include the observation that patients with acute AR had 
slightly smaller pre-operative LVEDV compared with patients with chronic AR suggesting the 
lack of LV remodeling to compensate the volume and pressure overload in the former group. 
Despite this observation, significant LV reverse remodeling after AVR was observed in both 
patients with acute AR and patients with chronic AR, with significantly smaller LVEDV and 
more preserved LV systolic function (based on speckle tracking echocardiography measure-
ments) at follow-up among patients with acute AR compared with patients with chronic AR. 
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Figure 1. Left ventricular volumes over time in acute and chronic AR.  
Data are displayed as estimated marginal means ± standard error of the mean. *p<0.05 compared with 
preoperative. AR: aortic regurgitation. LVEDV: left ventricular end-diastolic volume. LVESV: left ventricular 
end-systolic volume 
  
Figure 2. Left ventricular function over time in acute and chronic AR.  
Data are displayed as estimated marginal means ± standard error of the mean. *p<0.05 compared with 
preoperative. AR: aortic regurgitation. GLSi: global longitudinal strain indexed for left ventricular end-
diastolic volume. LVEF: left ventricular ejection fraction. 
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Acute versus chronic aortic regurgitation 
Timing of aortic valve repair/replacement for AR depends on the presence of symptoms or 
documentation of LV systolic function impairment or LV dilatation.
19
 Acute severe AR is usually 
associated with abrupt onset of heart failure symptoms, signs of low cardiac output and initial 
signs of LV remodeling, including LV dilatation and hypertrophy that cannot compensate the 
abrupt increase in volume and pressure overload.
20
 Experimental models have shown changes 
in extracellular matrix, perivascular fibrosis and increased cardiomyocyte cross-sectional area 
early after onset of acute severe AR.
20
 In contrast, in chronic severe AR, the adaptive changes 
in LV structure to compensate the gradual increase in volume and pressure overload result in 
larger LV dilatation and hypertrophy (compared with acute AR) that normalize wall stress and 
preserve LV systolic function.
4




In acute AR immediate surgical intervention is usually necessary and can be performed with 
good outcome,
24,25
 whereas in chronic AR patients, surgery is not recommended until 




Aortic valve and root surgery restoring the competence of the aortic valve reduces the LV 
volume and pressure overload inducing LV reverse remodeling. Previous studies have shown 
that LV reverse remodeling occurs, both after aortic valve and root replacement and after 
valve-sparing aortic root reconstruction in patients with chronic AR.
8-10
 In contrast, comparison 
of postoperative LV reverse remodeling and change in systolic function between patients 
operated for acute AR and patients operated for chronic AR have not been described 
extensively. Kumpuris et al. compared three patient groups with severe AR who underwent 
aortic valve surgery; chronic AR with postoperative LV reverse remodeling, chronic AR without 
postoperative LV reverse remodeling and acute AR.
26
 Patients operated for acute AR and 
patients operated for chronic AR who showed postoperative LV reverse remodeling had 
similar LV end-diastolic and LV end-systolic diameters preoperatively and postoperatively 
(median 30 days after surgery).
26
 The present evaluation also showed LV reverse remodeling in 
both groups of patients which was more pronounced among patients with acute AR than in 
patients with chronic AR. Probably, more advanced microscopic remodeling with increased 
myocardial fibrosis in patients with chronic AR may preclude normalization of LV volumes after 
AVR. 
Furthermore, recovery or normalization of LV systolic function is an important surgical 
outcome with prognostic implications. In chronic AR patients with preoperative LV systolic 
dysfunction or severe dilation who underwent aortic valve and root surgery, the LVEF 
improved significantly.
8,27
 Particularly, patients with LV reverse remodeling early after surgery 
experienced an increase in LVEF from 47±9% to 56±6% during follow up, whereas in patients 
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without LV reverse remodeling after surgery, the LVEF remained low (from 32±6% to 26±9%).
11
 
However, LVEF may not be a sensitive marker of LV systolic function in these patients. As 
previously demonstrated, patients with chronic severe AR may have impaired GLS despite 
having normal LVEF suggesting the presence of ultrastructural changes of the myocardium.
23
 
GLS may be also a better reflector of the LV performance after AVR. A previous study including 
47 chronic AR patients showed significant postoperative improvement in GLS normalized for 
LVEDV (from about -0.9 %/10 ml to -1.2 %/10 ml; p<0.01).
5
 We found similar results in chronic 
AR patients (from -0.96 %/10 ml to -1.29 %/10 ml; p<0.001). In addition, we demonstrated 
that patients with chronic AR had more impaired GLSi compared to acute AR patients before 
and after surgery suggesting more myocardial dysfunction in the former patients. 
 
Clinical implications 
The present study provides further insight into the effect of AR on LV performance before and 
after AVR. Chronic AR was associated with less LV reverse remodeling and less improvement in 
LV function after aortic valve and root surgery compared with acute AR, which might be 
attributed to increased myocardial fibrosis in patients with chronic AR. Although LVEF was not 
significantly different between patients with acute and chronic AR before as well as after 
surgery, GLSi was less affected in patients who underwent surgery for acute severe AR 
suggesting a lesser degree of microscopic remodeling (myocardial fibrosis and extracellular 
matrix changes) in these patients. 
Current guidelines recommend surgery in asymptomatic patients with chronic severe AR when 
LV dilation (LV end-diastolic diameter >75mm or LV end-systolic diameter >55mm) or LV 
dysfunction (LVEF <50%) occurs. The present study indicates that chronicity of AR is associated 
with diminished postoperative improvement in LV performance and normalization of LV 
volumes. Therefore, more sensitive parameters of LV dysfunction or early remodeling may be 
helpful to improve the outcomes of aortic valve surgery for chronic AR. GLSi is able to detect 
myocardial dysfunction in an earlier stage compared to LVEF.
5,23
 Studies including GLSi in 
surgical decision-making might help in the optimal timing of surgery in patients with chronic 




This was a retrospective study with a limited number of patients. Only patients with 
preoperative and follow-up echocardiography were included in the present analysis which 
might have introduced a selection bias. Clinical data for patients who did not meet the 
inclusion criteria were not collected and therefore comparisons between included and 
excluded patients are not feasible to investigate the differences and selection bias. 
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Furthermore, there was no prospective follow-up protocol, thus echocardiographic follow-up 
was performed at the discretion of the treating cardiologist. The exact duration of AR was 
unknown in the majority of patients with chronic AR; therefore no further analysis could be 




LV reverse remodeling occurs after aortic valve surgery both for acute and chronic AR. 
However, LVEDV was more reduced and GLSi was more preserved during follow-up in patients 
operated for acute AR than in patients with chronic AR. 
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Background: Left ventricular (LV) reverse remodeling after aortic valve replacement (AVR) for 
aortic regurgitation (AR) is associated with superior prognosis. The outcomes of valve-sparing 
aortic root replacement techniques on LV performance have not been compared with LV 
reverse remodeling in AVR. The present evaluation compared the extent of long-term LV 
reverse remodeling in patients with aortic root pathology and/or AR who underwent aortic 
valve repair (AVr) with patients who underwent AVR. 
Methods: A total of 226 patients (54.7±14.3 years, 63% male) with AR or aortic root pathology 
who underwent AVr (n=135) or AVR with the Freestyle stentless aortic root bioprosthesis 
[Medtronic, Inc; Minneapolis, Minnesota] (n=91) were included in the present retrospective 
evaluation. LV volumes and ejection fraction were assessed preoperatively, postoperatively 
(before hospital discharge) and during follow-up. 
Results: Baseline characteristics were comparable between patient groups, except for higher 
prevalence of bicuspid aortic valve anatomy among AVR patients (38% vs. 16%, p<0.001). In 
addition, patients undergoing AVR had significantly larger LV end-diastolic and end-systolic 
volumes than their counterparts. After a median follow-up of 46 months (interquartile range: 
17-78 months), both groups of patients showed a significant and sustained reduction in LV 
end-diastolic and end-systolic volumes, with significantly larger reduction in patients 
undergoing AVR. Ejection fraction decreased significantly postoperatively and improved later 
during follow-up similarly in both groups. The incidence of significant AR at long-term follow-
up was comparable among groups (AVr: 8% vs. AVR: 7%). 
Conclusion: LV reverse remodeling occurs after AVR and AVr, reaching comparable LV volumes 
and function after a median of 4 years of follow-up. 
  




Aortic root pathology is present in 11% of patients with aortic regurgitation (AR).
1
 Valve-
sparing aortic root remodeling/replacement techniques have emerged as safe and effective 
techniques providing long-term stable aortic valve function in selected patients.
2-5
 In patients 
who are not suitable for valve-sparing aortic root remodeling/replacement, aortic root 
replacement with concomitant aortic valve replacement (AVR) using bioprostheses has 
demonstrated excellent results in terms of long-term outcomes, valve function and left 
ventricular (LV) function.
6-8
 In contrast to mitral valve repair and replacement, where the 
evidence shows that mitral valve repair is associated with superior LV function and remodeling 
than mitral valve replacement for patients with primary mitral regurgitation,
9
 the outcomes of 
valve-sparing aortic root remodeling/replacement techniques on LV performance have not 
been compared with AVR. Accordingly, the aim of the present evaluation was to compare 
changes in LV dimensions and function in patients with aortic root pathology and/or aortic 
valve regurgitation who underwent valve-sparing aortic root surgery with patients in whom 




From July 1993 to June 2013, 247 adult patients with AR and/or aortic root pathology 
underwent surgical valve-sparing aortic root reconstruction or surgical AVR using the Freestyle 
stentless aortic root bioprosthesis (Medtronic, Inc; Minneapolis, Minnesota) at the Leiden 
University Medical Center. Twenty-one patients were excluded due to lack of 
echocardiographic data. Patients with concomitant significant mitral or tricuspid valve disease 
(any grade of mitral or tricuspid stenosis and moderate or severe regurgitation) who were 
treated during the same surgical intervention were not excluded. Patients with more than mild 
aortic stenosis were excluded from the present analysis. 
Baseline clinical characteristics, EuroSCORE II and surgical procedures were recorded. In 
addition, LV volumes and function and valvular hemodynamics were assessed with two-
dimensional transthoracic echocardiography preoperatively, postoperatively and during 
follow-up when available. Demographic, clinical, surgical, and echocardiographic data were 
prospectively collected in the departmental Cardiology Information System (EPD-Vision, 
Leiden University Medical Center, Leiden, the Netherlands) and retrospectively analyzed. The 
institutional ethic committee approved this retrospective study and waived the need for 
individual patient consent.  
Patients were divided into two groups: patients undergoing aortic valve repair (AVr) and 
patients who underwent aortic valve replacement using the Freestyle stentless bioprosthesis 
(AVR-F). The incidence of recurrent aortic valve regurgitation over time was assessed. In 
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addition, changes in LV volumes and function over time were assessed and compared between 
these two groups. 
 
Two-dimensional transthoracic echocardiography 
Transthoracic echocardiography was performed at rest with patients in the left decubitus 
position using commercially available ultrasound systems (Vivid 7, E9 or System 5, General 
Electric Healthcare, Vingmed, Horten, Norway) equipped with 3.5-MHz or M5S transducers. 
Two-dimensional, M-mode and Doppler data were acquired at the parasternal, apical, 
subcostal and supra-sternal views according to current recommendations.
10
 The 
echocardiographic data were digitally stored in cine-loop format and data analysis was 
retrospectively performed using EchoPac (112.0.1, GE Medical Systems, Horten, Norway). 
LV end-diastolic (LVEDV) and end-systolic (LVESV) volumes were quantified in the apical 2- and 
4-chamber views using Simpson’s biplane method and LV ejection fraction (LVEF) was 
calculated.
11
 AR grade was assessed using colour, pulsed and continuous wave Doppler 
recordings and using a multiparametric approach that includes the measurement of the jet 
width relative to the LV outflow tract width, vena contracta, the pressure half time of the 
regurgitant flow (if feasible) according to current recommendations.
10
 AR was graded as 0 
(absent), 1 (mild), 2 (mild-moderate), 3 (moderate-severe) or 4 (severe). Peak and mean aortic 
valve gradient were obtained from continuous wave Doppler recordings on the apical long-axis 
of 5-chamber views. 
 
Surgery 
After median sternotomy, arterial cannulation was performed in the distal ascending aorta (in 
elective nondissected pathology and in the absence of dilatation of the distal part of the 
ascending aorta) or the subclavian or femoral artery (in patients with ascending aorta 
dissection or dilatation).  
For valve-sparing aortic root reconstruction, after resecting the native sinuses of Valsalva, a 
graft was implanted using the reimplantation technique (modified David procedure) or the 
remodeling technique (Yacoub technique), as previously described.
12-14
 Concomitant 
procedures (leaflet triangular resection, leaflet resuspension and plication of the free edge of 
the leaflet) were performed if needed. In addition, concomitant aortic arch replacement was 
performed if the luminal diameter at this level was >45 mm or – in cases of dissection – a 
(re)entry tear was present in the arch.  
For AVR using the Freestyle stentless bioprosthesis, the coronary buttons were mobilized and 
the sinuses of Valsalva and the aortic valve were excised. The bioprosthesis was then 
implanted, usually with a 120 degrees clockwise rotation, with interrupted sutures at one 
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Patients underwent transthoracic echocardiography postoperatively before discharge and at 
follow-up (at the discretion of the treating cardiologist).  
 
Statistical analysis 
All data analyses were performed using SPSS software version 20 (SPSS, Chicago, IL). 
Continuous variables were reported as mean ± standard deviation or as median and 
interquartile range (IQR) and categorical variables were reported as numbers and percentages. 
Differences between patients who underwent AVr and those who underwent AVR-F were 
analysed using the unpaired Student’s t-test, Mann-Whitney U test or a chi-square test. Linear 
mixed model analysis was used to assess the differences in change in LV dimensions and 
function over time between the two groups. Type of surgery (AVr or AVR-F) and moment of 
transthoracic echocardiography (preoperative, postoperative or late follow-up) were 
incorporated in the model as fixed variables as well as the interaction between type of surgery 
and moment of transthoracic echocardiography. An unstructured covariance matrix was 
applied. The estimated marginal means ± standard error of the mean were presented. All 
statistical tests were two-sided. A p-value<0.05 was considered statistically significant. 
 
Results 
A total of 226 patients (mean age 54.7±14.3 years, 63% men) who underwent aortic root and 
valve surgery because of aortic regurgitation or aortic root pathology were evaluated. AVr was 
performed in 135 patients. The remaining 91 patients underwent AVR-F. The clinical 
characteristics of both groups of patients were comparable (Table 1). In the AVR-F group, the 
number of patients with bicuspid aortic valve was significantly higher than in the AVr group. 
There were no differences in number of elective surgeries and the surgical risk was 
comparable between groups. There were no differences in the number and type of 
concomitant surgeries performed in both groups. The surgical techniques are summarized in 
Table 1.  
 
Surgical outcome 
There were 5 in-hospital deaths, 2 (1%) in the AVr group and 3 (3%) in the AVR-F group 
(p=0.654). Perioperative complications were comparable between both groups. Postoperative 
bleeding with cardiac tamponade was treated by pericardiocentesis in 20 (15%) AVr and 9 
(10%) AVR-F patients (p=0.377) and/or by resternotomy in 17 (13%) and 8 (9%) patients, 
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respectively (p=0.498). Thromboembolic complications occurred in 14 (10%) AVr patients and 
4 (4%) AVR-F patients (p=0.169). Postoperative atrial fibrillation or flutter was present in 47 
(35%) AVr and 32 (35%) AVR-F patients (p=1).  
 
Table 1. Baseline characteristics.  
 AVr (n=135) AVR-F (n=91) p-value 
Age (years)  54.4 ±13.8 55.2 ±15.0 0.65 
Male   83 (61%) 59 (65%) 0.71 
Smoking  37 (27%) 18 (20%) 0.30 
Diabetes Mellitus  6 (4%) 8 (9%) 0.29 
Hypertension  56 (41%) 33 (36%) 0.54 
Dyslipidaemia  19 (14%) 20 (22%) 0.09 
NYHA functional class    0.47 
 I 58 (43%) 38 (42%)  
 II 45 (33%) 28 (31%)  
 III 19 (14%) 14 (15%)  
 IV 6 (4%) 9 (10%)  
Creatinine clearance (ml/min) 93.6 ± 34.7 97.2 ± 36.8 0.47 
EuroSCORE II (%) 4.3 ± 5.3 5.7 ± 8.9 0.14 
Bicuspid aortic valve 22 (16%) 35 (38%) <0.001 
Elective surgery 96 (71%) 64 (70%) 1 
Mitral valve surgery 25 (19%) 13 (14%) 0.51 
Tricuspid valve surgery 14 (10%) 7 (8%) 0.66 
CABG 19 (14%) 12 (13%) 1 
Valve-sparing aortic root repair 
technique 
   
 None 5 (4%)   
 Restoration STJ 46 (34%)   
 David 68 (50%)   
 Yacoub + Hemi-Yacoub 16 (12%)   
Additional aortic cusp repair 21 (16%)   
Data are presented as mean ± standard deviation or as number (percentage). CABG: coronary artery by-
pass grafting. EuroSCORE: European System for Cardiac Operative Risk Evaluation. NYHA: New York Heart 
Association; STJ: sinotubular junction 
 
Valvular hemodynamics after AVr versus AVR-F 
In the entire cohort, the median echocardiographic follow-up duration was 46 months (IQR: 17 
to 78 months). The median echocardiographic follow-up duration was 49 months (IQR: 18 to 
76 months) in the AVr group and 34 months (IQR: 12 to 83 months) in the AVR-F group 
(p=0.697). The AR grade over time is displayed in Figure 1. In the AVr group, 44% of the 
patients had preoperatively grade 3 or 4 AR, compared to 47% in the AVR-F group (p=0.81). 
Immediately after surgery, 99% of the patients in the AVR-F group had grade <2 AR, compared 
to 83% in AVr group (p = 0.002). During follow-up, the percentage of AR grade 3 and 4 was 
similar between groups (AVr: 8% vs. AVR-F: 7%, p=1).  




Figure 1. Aortic regurgitation grade over time 
Displayed as percentages per group in AVr and AVR-F. AR: aortic regurgitation.  
 
The peak and mean aortic valve gradients over time are displayed in table 2. The peak aortic 
valve gradient was preoperatively and postoperatively lower in the AVr group compared to the 
AVR-F group. At late follow-up, there was no significant difference in peak aortic valve 
gradient between the two groups. The mean aortic valve gradient in the AVr group remained 
stable over time. In the AVR-F group, the mean aortic valve gradient was slightly higher before 
surgery as well as after surgery compared to the AVr group. There was a significant difference 
in peak and mean gradients over time between the groups (p=0.002 and p=0.005, 
respectively).  
 
LV reverse remodeling after AVr versus AVR-F 
Table 2 summarizes echocardiographic characteristics of patients undergoing AVr and AVR-F at 
baseline, immediately postoperatively and during follow-up. Patients treated with AVR-F 
showed significantly larger LVEDV and LVESV at baseline compared with patients undergoing  
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Table 2. Echocardiographic characteristics. 
Data are presented as estimated marginal means ± standard error of the mean. Within groups: * p<0.05 
vs preoperative, 
†
 p<0.05 vs. postoperative. LVEDD: left ventricular end-diastolic diameter, LVEDV: left 
ventricular end-diastolic volume; LVEF: left ventricular ejection fraction; LVESD: left ventricular end-
systolic diameter; LVESV: left ventricular end-systolic volume. 
 
AVr. However, LVEF was comparable between the two groups. Figure 2 illustrates the changes 
in LV volumes and function over time. In the AVr-group there was a significant decrease in 
LVEDV acutely after surgery and remained stable at long-term follow-up. In contrast, LVESV 
remained unchanged immediately after surgery and reduced significantly at long-term follow-
up.  LVEF decreased significantly postoperatively but normalized at long-term follow-up. In 
patients who underwent AVR-F, LVEDV and LVESV showed a significant reduction immediately 
after surgery and remained stable at long-term follow-up. Similarly to the group of patients 
undergoing AVr, LVEF decreased significantly after surgery and normalized later during follow-
up.  
 
 AVr (n=135) AVR-F (n=91) p-value 
Peak aortic valve gradient (mmHg)    
 Preoperative 11.2 ± 0.7 18.9 ± 1.1 <0.001 
 Postoperative 11.5 ± 0.6 15.1 ± 1.0 *  0.01 
 Late follow-up 17.9 ± 7.1 14.1 ± 1.6 * 0.83 
Mean aortic valve gradient (mmHg)    
 Preoperative 6.4 ± 0.4 10.7 ± 0.6 <0.001 
 Postoperative 6.6 ± 0.3 8.4 ± 0.6 * 0.04 
 Late follow-up 5.8 ± 0.3 8.2 ± 1.1 0.002 
LVEDD (mm)    
 Preoperative 53.4 ± 0.9 56.1 ± 1.2 0.20 
 Postoperative 47.2 ± 0.7 * 48.5 ± 0.9 * 0.61 
 Late follow-up 49.2 ± 0.8 *
†
 48.7 ± 1.2 * 0.91 
LVESD (mm)    
 Preoperative 36.1 ± 0.9 37.0 ± 1.2 0.75 
 Postoperative 34.3 ± 0.8 35.9 ± 1.0  0.41 
 Late follow-up 33.0 ± 0.9 * 32.2 ± 1.2 *
†
 0.66 
LVEDV (ml)    
 Preoperative 125.9 ± 4.8 156.5 ± 6.4 0.002 
 Postoperative 109.9 ± 3.7 * 116.3 ± 4.8 * 0.36 
 Late follow-up 112.3 ± 4.0 * 117.0 ± 6.6 * 0.65 
LVESV (ml)    
 Preoperative 59.0 ± 3.4 75.0 ± 4.3 0.045 
 Postoperative 56.6 ± 3.0 60.1 ± 3.7 * 0.56 
 Late follow-up 51.0 ± 2.7 * 56.4 ± 4.8 * 0.43 
LVEF (%)    
 Preoperative 55.1 ± 1.0 54.0 ± 1.0 0.86 
 Postoperative 50.9 ± 1.0 * 50.9 ± 1.1 * 0.99 
 Late follow-up 56.5 ± 0.9 
†
 54.8 ± 1.4 
†
 0.34 
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Figure 2. Left ventricular volumes and function over time in AVr compared to AVR-F.  
Data are displayed as estimated marginal means ± standard error of the mean. Group-time interaction p-
value is given per variable. LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular ejection 
fraction; LVESV: left ventricular end-systolic volume. 
 
The change in LVEDV and LVESV was significantly different between groups since the group of 
patients undergoing AVR-F had significantly larger volumes at baseline compared to the group 
of patients treated with AVr. In contrast, there were no significant differences in LVEF changes 
between groups (Figure 2). 
 
Discussion 
The present study compared the effect of valve-sparing aortic root reconstruction versus AVR 
on LV remodeling and function at follow-up. Patients with aortic root pathology and/or AR 
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who undergo these surgical techniques have long-term freedom of recurrence of AR ≥ grade 3 
and show favourable LV reverse remodeling with preserved LVEF during follow-up.   
Chronic significant AR leads to volume and pressure overload of the LV which responds with 
an increase in LV dimensions to maintain LVEF.
16
 If left untreated, the compensatory LV 
remodeling eventually fails and LVEF decreases. Patients with severe AR and LV dilation or 
dysfunction have poor survival if they remain under medical treatment and consequently 
current guidelines recommend surgical aortic valve replacement in case of symptoms, 
LVEF<50% or LV end-diastolic diameter >75 mm or end-systolic diameter >55mm.
17
 The 
surgical technique to use depends on the anatomical characteristics of the aortic valve and 
aortic root and the experience of the surgeon. Aortic valve repair techniques have shown good 
outcomes in selected patients. A systematic review of the outcomes of aortic valve repair 
pooling data from 2,891 patients undergoing aortic valve repair procedures showed an early 
mortality of 2.6% and a 5-year survival free from aortic valve reintervention and >grade 2 AR 
of 92% and 88%, respectively.
18
 The late mortality was 1.3%/patient-year.
18
 However, these 
results are derived from centers with high experience in aortic valve repair techniques which 
are continuously evolving. In addition, previous series have not compared aortic valve repair 
and replacement in terms of LV performance outcomes. In contrast to mitral valve repair for 
primary mitral regurgitation, with an overwhelming evidence showing the superior outcomes 
in terms of LV function and remodeling over mitral valve replacement (particularly without 
preserving the subvalvular apparatus),
9
 there is a paucity of data on the LV outcomes of aortic 
valve repair and replacement techniques.   
Changes in LV dimensions and function after AVR for significant AR have been reported in 
several studies.
19,20
 In a series of 40 patients with severe AR, Gentles et al. showed significant 
decreases in LVEDV and LVESV at 7 ± 2 months after AVR while LVEF remained stable.
20
 This 
decrease in LV volumes can be observed acutely after AVR due to an acute correction of the 
volume overload with the consequent reduction in LVEF. However, at follow-up, this LV 
reverse remodeling remains with further reduction in LVESV which results in improvement and 
sometimes normalization of LVEF.
8,21,22 
In 93 patients with severe AR undergoing surgical AVR, 
Tanoue et al. showed that the LVEF changed from 60.2 ± 11.0% preoperatively to 51.9 ± 14.6% 
directly postoperative and to 57.9 ± 15.2% at 1 year follow-up.
22
 This was accompanied by 
significant reductions in LVEDV and LVESV that were sustained at 1 year follow-up.    
A few series have described changes in LV volumes and function after valve sparing aortic root 
reconstruction.
23,24
 In patients undergoing these surgical techniques, the presence of 
recurrent, significant AR may theoretically halt the LV reverse remodeling process. However, 
this has not been described. Leshnower et al. evaluated changes in LV volumes and function in 
51 patients undergoing David-V reimplantation technique.
23
 The authors reported a significant 
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decrease in LV end-diastolic and end-systolic diameters during follow-up. Furthermore, LVEF 
improved from 51 ± 7% to 57 ± 6% during a mean follow-up period of 18 months.  
The present study provides further insight into this field by comparing changes in LV volumes 
and function between patients undergoing AVr and patients treated with AVR-F. Both groups 
of patients showed significant reductions in LVEDV acutely after surgery and remained stable 
at follow-up. However, LVESV significantly reduced acutely in the group of patients undergoing 
AVR-F whereas their counterparts showed a further significant LV reverse remodeling at long-
term follow-up. This indicates either a different pattern of LV reverse remodeling that may be 
associated with the surgical technique, or be related to the larger pre-operative volumes in the 
AVR-F group. Additional studies including larger number of patients are needed to confirm 
these results. In addition, similarly to previous series, LVEF reduced immediately after surgery 
but recovered at long-term follow-up.  
The results of the present study demonstrate that a durable repair of the aortic valve in 
patients with AR or aortic root pathology is associated with beneficial LV reverse remodeling 
and preserved LVEF at follow-up. LV dimensions and function are important prognostic 
determinants in patients with significant AR and accordingly, current guidelines recommend 
AVR when significant LV dilatation or reduced LVEF coexist.
17
 Similarly to mitral valve repair for 
primary mitral regurgitation, the possibility of performing a durable aortic valve repair may 
impact on current guidelines, recommending aortic valve repair in patients with severe AR 
who do not have yet a significant damage of the left ventricle (LV dilatation or reduced LVEF). 
Prospective randomized trials comparing a watchful waiting strategy versus aortic valve repair 
would provide the evidence to this unmet clinical need.  
Some limitations should be acknowledged. The present study was retrospective and non-
randomized. The surgeon decided intraoperatively whether AVr was feasible. If not, AVR-F was 
performed, which may have introduced a selection bias. Furthermore systematic preoperative, 
postoperative and follow-up echocardiography was not available in few patients. In addition, 
the duration of significant AR before surgery was not recorded. This may have resulted in 
higher preoperative LV volumes in the AVR-F group which may have the effect of more 
impressive LV reverse remodeling postoperatively. This study compared the Freestyle stentless 
aortic root bioprosthesis with a valve sparing technique. Similar results may not occur with 
stented bioprosthetic or mechanical valves as the replacement technique. 
 
Conclusion 
In conclusion, LV reverse remodeling occurs both after aortic valve replacement and repair 
and comparable LV volumes and function are reached during a median follow-up of 4 years. 
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Background: Differences in recurrence rate of aortic regurgitation (AR) and extent of left 
ventricular (LV) remodeling across the different surgical options in patients operated for type 
A aortic dissection remain unknown. The present evaluation compared the AR recurrence rate 
and changes in LV volumes and systolic function among valve-sparing aortic root replacement 
(VSAR), supracoronary ascending aorta replacement (SCAR) and aortic valve and root 
replacement (AVAR). 
Methods: A total of 97 patients (58±12 years, 62% men) with acute type A aortic dissection 
who underwent VSAR (n=24), SCAR (n=43) or AVAR (n=30) were evaluated. Changes in LV 
volumes and function between postoperative and follow-up were compared using linear 
mixed models.  
Results: Postoperative AR grades were not significantly different between groups. However 
after median follow-up of 47 months, AR grade ≥2 was significantly more often observed in 
SCAR (55%) and VSAR (25%) compared to AVAR (0%, p<0.001). LV volumes remained stable in 
VSAR and AVAR but increased significantly in SCAR (LV end-diastolic volume: from 99±4 to 
131±6 ml; p<0.001; LV end-systolic volume: from 49±3 to 66±5 ml; p=0.002). Among patients 
with recurrent AR grade ≥2 at follow-up, LV volumes increased whereas patients without 
recurrent AR did not show significant LV dilatation. 
Conclusion: Patients with acute type A aortic dissection who underwent SCAR or VSAR showed 
more frequently AR grade ≥2 recurrence compared to AVAR. However, only patients who 
underwent SCAR experienced adverse LV remodeling at follow-up. Recurrence of AR grade ≥2 








Acute type A aortic dissection is a life-threatening condition with 50% mortality within the first 
48 hours if left unoperated.
1
 Resection of the primary intimal tear, stabilization of the aortic 
wall and prevention of aortic rupture are the surgical goals and can be achieved by performing 
a valve-sparing aorta replacement (VSAR), supracoronary ascending aorta replacement (SCAR) 
or aortic valve and aorta replacement (AVAR).
2
 Previous studies showed no difference in 
perioperative and mid-term survival between these surgical procedures.
3,4
 However, SCAR is 
associated with dilatation of the aortic sinuses and recurrence of aortic regurgitation (AR) at 
follow-up which may warrant a relatively high risk on reoperation.
1,5
 Furthermore, recurrence 
of AR at follow-up may lead to left ventricular (LV) dilation and systolic dysfunction. However, 
the effects of the type of surgery for acute type A aortic dissection on LV volumes and function 
during follow-up have not been evaluated. The aim of the present study was to assess 
differences in LV remodeling during follow-up for the several surgical procedures in patients 





Patients with acute type A aortic dissection who underwent surgery at the Leiden University 
Medical Center between 1 July 1994 and 1 July 2013 and who survived the initial 
hospitalization were evaluated. Patients were included if postoperative transthoracic 
echocardiography was available. Ninety-seven patients were divided into three groups 
according to the surgical procedure performed: VSAR (n=24), SCAR (n=43) or AVAR (n=30). 
Patients with connective tissue disease were excluded.  
Clinical and surgical characteristics were prospectively collected in the departmental 
Cardiology Information System (EPD-Vision®, Leiden University Medical Center, Leiden, The 
Netherlands) and retrospectively analyzed. LV volumes and function were evaluated with two-
dimensional transthoracic echocardiography postoperatively and during follow-up (≥6 months 
after surgery, available in 53 patients). The institutional ethical committee approved this 
retrospective study and waived the need for informed consent in patients followed in the 
Leiden University Medical Center. Written informed consent was obtained when patients were 
followed in the referral hospital. Changes in LV volumes and function over time were assessed 
and compared between the three different surgical procedures. In addition, the incidence of 
recurrent AR over time was assessed. 
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Two-dimensional transthoracic echocardiography 
Transthoracic echocardiography was performed with commercially available ultrasound 
systems (Vivid 7, E9 or System 5, General Electric Healthcare, Vingmed, Horten, Norway) 
equipped with 3.5-MHz or M5S transducers. The echocardiographic data were digitally stored 
in cine-loop format and data analysis was retrospectively performed using EchoPac (112.0.1, 
GE Medical Systems, Horten, Norway). LV volumes were quantified at end-diastole and end-
systole in the apical 2- and 4- chamber views using the Simpson’s biplane method and LV 
ejection fraction was calculated.6 AR grade was assessed using a multiparametric approach 
that included the measurement of the jet width relative to the LV outflow tract width, vena 






The decision to perform VSAR, SCAR or AVAR was left at the discretion of the surgeon on duty. 
During VSAR, the native sinuses of Valsalva were resected and a graft was implanted using the 
reimplantation technique (modified David procedure, n=19) or the remodeling technique 
(Yacoub technique, n=5), as previously described.
8,9
 Concomitant procedures (leaflet triangular 
resection, leaflet resuspension and plication of the free edge of the leaflet) were performed if 
needed. For SCAR, the ascending aorta was resected until the sinotubular junction and 
replaced by a Hemashield tubular graft.
10
 If necessary, resuspension of the commissures 
(n=15) and/or restoration of the sinuses of Valsalva using bioglue (n=24) or gelatin-resorcin-
formalin glue (n=5) was performed.
11
 During AVAR, the native sinuses of Valsalva and valve 
were excised and replaced by either a biological (n=18) or mechanical prosthesis (n=12).
12,13
 In 
every patient the distal ascending aorta and arch were inspected under deep hypothermic 
circulatory arrest. If a (re)entry tear was present in the arch, concomitant (hemi-)arch 
replacement was performed.  
Follow-up 
All patients underwent transthoracic echocardiography postoperatively before discharge. 
Transthoracic echocardiography at follow-up was performed at the discretion of the treating 
cardiologist. Follow-up echocardiography was available in 53 patients and was included in the 
present study when it was performed at least 6 months after surgery. The median 
echocardiographic follow-up duration was 47 months (interquartile range: 18-76 months) and 
comparable between the 3 groups (VSAR: 49 months, interquartile range: 19-74 months. 
SCAR: 55 months, interquartile range: 31-77 months. AVAR: 24 months, interquartile range: 
12-56 months; p=0.150).  
 
  




Data analysis was performed using SPSS software version 20 (SPSS, Chicago, IL). Continuous 
variables were reported as mean±standard deviation or median and interquartile range (IQR) 
when appropriate. Categorical variables were reported as numbers and percentages. 
Differences between the 3 different surgical procedures were analysed using analysis of 
variance test, Kruskall-Wallis test or Chi-square test. Survival and freedom from reoperation 
were analyzed using the Kaplan-Meier curves and differences among surgical procedures were 
assessed with the log-rank test. Linear mixed model analysis was used to assess the 
differences in change in LV volumes and LV ejection fraction over time among the groups. 
Type of surgery (VSAR, SCAR or AVAR) and timing of transthoracic echocardiography 
(postoperative or late follow-up) were incorporated in the model as fixed variables as well as 
the interaction between type of surgery and timing of transthoracic echocardiography. An 
unstructured covariance matrix was applied. The estimated marginal mean ± standard error of 
the mean was presented. Post-hoc analyses were performed using the Bonferroni test to 
correct for multiple comparisons. Subgroup analysis was performed to compare LV remodeling 
in patients with and without recurrent AR grade ≥2. All statistical tests were two-sided. A p-
value<0.05 was considered statistically significant. 
 
Table 1. Baseline clinical and surgical characteristics.  







Age (years) 50±7 62±11 58±14 <0.001 
Male gender 20 (83%) 22 (51%) 18 (60%) 0.033 
Diabetes mellitus 0 (0%) 0 (0%) 2 (7%) 0.087 
Hypertension 6 (25%) 26 (60%) 12 (40%) 0.018 
Dyslipidemia 0 (0%) 4 (9%) 2 (7%) 0.374 
Critical preoperative state 0 (0%) 2 (5%) 2 (7%) 0.460 
EuroSCORE II (%) 4.7 (4.1-6.4) 5.3 (3.4-7.2) 6.0 (4.8-8.0) 0.069 
Bicuspid aortic valve 1 (4%) 0 (0%) 6 (20%) 0.004 
CPB time (min) 267±75 191±48 253±66 <0.001 
AoX time (min) 209±66 119±38 178±48 <0.001 
Aortic (hemi-)arch replacement 14 (58%) 16 (37%) 15 (50%) 0.299 
Mitral valve surgery 0 (0%) 1 (2%) 0 (0%) 0.530 
Coronary bypass   0 (0%) 1 (2%) 2 (7%) 0.345 
Data are presented as mean ± standard deviation, median (interquartile range) or as number 
(percentage). AoX time: Aortic cross clamp time. AVAR: Aortic valve and aorta replacement. CPB time: 
Cardiopulmonary Bypass time. EuroSCORE II: European System for Cardiac Operative Risk Evaluation. 
SCAR: Supracoronary ascending aorta replacement. VSAR: Valve sparing root replacement. 
 
  




A total of 97 patients (mean age 58±12 years, 62% men) who underwent emergent surgery for 
acute type A aortic dissection and survived the index hospitalization were evaluated. Table 1 
shows the baseline clinical and surgical characteristics of the patients. Patients who 
underwent VSAR were significantly younger and more often male than patients who 
underwent SCAR or AVAR. Hypertension was more often present in patients undergoing SCAR 
compared to patients treated with VSAR or AVAR. The EuroSCORE II was slightly higher among 
patients who underwent AVAR compared to VSAR and SCAR. In SCAR, the cardiopulmonary 
bypass and aortic cross clamp times were significantly shorter compared to VSAR and AVAR. 
 
Survival and reoperation during follow-up 
The 5-year survival in this cohort was 91±4% and was not significantly different between the 
surgical procedures (VSAR: 100%, SCAR: 90±6%, AVAR: 82±10%; log rank p=0.653; Figure 1A). 
Reoperation at follow-up on the proximal and/or distal thoracic aorta was performed in 2 
VSAR, 8 SCAR and 4 AVAR patients. The freedom from reoperation on the proximal and or 
distal aortic after 5 years follow-up was 86±5% and comparable between the groups (VSAR: 
95±5%, SCAR 83±8%, AVAR: 77±13%; log rank p=0.516; Figure 1B).  
However, when considering only reoperation on the proximal aorta, aortic valve replacement 
was performed in 2 and 7 patients treated initially with VSAR and SCAR respectively, while 
none of the patients treated with AVAR required reoperation of the proximal aorta. Reasons 
for reoperation were severe recurrent AR in 7 patients, dilatation of the sinuses of Valsalva 
without AR in 1 patient and aortic valve stenosis in 1 patient. Therefore, the 5-year freedom 
from proximal reoperation after SCAR (88±7%) was slightly less favorable compared with VSAR 
and AVAR (95±5% and 100%, log rank p=0.060; Figure 1C). 
 
Aortic regurgitation after surgery 
The prevalence of significant AR directly postoperatively and during follow-up is displayed in 
Figure 2. Postoperative AR grade ≥2 was present in 13% of patients who underwent VSAR 
compared to 8% in patients who underwent SCAR and 4% of patients who underwent AVAR 
(p=0.136). In contrast, at long-term follow-up, there was a significant difference in AR grade 
between the surgical procedures: in patients who underwent VSAR or SCAR, AR grade ≥2 was 
observed in 25% and 55% of patients, respectively, whereas none of the patients who 








Figure 1. Kaplan-Meier curves for survival, survival-freedom from reoperation and survival-freedom 
from proximal aorta reoperation. 
AVAR: Aortic valve and aorta replacement. SCAR: Supracoronary ascending aorta replacement. VSAR: 
Valve sparing aorta replacement. 




Figure 2. Aortic regurgitation grade postoperatively and during follow-up.  
AR: Aortic regurgitation. AVAR: Aortic valve and root replacement. SCAR: Supracoronary ascending aorta 
replacement. VSAR: Valve sparing root replacement. 
 
LV remodeling after surgery 
The immediately postoperative LV end-diastolic volume, LV end-systolic volume and LV 
ejection fraction were comparable among the 3 groups (Figure 3). However, there was a 
significant difference in the LV end-diastolic volume and LV end-systolic volume at late follow-
up among the surgical procedures. In the VSAR group, the LV end-diastolic volume (108±9 vs. 
105±9 ml; p=0.756) and LV end-systolic volume (54±7 ml vs. 47±6 ml; p=0.387) remained 
stable. In contrast, the LV end-diastolic volume increased during follow-up in SCAR (99±4 vs. 
131±6 ml; p<0.001). The LV end-systolic volume also increased significantly in the SCAR group 
from 49±3 to 66±5 ml (p=0.002). After AVAR, the volumes remained stable. 
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Figure 3. Left ventricular volumes and 
function over time. 
Left ventricular volumes and function over 
time in VSAR, SCAR and AVAR. Data are 
displayed as estimated marginal means ± 
standard error of the mean. Time 1 
represents measurement directly 
postoperatively and time 2 represents 
measurement during follow-up. * p<0.05 
compared to postoperative. Group-time 
interaction p-value is given per variable. 
AVAR: Aortic valve and aorta replacement. 
LVEDV: left ventricular end-diastolic volume; 
LVEF: left ventricular ejection fraction; 
LVESV: left ventricular end-systolic volume. 
SCAR: Supracoronary ascending aorta 
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The LV ejection fraction tended to improve in VSAR patients (53±2 vs. 57±2%; p=0.074), while 
it remained stable in both SCAR (52±1 vs. 51±2%; p=0.546) and AVAR (52±1 vs. 54±2%; 
p=0.489). The group-time interaction effect on LV end-diastolic volume (p=0.008) and LV end-
systolic volume (p=0.018) indicated a significant effect of the type of surgery on the change in 
LV volumes over time. 
 
Effect of recurrent AR on LV remodeling 
A subgroup analysis was performed in 53 patients with late follow-up echocardiography 
available to compare LV remodeling in patients with recurrent AR grade ≥2 versus patients 
without recurrent AR during follow-up (Table 2). Patients with recurrent AR grade ≥2 
experienced significant increase in the LV end-diastolic volume and LV end-systolic volume 
whereas the LV volumes remained stable in patients without recurrent AR. Furthermore, the 
LV ejection fraction improved in patients without recurrent AR compared to deterioration in 
patients with recurrent AR grade ≥2. 
 
Table 2. LV remodeling in patients with and without recurrent aortic regurgitation. 
 Recurrent aortic regurgitation  
 No (n=38) Yes (n=15) p-value 
LV end-diastolic volume (ml)   0.001 
 Postoperative 112±6 89±7  
 Late follow-up 115±6 132±9*  
LV end-systolic volume (ml)   0.001 
 Postoperative 55±4 43±5  
 Late follow-up 52±4 69±7*  
LV ejection fraction (%)   0.003 
 Postoperative 53±1 53±3  
 Late follow-up 56±1* 49±3*  
Data are presented as estimated marginal means ± standard error of the mean. Within groups: *p<0.05 
vs postoperative, LV: left ventricular. 
 
Discussion 
The main findings of the present evaluation can be summarized as follows: patients who 
underwent SCAR for acute type A aortic dissection had more adverse LV remodeling and 
recurrent AR grade ≥2 at follow-up as compared with patients who underwent VSAR or AVAR. 
Furthermore, recurrent AR grade ≥2 at follow-up was associated with more adverse LV 
remodeling and deterioration of LV function. 
 
Selection of operative technique in acute type A aortic dissection  
Surgical treatment reduces the mortality of acute type A aortic dissection from 90% to 30% 
and therefore is considered the treatment of choice.
1,14
 The optimal operative technique will 
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depend on the underlying pathophysiology (pre-existing aortopathy associated with 
connective tissue), extent of the proximal dissection towards the aortic valve, aortic valve 
competence, aortic annulus dimensions and associated patient’s comorbidities. While the 
SCAR approach is the quickest technique, it is well known that in patients with diseased aortic 
tissue (i.e. Marfan syndrome), this technique is associated with increased risk of redissection, 
aneurysm formation and subsequent significant AR because of aortic dilatation (incidence 
between 25-45%).
15,16
 In contrast, AVAR replaces the ascending aorta with a valved tubular 
graft and has shown excellent results.
3
 However, this technique (when performed using a 
mechanical prosthesis) is associated with the need of lifelong anticoagulation and increased 
risk of bleeding and thromboembolic complications.
17
 Accumulating data have shown the 
feasibility and safety of the VSAR procedure with excellent results at short- and long-term 
follow-up.
3,18-20
 Although the VSAR procedure is more time-demanding, several registries have 
shown lower early mortality and similar long-term survival for this technique compared with 
SCAR and AVAR.
3,18
 In addition, VSAR and AVAR resulted in comparable AR recurrence rates.
21 
Early mortality is one of the main factors to choose the appropriate surgical technique in 
patients with acute type A aortic dissection. According to previous series, the 5-year survival of 
initial hospital survivors is comparable between the 3 surgical procedures ranging between 
65%-88% after AVAR, 64%-81% after SCAR and 65%-89% after VSAR.
3,18-20, 22-24
 The present 
study showed comparable 5-year survival rates for each surgical technique. However, the 
long-term outcomes of the surgical techniques differ significantly among the 3 surgical 
techniques in terms of reoperation due to aneurysm formation and significant AR recurrence. 
Similarly to previous series, the present study showed increased risk of reoperation due to 
significant AR among patients treated with SCAR.
3,5
  
However, to date, the effects of recurrent significant AR on LV dimensions and function have 
not been evaluated. The present study showed significant adverse LV remodeling after SCAR. 
Furthermore, adverse LV remodeling was present in patient with recurrent AR grade ≥2 
compared to stable LV volumes in patients without recurrent AR. Aiming at restoring aortic 
valve competence and performing a durable repair is an important goal in surgical techniques 
for acute type A aortic dissection in order to avoid AR recurrence and further deterioration of 
the left ventricle at follow-up. 
 
Clinical perspective 
The present study provides additional information to be taken into consideration when 
selecting the surgical approach in patients with acute type A aortic dissection. Patients who 
undergo SCAR benefit from shorter cardiopulmonary bypass and aortic cross clamp times, 
which is therefore often performed in older patients.
3
 However, SCAR is associated with higher 
rates of AR recurrence, adverse LV remodeling during mid-term follow-up and higher 
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reoperation rate on the aortic valve and proximal aorta. Therefore, the risk of the initial 
surgery should be weighed against long-term outcome when selecting the surgical procedure. 
Whether LV remodeling after surgery for acute type A aortic dissection is associated with 
worse clinical outcome should be elucidated in future clinical research. 
 
Limitations 
Some limitations should be acknowledged. This was a retrospective study with a limited 
number of patients. Patients who survived the initial hospitalization and who underwent 
transthoracic echocardiography before discharge were included introducing an important 
selection bias. The applied surgical technique was not randomly assigned. Preoperative 
transthoracic echocardiography was not systematically available and therefore preoperative 
AR grade, LV volumes and LV function, which could be different between the groups, were not 
included in the analysis. Furthermore, late follow-up echocardiography could only be 
performed in patients who survived the first 6 months after surgery. The present study was 
performed in a tertiary care hospital to which patients were referred from other hospitals. 
Follow-up echocardiograms were performed at the discretion of the treating cardiologist and 
were retrieved from the referring hospital when possible. Therefore, late follow-up 
echocardiography was available in only 53 patients of the complete cohort of 97 patients. In 
addition, computed tomography data of the aorta were not systematically available. The small 
number of patients limited further multivariate analyses to assess independent predictors of 
AR recurrence after surgery for acute type A dissection. Furthermore, the impact of changes in 
LV volumes and function at follow-up on the clinical outcome was not evaluated.  
 
Conclusion 
Patients with acute type A aortic dissection who underwent SCAR showed more frequently AR 
grade ≥2 recurrence which was associated with adverse LV remodeling. 
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Background: Conventional aortic valve replacement (AVR), sutureless AVR (su-AVR) or 
transcatheter AVR (TAVI) for severe aortic stenosis (AS) are associated with conduction 
abnormalities. The aim of the present study was to assess the incidence of left bundle branch 
block (LBBB) after su-AVR and TAVI, in comparison to conventional AVR. 
Methods: A total of 501 patients (mean age 74±8 years, 53% men) without preoperative 
cardiac conduction disturbances who underwent AVR or TAVI were included. 
Results: Su-AVR patients and TAVI patients had a higher incidence of new-onset LBBB at 
hospital discharge (23% and 16%, respectively) compared to patients treated with 
conventional AVR (4%; p<0.001). On multivariate logistic regression analyses, type of surgery 
was independently associated with complete LBBB, taking age, preoperative QRS duration and 
heart rate into account (su-AVR and TAVI relative to the reference category  conventional AVR: 
odds ratio, 8.5; 95% confidence interval, 3.7-19.5; p<0.001 and odds ratio, 5.8; 95% confidence 
interval, 2.4 – 14.1; p<0.001, respectively). 
Conclusion: Su-AVR and TAVI were associated with higher risk of developing postoperative 
LBBB compared to conventional AVR, after adjusting for age, preoperative heart rate and QRS 
duration.  




Severe aortic stenosis (AS) is the most prevalent valvular heart disease among elderly 
populations.
1
 Selection of type of aortic valve replacement (AVR, surgical versus transcatheter) 
and type of prosthesis (biological versus mechanical) depends on clinical characteristics and 
operative risks of the patients.
2
 Particularly in the subgroup of elderly patients with 
symptomatic severe AS, a bioprosthesis is preferred over a mechanical prosthesis in order to 
minimize the risks of bleeding associated with life-long anticoagulation treatment.
3
 The advent 
of transcatheter aortic valve implantation (TAVI) and the development of sutureless biological 
prostheses have expanded the therapeutic alternatives in elderly patients with symptomatic 
severe AS. In high surgical risk patients, several studies have shown comparable mid-term 
outcomes of transcatheter bioprostheses, sutureless bioprostheses and stented 
bioprostheses.
4,5
 One of the complications that may occur after TAVI and surgical aortic valve 
replacement (AVR) is new-onset left bundle branch block (LBBB).
6
 However, there is a wide 
range in reported incidences of new-onset LBBB which may be explained by the presence of 
pre-existing conduction disturbances, position of the prosthesis into the left ventricular (LV) 
outflow tract and type of prosthesis.
7-10
 The aim of the present study was to assess the 
incidence and factors associated with the development of LBBB after su-AVR and TAVI, in 




Of 682 patients who underwent AVR from 2008 to 2014 at the Leiden University Medical 
Center (The Netherlands), 501 were considered eligible based on analyzable pre- and 
postoperative electrocardiograms (ECG) and preoperative transthoracic echocardiography. 
Patients were divided into three groups, based on the treatment: su-AVR, TAVI or 
conventional AVR (Figure 1). Clinical characteristics were prospectively collected in the 
departmental Cardiology Information System (EPD-Vision®, Leiden University Medical Center, 
Leiden, The Netherlands) and retrospectively analyzed. The institutional review board 
approved this retrospective analysis of clinically acquired data and waived the need for patient 
written informed consent. 
 
Electrocardiography 
Standard 12-lead ECG were obtained before and after surgery at the day of hospital discharge. 
Heart rate, rhythm, heart axis, QRS duration and presence of bundle branch block were 
assessed. Right bundle branch block (RBBB) was defined as a QRS duration >120 ms in the 
presence of typical RBBB-morphology (rR’ in V1). Left bundle branch block (LBBB) was defined  





Figure 1. Flowchart of patient inclusion. 
AVR: aortic valve replacement; BBB, bundle branch block; ICD, implantable cardioverter defibrillator; 
LBBB, left bundle branch block; RBBB, right bundle branch block; su-AVR, sutureless aortic valve 
replacement; TAVI, transcatheter aortic valve implantation.   
 
as QRS duration >120 ms and QRS complex negative in V1 with a small R or no R. Strict criteria 
were applied to define complete LBBB (QRS >140 ms in male and >130 ms in female with 




Two-dimensional transthoracic echocardiography 
Preoperative transthoracic echocardiography was performed using commercially available 
ultrasound systems (System Five, Vivid 7, and E9, General Electric Healthcare, Vingmed, 
Horten, Norway) equipped with 3.5-MHz or M5S transducers. Parasternal, apical, subcostal 
and supra-sternal views were obtained according to current recommendations.
12
 The 
echocardiographic data were digitally stored in cine-loop format and data were retrospectively 
analyzed using commercially available software (EchoPac 112.0.1, GE Medical Systems, 
Horten, Norway). Left ventricular (LV) dimensions and ejection fraction (LVEF) were assessed 
as recommended.
12,13
 Preoperative aortic valve function was evaluated using colour Doppler, 
continuous and pulsed wave Doppler according to current recommendations.
14,15
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Aortic valve replacement and transcatheter aortic valve implantation   
Treatment of aortic stenosis (surgical versus transcatheter) was decided based upon heart 
team discussions. Among patients who underwent surgical AVR, only patients who received a 
stented bioprostheses were selected in order to minimize heterogeneity and to ensure 
comparable groups in terms of number of patients. Su-AVR was performed as previously 
described with Sorin Perceval S valve (Sorin Biomedica Cardio Srl, Sallugia, Italy) or Medtronic 
3f Enable valve (Medtronic Inc, Minneapolis, Minnesota).
16
  
TAVI was performed according to current recommendations.
17
 Only patients who underwent 
TAVI via the transfemoral approach were included to minimize heterogeneity. Balloon 
valvuloplasty was performed under rapid right ventricular pacing prior to transfemoral 
implantation of a balloon-expandable prosthesis (Edwards SAPIEN valve, Edwards Lifescienes 
Corp, Irvine, California) or self-expandable prosthesis (Medtronic CoreValve, Medtronic Inc, 
Minneapolis, Minnesota). Figure 2 shows schematically the position of the different implanted 
prostheses in relation to the conduction system, in particular the left bundle branch.  
 
 
Figure 2. Schematic overview of prosthesis implantation. 
A: a 3-chamber view with the bundle branches. The su-AVR prosthesis (B) and TAVI prosthesis (C) were 
placed intra-annular. The conventional stented AVR prosthesis (D) was placed supra-annular.  Ao, aorta; 
LA, left atrium; LBB, left bundle branch; LV, left ventricle; RBB, right bundle branch 
 
Statistical analyses 
All data analyses were performed using the SPSS software (Version 20.0. Armonk, NY: IBM 
Corp). Continuous variables were reported as mean ± standard deviation or median and 
interquartile range, as appropriate. Categorical variables were reported as counts and 
percentages. Differences were analysed using ANOVA or Kruskal Wallis tests and chi-square 
test. Linear mixed model analysis was performed to compare changes in heart rate and QRS 
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duration over time between the three groups. Type of surgery and time of ECG were 
incorporated in the model as fixed variables. An unstructured covariance matrix was applied. 
The estimated marginal means ± standard error of the mean were presented.  
Logistic regression analysis was performed to assess baseline factors associated with 
postoperative complete LBBB. All variables with p-value <0.1 on univariate logistic regression 
analysis were included in the multivariate model. The odds ratio and 95% confidence interval 




A total of 501 patients (mean age 74±8 years, 53% men) were included in the present analysis. 
Patients who underwent conventional AVR were significantly younger and more often male 
compared to su-AVR and TAVI groups. Preoperative characteristics are shown in Table 1. 
 
Table 1: Baseline characteristics 







Age (years) 77±5 80±7 71±8 <0.001 
Male gender 29 (35%) 49 (45%) 189 (61%) <0.001 
Body surface area (m
2
) 1.88±0.20 1.87±0.21 1.95±0.21 0.001 
Hypertension 58 (70%) 78 (72%) 179 (58%) 0.014 
Dyslipidaemia 55 (66%) 59 (54%) 189 (61%) 0.216 
Diabetes 25 (30%) 33 (30%) 72 (23%) 0.230 
Smoking 4 (5%) 15 (14%) 5 (2%) 0.024 
Coronary artery disease 48 (58%) 63 (58%) 160 (52%) 0.420 
Creatinine clearance (ml/min) 66±20 61±21 76±26 <0.001 
LV end-diastolic diameter (mm) 45±6 45±8 47±8 0.019 
LV end-systolic diameter (mm) 28±7 29±9 29±9 0.631 
LV ejection fraction (%) 59±11 57±10 58±9 0.302 
LV mass indexed (m
2
) 118±30 133±41 141±47 <0.001 
Continuous variables were reported as mean ± standard deviation. Categorical variables were reported as 
counts and percentages. AVR: aortic valve replacement; LV: left ventricular; su-AVR: sutureless aortic 
valve replacement; TAVI: transcatheter aortic valve implantation.  
 
Surgical characteristics 
Su-AVR was performed with the Medtronic 3f Enable valve in 68 patients (82%) and with the 
Perceval S valve in 15 patients (18%). TAVI was performed in 86 patients (79%) with Edwards 
SAPIEN valve and in 23 patients (21%) with Medtronic CoreValve. Conventional AVR was 
performed with stented bioprostheses: Carpentier-Edwards Perimount Magna valve (Edwards 
Lifesciences, Irvine, California) in 111 patients (36%), the Hancock valve (Medtronic Inc, 
Mineapolis, Minnesota) in 182 patients (59%) and the St Jude Medical Trifecta valve (St Jude 
Medical, St Paul, Minnesota) in the remaining 16 patients (5%). The size of the prosthesis was 
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significantly different between the three surgical techniques, the mean size in su-AVR patients 
was 23.5±2.0, in TAVI patients 25.9±2.2 and in patients undergoing conventional AVR 24.5±1.8 
(p<0.001). 
 
ECG changes after AVR 
Table 2 shows the ECG parameters pre- and postoperatively at hospital discharge. 
Postoperative ECG was performed 3 (interquartile range: 2-4) days after TAVI compared to 6 
(interquartile range: 5-8) days after su-AVR and 6 (interquartile range: 5-8) days after 
conventional AVR (p<0.001). The heart rate increased significantly after intervention in all 
three groups. The majority of the patients were in sinus rhythm (85%) before surgery. After 
surgery, the percentage of patients with atrial fibrillation increased to 17%, 17 patients 
showed atrial arrhythmia or junctional rhythm and 11 patients showed paced rhythm.  
The QRS duration increased significantly in all three groups after AVR. In addition, at hospital 
discharge, the QRS duration differed significantly between groups. Postoperatively, complete 
LBBB was observed significantly more often after su-AVR (23%) and TAVI (16%) compared to 
conventional AVR (4%; p<0.001). In addition, there were in total 12 patients (2%) with a RBBB 
and 19 patients (4%) with incomplete LBBB. 
 
Factors associated with complete LBBB 
Type of AVR was significantly associated with complete LBBB on univariate logistic regression 
analysis. Su-AVR (odds ratio: 8.5; 95% confidence interval: 3.7-19.5; p<0.001) and TAVI (odds 
ratio: 5.8; 95% confidence interval: 2.4 – 14.1; p<0.001) were independently associated with 
complete LBBB, after adjusting for age, preoperative rhythm and preoperative QRS duration. 
 
Discussion 
The main findings of the present study can be summarized as follows: the incidence of LBBB 
was 23% at discharge after su-AVR and 16% in TAVI patients, compared to 4% in patients 
undergoing conventional AVR. Su-AVR patients and TAVI patients more often new-onset 
complete LBBB, in comparison to patients treated with conventional AVR. 
 
Incidence of LBBB after AVR 
The incidence of new-onset LBBB after AVR ranged between 4 and 51% in previous studies.
9,10
 
Differences in incidence of LBBB can be explained by differences in type of procedure, valve 
type and follow-up duration. In conventional AVR with a stented bioprosthesis, the incidence 
of LBBB at hospital discharge was low (4-6%).
10,19,20
 In contrast, studies reporting the incidence 
of LBBB after su-AVR or TAVI have shown considerably higher incidences compared with 
conventional AVR (39% and about 21%, respectively).
7-9,20-23
 In TAVI, the type of valve was an  
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Table 2: Electrocardiographic parameters preoperative and postoperative. 
Continuous variables were analysed using linear mixed models and were reported as mean ± standard 
error of the mean. Categorical variables were reported as counts and percentages. Other atrial rhythm 
includes atrial rhythm, atrial flutter and atrial tachycardia. AVR: aortic valve replacement; cLBBB: 
complete left bundle branch block; iLBBB: incomplete left bundle branch block; RBBB: right bundle branch 
block; su-AVR: sutureless aortic valve replacement; TAVI: transcatheter aortic valve implantation.  
 
important determinant of new-onset LBBB: Medtronic CoreValve was associated with a higher 
incidence of LBBB (48-51%) compared with Edwards SAPIEN valve (12-27%).
9,21
 The present 
study showed higher incidence of LBBB in TAVI with Medtronic CoreValve (22%) compared to 
the SAPIEN valve (14%), although not statistically significant (p=0.555). Studies with longer 
follow-up duration demonstrated that new-onset LBBB present at hospital discharge was 
transient in some cases and resolved after months of follow-up. Persistent LBBB was present 
in only 9% of TAVI patients and 2% of patients treated with conventional AVR.
8,10
 Local 
inflammation, oedema and ischemia of the surrounding tissue following aortic valve 




Preoperative su-AVR (n=83) TAVI (n=109) 
Conventional 
AVR (n=309) p-value 
Heart rate (bpm) 70±1 74±1 70±1 0.050 
Rhythm    0.027 
  Sinus rhythm 72 (87%) 85 (78%) 271 (87%)  
  Atrial fibrillation  11 (13%) 20 (18%) 36 (12%)  
  Other atrial rhythm 0 (0%) 4 (4%) 2 (1%)  
QRS axis 0 (0%) 0 (0%) 0 (0%)  
  Normal     0.543 
  Left 74 (89%) 99 (91%) 280 (91%)  
   Right 9 (11%) 10 (9%) 25 (8%)  
QRS-duration (ms) 0 (0%) 0 (0%) 4 (1%)  
Bundle branch block 0 (0%) 0 (0%) 0 (0%)  
Postoperative su-AVR (n=83) TAVI (n=109) 
Conventional 
AVR (n=309) p-value 
Heart rate (bpm) 81±2 80±1 83±1 0.170 
Rhythm    0.021 
  Sinus rhythm 62 (75%) 78 (72%) 249 (81%)  
  Atrial fibrillation  18 (21%) 20 (18%) 46 (15%)  
  Other atrial rhythm 3 (4%) 4 (4%) 10 (3%)  
QRS axis 0 (0%) 7 (6%) 4 (1%)  
  Normal     <0.001 
  Left 73 (88%) 85 (78%) 288 (93%)  
   Right 10 (12%) 20 (18%) 20 (6%)  
QRS-duration (ms) 0 (0%) 3 (3%) 0 (0%)  
Bundle branch block 0 (0%) 1 (1%) 1 (1%)  
  RBBB 113±2 113±2 102±1 <0.001 
  iLBBB     <0.001 
  cLBBB 3 (4%) 1 (1%) 8 (3%)  
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Mechanism underlying AVR-induced LBBB 
New-onset LBBB after AVR can be related to compression by the prosthesis on the conduction 
system. The bundle branch initiates at the base of the interleaflet triangle between the non-
coronary and right-coronary cusps, located at the aortic annulus.
6
 Stented biological 
prostheses are placed supra-annular whereas the su-AVR and TAVI prostheses are placed 
intra-annular, close to the bundle branch which may lead to increased risk of damage of the 
conduction system. Previous studies in TAVI patients showed that a lower implantation depth 
was associated with new-onset LBBB.
25,26 
Besides the position of the valve, the size of the implanted prosthesis relative to the annulus 
size is important in the pathophysiology of conduction abnormalities. In su-AVR and TAVI, 
slight oversizing is necessary to prevent severe paravalvular leakage.
27
 However, excessive 
oversizing can result in increased compression of the conduction system and aortic annulus 
rupture.
28 
Another factor responsible for the occurrence of LBBB after AVR might be related to the 
expandable property of the su-AVR and TAVI prostheses. The stented biological prostheses are 
sutured to the annulus and afterwards, the prosthesis does not generate a radial force that 
compresses the conduction system. In contrast, the su-AVR and TAVI prostheses are anchored 
into the aortic root and generate a radial force expansion that may compress the conduction 
system and lead to conduction abnormalities. Previous studies hypothesized that the nitinol 
frame of the Medtronic CoreValve, with the unique property of shape memory, is responsible 
for increased ongoing compression on the conduction system, resulting in more frequent LBBB 
in comparison to the SAPIEN valve.
28
 This may additionally explain the higher incidence of 
LBBB in su-AVR prostheses mounted in a nitinol frame. However, in a direct comparison 
between Medtronic CoreValve (with nitinol frame) and SAPIEN XT (with cobalt chromium 




The present study showed a significantly higher incidence of new-onset LBBB after su-AVR and 
TAVI in comparison to conventional AVR. The present results may impact on the selection of 
the type of surgery, especially in patients with an intermediate surgical risk. Furthermore, 
attention should be paid to the sizing and positioning of the prostheses in su-AVR and TAVI to 
improve outcomes with lower incidences of LBBB. Further technical development of both TAVI 
valves and sutureless valves and careful implantation of the valve (not too deep into the LVOT) 
may help to reduce the incidence of LBBB. Additionally, further clinical research should 
elucidate whether the occurrence of LBBB is transient or persistent and whether it impacts on 
the postoperative LV systolic function. In particular in older patients with preoperative 
reduced systolic function, this could be of importance when selecting the type of surgery. It 
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might influence the need for cardiac resynchronization therapy in patients with an impaired LV 
function who developed LBBB after AVR. Future studies should analyse which patients are 
more at risk in developing persistent LBBB and what actions can prevent new-onset LBBB.  
 
Study limitations  
The present study was retrospective, with all the inherent limitations of such a study design. 
The ECG parameters were assessed preoperatively and at discharge, with the strict criteria for 
complete LBBB.
11
 However, ECG follow-up was not systematically performed and, therefore, 
information on whether LBBB was persistent during long-term follow-up was lacking. The LBBB 
directly postoperative might have been transient and its clinical implications remain unclear. 
Because patients were discharged earlier after TAVI, the duration between surgery and 
postoperative ECG at discharge was shortest in this group compared to su-AVR and 
conventional AVR, which may resulted in an increased number of transient LBBB among TAVI 
patients. In addition, both Medtronic Corevalve and Edwards Sapien TAVI were used in the 
TAVI cohort. The Medtronic Corevalve tended to result in more complete LBBB than the 
Edwards Sapien valve, however this difference was not statistically significant and therefore 
both types of valves were included in the present analysis. Results cannot be extrapolated to 
stentless biological and mechanical prostheses and non-transfemoral TAVI. Furthermore, the 
present study described the first series of su-AVR patients; therefore the learning curve could 
be a contributing factor to the relatively high incidence of LBBB. The depth of implant of the 
three types of prostheses was not evaluated and therefore analyses whether depth of implant 
influenced the prevalence of new-onset LBBB could not be performed. 
   
Conclusion 
In conclusion, su-AVR and TAVI patients developed more frequently postoperative LBBB at 
discharge, in comparison to patients treated with conventional stented AVR bioprostheses. Su-
AVR and TAVI were associated with higher risk on developing postoperative LBBB compared to 
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Background: It remains unclear whether aortic valve replacement (AVR) has an effect on the 
aortic root dilation rate in patients with bicuspid (BAV) and tricuspid aortic valves (TAV). The 
present study evaluated the pre- and postoperative annual aortic root dilation rate in BAV and 
TAV. 
Methods: A total of 93 patients (67 ± 11 years, 71% male) who underwent AVR between 2003 
and 2013 and had at least 2 pre- and post-operative echocardiographic studies 1 year or more 
apart were included in this retrospective observational study. The sinus of Valsalva (SOV), 
sinotubular junction (STJ) and ascending aorta (AAo) were measured in the parasternal long-
axis view. 
Results: Patients with BAV (n=22) were significantly younger and had less coronary artery 
disease than patients with TAV (n=71). At all points in time, the aortic root diameters were 
larger in BAV compared with TAV. Preoperatively, the STJ and AAo grew significantly faster in 
BAV compared with TAV (STJ: 0.27 vs. 0.04 mm/year; p=0.021 and AAo: 0.42 vs. 0.15 
mm/year; p=0.019). After surgery, there were no significant differences in aortic root dilation 
rates between BAV and TAV (SOV: -0.01 vs. 0.15 mm/year; p=0.096, STJ: 0.08 vs. 0.05 
mm/year; p=0.676 and AAo 0.28 vs. 0.35 mm/year; p=0.745). 
Conclusion: The annual aortic root dilation rates were significantly higher in BAV compared 
with TAV before AVR. However, after AVR, aortic root dilation rates were similar in BAV and 
TAV, suggesting an important role of hemodynamics on aortic root dilation in BAV. 
 
 




Bicuspid aortic valve (BAV) anatomy is associated with increased dilation rate of the aortic root 
compared to tricuspid aortic valve (TAV) anatomy.
1
 Although intrinsic differences in the aortic 
wall structure due to an underlying genetic substrate may explain the differences in aortic root 
dilatation over time between patients with BAV and those with TAV,
2
 abnormal aortic wall 
stress distribution in patients with BAV is also an important pathophysiologic mechanism 
explaining faster aortic root dilation compared with patients with TAV.
3
   
Surgical aortic valve replacement (AVR) changes valvular hemodynamics and their impact on 
aortic wall stress distribution, and therefore, we could hypothesize that after AVR, differences 
in aortic root dilation rate between patients with TAV and those with BAV would be secondary 
to the underlying genetic substrate. To date, the evidence characterizing aortic root dilation 
rate after AVR in patients with TAV and those with BAV is controversial.
4-9
 The aim of the 
present study was to assess the differences in patients with TAV and those with 




Adult patients with symptomatic moderate and severe aortic valve dysfunction and an aortic 
root and ascending thoracic aorta of less than 45 mm who underwent AVR between 2003 and 
2013 at the Leiden University Medical Center, The Netherlands were considered eligible for 
the present observational study. Patients should have had 2 preoperative and 2 postoperative 
transthoracic echocardiograms (TTEs) performed with at least 1 year between each. The last 
TTE was included as the follow-up TTE. In case of repeated aortic root operations during 
follow-up, the last TTE before the repeated operation was evaluated. Of 656 patients who 
underwent AVR and who had a preoperative TTE, 123 patients had 4 echocardiograms (2 
preoperative and 2 postoperative) meeting the inclusion criteria. Thirty patients were 
excluded because of aortic coarctation, connective tissue disease, an aortic root diameter of 
45 mm or greater at time of AVR and/or concomitant aortic root or ascending aorta 
replacement during initial surgery. Patients with aortic root or ascending thoracic aorta 45 mm 
or greater were excluded because contemporary guidelines consider it reasonable to perform 
aortic root/ascending aorta replacement in patients with dysfunctional bicuspid aortic valves 
and an indication for AVR (Class IIaC). 
9,10
 Patients who underwent other concomitant surgical 
procedures (coronary artery bypass grafting, mitral valve or tricuspid valve surgery) were not 
excluded. Clinical and echocardiographic characteristics were prospectively collected in the 
departmental Cardiology Information System (EPD-Vision®, Leiden University Medical Center, 
Leiden, The Netherlands) and the echocardiographic database (ImageVault General Electric 
Healthcare) and retrospectively analyzed. The institutional review board approved this 
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retrospective study of clinically acquired data and waived the need for patient written 
informed consent. 
 
Two-dimensional transthoracic echocardiography 
TTE was performed using commercially available ultrasound systems (System Five, Vivid 7, and 
E9, General Electric Healthcare, Vingmed, Horten, Norway) equipped with 3.5-MHz or M5S 
transducers. Two-dimensional, M-mode and Doppler data were acquired according to current 
recommendations.
11
 The echocardiographic data were digitally stored in cine-loop format and 
data were retrospectively analyzed using commercially available software (EchoPac 112.0.1, 
GE Medical Systems, Horten, Norway). 
Left ventricular (LV) end-diastolic and end-systolic diameters were measured in the M-mode 
parasternal long-axis view. LV end-diastolic and end-systolic volumes were measured and LV 
ejection fraction was calculated in the apical 2- and 4-chamber views according to the 
Simpson’s biplane method.
11 
Preoperative aortic valve function was evaluated using color, continuous and pulsed-wave 
Doppler. Aortic regurgitation (AR) grade was assessed using a multiparametric approach 
including the measurement of the jet width relative to the LV outflow tract width and the vena 
contracta in parasternal and apical views and the pressure half time of the regurgitant flow (if 
feasible). AR was graded as 0 (absent), 1 (mild), 2 (mild-moderate), 3 (moderate-severe) or 4 
(severe).
12
 Aortic stenosis (AS) grade was assessed measuring the aortic jet velocity and 
transaortic mean pressure gradient and calculating the aortic valve area using the continuity 
equation.
13
 Pre- and postoperative aortic root dimensions were measured at and end-diastolic 
frame in the parasternal long-axis view at 3 predefined levels: (1) the sinuses of Valsalva (SOV), 





After median sternotomy, arterial cannulation of the AAo was performed. Blood cardioplegia 
was delivered antegrade first into the aortic root and later selectively into the coronary ostia. 
The AAo was incised and the aortic valve was inspected. The presence of BAV or TAV anatomy 
was noted in the surgical report. The aortic valve was excised and replaced by mechanical or 
biological aortic valve prosthesis.  
 
Statistical analysis 
Continuous variables were reported as mean ± standard deviation or median and interquartile 
range (IQR) when appropriate. Categorical variables were reported as numbers and 
percentages. Continuous and categorical variables were compared with the Student’s t-test (or 
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Mann Whitney U test in non-normally distributed variables) and the chi-square test, 
respectively.  
Repeated-measurement analysis of variance was performed to assess the impact of BAV on 
the aortic root diameters at each point in time. BAV was incorporated in the model as factor. 
Estimated marginal means ± standard error of the mean for the aortic root diameters were 
reported.  
The aortic root dilation was assumed to be linear and, therefore linear regression analysis 
without including an intercept was performed separately in BAV and TAV to assess aortic root 
dilation in millimeters per year in both groups before and after operation. We included BAV 
multiplied by follow-up duration in years to assess the difference in dilation of the aortic root 
between BAV and TAV.
15
 All statistical tests were two-sided. A p-value <0.05 was considered 
statistically significant. Data analyses were performed using IBM SPSS Statistics version 20.0 
(SPSS Inc, Chicago, IL). 
 
Results 
Ninety-three patients (mean age 67 ± 11 years, 71% men) were included. There were 22 (24%) 
patients with BAV and 71 (76%) patients with TAV. Of the patients with BAV, 19 patients had 
fusion of the right and left coronary cusps and 3 patients had fusion of the right and 
noncoronary cusps. Clinical and echocardiographic characteristics at baseline are presented in 
Table 1. 
 
Preoperative aortic root dilation rate 
The estimated mean duration between baseline and preoperative echocardiographic 
measurements was 5.5 years. The aortic root diameters at baseline and before operation are 
displayed in Figure 1 and Table 2. The diameters of the aortic root were significantly larger in 
patients with BAV compared with patients with TAV at baseline and directly preoperatively. In 
the entire cohort, the average annual dilation rate of the aortic root was 0.13 mm/year at the 
SOV level, 0.07 mm/year at the STJ and 0.19 mm/year at the AAo. The preoperative aortic root 
dilation rate for BAV and TAV patients is displayed in Table 3. The dilation of the STJ and AAo 
was significantly faster in patients with BAV compared with patients with TAV. 
 
Postoperative aortic root dilation rate 
The estimated mean duration between postoperative and late follow-up echocardiographic 
measurements was 4.1 years. The aortic root diameters after surgery are presented in Figure 2 
and Table 2. The diameter of the aortic root remained significantly larger in patients with BAV 
compared with patients with TAV directly postoperatively and during follow-up. In the entire 
cohort, the average annual dilation rate of the aortic root was 0.11 mm/year at the SOV level,  
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Table 1. Baseline clinical, echocardiographic and surgical characteristics.  





Age (years) 60±10 69±10 0.001 
Male   18 (82%) 48 (68%) 0.310 
Body surface area (m
2
) 2.01±0.20 1.96±0.21 0.287 
Smoking  4 (18%) 12 (17%) 1 
Diabetes mellitus  1 (5%) 18 (25%) 0.070 
Hypertension  9 (41%) 44 (62%) 0.134 
Dyslipidemia 9 (41%) 58 (82%) 0.001 
NYHA functional class III/IV 6 (27%) 30 (42%) 0.313 
Previous cardiac surgery 1 (5%) 11 (15%) 0.330 
Coronary artery disease 7 (32%) 46 (65%) 0.013 
LV end-diastolic diameter (mm) 52±9 49±8 0.160 
LV end-systolic diameter (mm)  34±10 31±8 0.280 
LV end-diastolic volume (ml) 149±70 135±48 0.300 
LV end-systolic volume (ml) 69±46 63±36 0.522 
LV ejection fraction (%) 56±8 55±9 0.637 
Aortic regurgitation   0.677 
 grade 0 7 (32%) 32 (45%)  
 grade 1 4 (18%) 13 (18%)  
 grade 2  10 (45%) 21 (30%)  
 grade 3 1 (5%) 4 (6%)  
 grade 4 0 (0%) 1 (1%)  
Aortic stenosis   0.121 
 mild 3 (14%) 11 (15%)  
 moderate 6 (27%) 35 (49%)  
 severe 13 (59%) 25 (35%)  
EuroSCORE II (%) 1.0 (0.8-2.0) 2.3 (1.5-5.5) <0.001 
AVR type     0.195 
 Biological 14 (64%) 55 (77%)  
 Mechanical  8 (36%) 16 (23%)  
AVR size 25.3±2.3 23.9±2.1 0.012 
Cardio-pulmonary bypass time (min) 140±58 161±62 0.207 
Aortic cross clamp time (min) 112±43 117±48 0.638 
Mitral valve surgery 3 (14%) 8 (11%) 1 
Tricuspid valve surgery 2 (9%) 5 (7%) 1 
CABG 6 (27%) 37 (52%) 0.072 
Continuous data are presented as mean ± SD or median (interquartile range). Categorical data are 
presented as number (percentage).  AVR: aortic valve replacement; CABG: coronary artery bypass 
grafting; LV: left ventricular; NYHA: New York Heart Association. 
 
0.06 mm/year at the STJ and 0.33 mm/year at the AAo. Table 3 shows the postoperative aortic 
root dilation rate for patients with BAV and TAV, which was not significantly different at all 
levels. 
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 Figure 1. Preoperative change in aortic diameters over time. 
Data are presented as estimated marginal mean ± SEM. AAo: ascending aorta, BAV: bicuspid aortic valve, 
SOV: sinus of Valsalva, STJ: sinotubular junction, TAV: tricuspid aortic valve. Estimation at mean follow-up 





Figure 2. Postoperative change in aortic diameters over time. 
Data are presented as estimated marginal mean ± SEM. AAo: ascending aorta, BAV: bicuspid aortic valve, 
SOV: sinus of Valsalva, STJ: sinotubular junction, TAV: tricuspid aortic valve. Estimation at mean follow-up 
duration between postoperative and follow-up of 4.1 years. 
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Table 2. Aortic diameters at baseline, preoperative, postoperative and follow-up. 





Sinus of Valsalva (mm)    
 Baseline 34.6±0.8 32.5±0.4 0.026 
 Preoperative 36.1±0.8 33.4±0.4 0.003 
 Postoperative 36.4±0.8 33.1±0.4 <0.001 
 Follow-up 36.6±0.8 34.0±0.5 0.006 
Sinotubular junction (mm)    
 Baseline 30.4±0.8 28.2±0.5 0.022 
 Preoperative 31.7±0.8 28.6±0.4 <0.001 
 Postoperative 31.7±0.8 28.9±0.4 0.001 
 Follow-up 32.3±0.8 29.2±0.4 0.001 
Ascending aorta (mm)    
 Baseline 34.7±0.9 31.1±0.5 <0.001 
 Preoperative 37.0±0.8 32.2±0.5 <0.001 
 Postoperative 37.1±0.5 32.5±0.5 <0.001 
 Follow-up 38.3±0.8 34.1±0.5 <0.001 
Data are presented as estimated marginal means and standard error of the mean. BAV: bicuspid aortic 
valve, TAV: tricuspid aortic valve. Average time between baseline and preoperative TTE is 5.5 years. 
Average time between postoperative and follow-up TTE is 4.1 years. 
 
Table 3. Average preoperative and postoperative annual dilation rates in mm/year per aortic segment 
in BAV and TAV. 
 BAV TAV BAV vs. TAV 
 B (95% CI) p-value B (95% CI) p-value p-value 
Preoperative 
SOV 0.24 (0.02-0.46) 0.034 0.11 (0.04-0.19) 0.003 0.207 
STJ 0.27 (0.07-0.46) 0.010 0.04 (-0.04-0.11) 0.295 0.021 
AAo 0.42 (0.21-0.63) <0.001 0.15 (0.07-0.24) 0.001 0.019 
Postoperative 
SOV -0.01 (-0.22-0.19) 0.884 0.15 (0.03-0.27) 0.015 0.170 
STJ 0.08 (-0.08-0.24) 0.321 0.05 (-0.05-0.15) 0.307 0.790 
AAo 0.28 (0.15-0.42) <0.001 0.35 (0.24-0.46) <0.001 0.546 
Data are presented as regression coefficient (B) and 95% confidence interval (95% CI) indicating annual 
dilation rates in mm/year. AAo: ascending aorta, BAV: bicuspid aortic valve, SOV: sinus of Valsalva, STJ: 
sinotubular junction, TAV: tricuspid aortic valve. 
 
Aortic valve hemodynamics 
In patients who underwent AVR for severe aortic stenosis, the transaortic mean pressure 
gradient was 26.7±2.9 mmHg and 22.8±2.0 mmHg at baseline in BAV and TAV, respectively 
(p=0.273). The transaortic mean pressure gradient was 49.8±3.3 mmHg in patients with BAV 
and 53.1±2.3 mmHg in patients with TAV at the preoperative TTE (p=0.420). After AVR, in the 
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overall population, the transaortic mean pressure gradient was comparable immediate after 
AVR (BAV vs. TAV: 12.5±1.1 vs. 13.0±0.6 mmHg, p=0.702) and during follow-up (BAV vs. TAV: 
10.1±1.4 vs. 12.6±0.8 mmHg, p=0.115). 
 
Discussion 
The present study shows that patients with BAV had larger aortic roots and significantly faster 
dilation before surgical AVR compared with patients with TAV. However, in this particular 
group of patients with BAV, with baseline aortic root diameters <45 mm and who underwent 
AVR mainly because of severe AS, the aortic root diameters remained relatively stable after 
AVR and similar to that of patients with TAV. 
 
Aortic root dilation rate before AVR  
Before AVR, the dilation rate of the AAo in patients with BAV described in the present study 
was comparable to previously reported rates. In a study including 353 patients with BAV, 
Detaint et al showed a dilation rate of the SOV and AAo of 0.21 mm/year and 0.42 mm/year, 
respectively.
1
 In the control group with 51 patients with TAV, these dilation rates were 
significantly lower (0.09 mm/year and 0.20 mm/year, respectively).
1
 In addition, Etz and 
associates showed an AAo dilation rate of 0.77 mm/year in 116 patients with BAV, which was 




Currently there are 2 main hypotheses explaining the relation between BAV and aortic root 
dilation (aortopathy).
2,3
 The first factor which might explain the difference in aortic dilation 
between BAV and TAV is an underlying genetic substrate. The autosomal dominant inheritance 
of BAV with reduced penetrance is well documented.
18
 In relatives of patients with BAV, 14% 
had BAV, and of these individuals 67% had associated thoracic aortic aneurysm. Interestingly, 
30% of relatives of patients with BAV with normal functioning TAV anatomy also had thoracic 
aortic aneurysm.
19
 Histopathologic studies showed increased smooth muscle cell apoptosis, 
increased matrix metalloproteinase-9 and lower expression of α smooth muscle actin, smooth 
muscle 22α, calponin, smoothelin and lamin A/C in aortic wall of patients with BAV.
20,21
 
Although collagen orientation is almost identical in BAV and TAV, there are some differences 
in biomechanical properties of the aortic wall that may explain the differences in dilation rate 




The second hypothesis on the association between BAV and aortic root dilatation is the 
hemodynamics theory. Recent studies using 4-dimensional flow magnetic resonance imaging 
have provided more insight into the different hemodynamic burden on the aortic wall caused 
by flow disturbances.
3,24
 In TAV, the flow is directed along the curvature of the aorta. In BAV, 
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the flow angle is disturbed resulting in different increased wall shear stress, depending on the 
orientation of the cusps.
3,24
 In BAV with fusion of the right and left coronary cusps the flow is 
directed toward the right anterior, with increased wall shear stress in this region, resulting in 
aortic root dilation. In BAV, with fusion of the right and noncoronary cusps, the flow is directed 
higher into the AAo toward the posterior aortic wall resulting in AAo dilation.
3,24
  
In addition, these two theories may overlap because increased wall shear stress influences 
gene expression in the aortic wall.
25
 Preliminary clinical data comparing regions with increased 
and normal wall shear stress in BAV aortas showed increased collagen stiffness and increased 





Aortic root dilation rate after AVR  
In patients with BAV with an indication for AVR, it is debatable whether concomitant aortic 
root or AAo replacement, or both, should be performed if the aortic dimensions do not exceed 
specific cutoff values.
27-29
 Current guidelines advise aortic root operations in BAV with aortic 
root dilation 55 mm or more or 50 mm or more in the presence of additional risk factors 
(family history, systemic hypertension, coarctation of the aorta or aortic dilation 
>3mm/year).
30
 For patients with an indication for AVR, lower thresholds (>45 mm) can be used 
for concomitant aortic root and AAo replacement.
30 
If the genetics hypothesis is the only factor determining aortic dilation in BAV, the aortic root 
dilation rate after AVR would be as high as is was preoperatively. This may result in higher 
rates of AAo-related complications in operated patients with BAV compared with patients with 
TAV. However, if the hemodynamics theory were the only factor explaining the different aortic 
dilation rate between BAV and TAV, once the dysfunctional aortic valve has been replaced, the 
aortic dilation rate and the risk of adverse aortic events at follow-up would be similar between 
BAV and TAV. There is conflicting evidence regarding aortic root dilation after AVR. Dayan and 
colleagues reported that after AVR, the aortic root dimensions remained stable in patients 
with BAV.
4
 Similarly, in a study comparing 143 patients with BAV and 129 patients with TAV 
undergoing isolated AVR, the aortic dimensions remained stable.
5
 Furthermore, Charitos and 
coworkers compared the aortic dilation rate after AVR in 361 patients with BAV and 87 
patients with TAV and observed no significant difference in SOV diameter directly 
postoperative (difference 0.6±0.5 mm, p=0.2) between BAV and TAV, with comparable 
postoperative SOV dilation rate (0.13±0.04 mm/year in the entire cohort; difference between 
BAV and TAV 0.08±0.05 mm/year, p=0.12).
8
 Furthermore, the AAo dimensions were slightly 
larger in patients with BAV compared to those with TAV directly after AVR (difference: 1.2±0.7 
mm, p=0.09) whereas the postoperative AAo dilation rate was 0.25±0.05 mm/year in their 
entire cohort with no significant difference in dilation rate between BAV and TAV.
8
 Similar to 
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the present study, these studies would confirm the role of hemodynamics on the dilation rate 
of the aortic root and AAo. In contrast, Yasuda and associates showed increased ascending 
aortic dilation in BAV (0.18 mm/m2/year) compared with regression in aortic size in TAV (-0.08 
mm/m2/year; p=0.03) [6], which would confirm the genetics theory.  
 
Study limitations 
Several limitations should be acknowledged. This was a small retrospective, single center study 
in which patients were included when at least 2 preoperative and 2 postoperative TTEs were 
available. Two-dimensional TTE may underestimate aortic root diameters and is prone for off-
axis measurements. In addition, TTE measurements of the aortic diameters, especially at the 
level of the distal ascending aorta, are challenging and the spatial resolution of TTE is inferior 
to that of computed tomography or magnetic resonance imaging which may influence on the 
reproducibility of the measurements.
30
 We previously reported the inter-observer and intra-
observer variability in aortic root diameter measurements by two-dimensional TTE.
31
 Patients 
with aortic aneurysms 45mm or larger at the time of surgery were excluded; therefore the 
results of the study cannot be extrapolated to patients with aortic dimensions beyond this 
cutoff value. Patients with coarctation of the aorta were also excluded since their aortopathy 
might be of different genesis. Patients with BAV and TAV were different in clinical 
characteristics such as age and the presence of coronary artery disease which may hamper the 
comparison between the two groups. The patients included in the BAV group were relatively 
old (mean age 60 years) and underwent AVR predominantly because of AS. The conclusions 
drawn from the present study may therefore not be applicable to a younger BAV patient 
cohort with predominantly AR. Moreover, subanalysis comparing different morphologic types 
of BAV (fusion of the right and left coronary cusps versus fusion of the right and noncoronary 
cusps) or different types of valve dysfunction (AR versus AS) was not possible because of the 
small cohort of patients. 
 
Conclusion 
The annual aortic root dilation rates of patients with BAV was significantly higher compared 
with patients with TAV before AVR. After AVR, there was no significant difference in aortic 
root dilation rates, indicating that hemodynamics seem to play an important role in aortic 
dilation. BAV patients who undergo operation in whom the aortic root is not yet dilated should 
not be treated differently from TAV patients, and regular surveillance after AVR should be 
similar in both groups of patients. 
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Background: The present study assessed whether descending thoracic aorta growth can be 
measured reliably on volumetric analysis using multidetector row computed tomography 
(MDCT) and whether increased growth influences freedom from another aortic intervention in 
survivors of acute type A aortic dissection. 
Methods: A total of 51 patients (58±11 years, 61% male) who underwent surgery for type A 
aortic dissection DeBakey type 1 with ≥2 postoperative MDCT scans ≥5 months apart were 
included. Volumetric analysis of the descending thoracic aorta between the left subclavian 
artery and the level of the apex of the heart was performed with acceptable intraobserver 
variability.  Growth of the complete, false and true lumen was estimated in ml/year and 
defined as slow growth when it was less than average growth rate and fast growth when it 
was more than average growth rate. 
Results: The complete lumen volume increased from 133±8 ml to 163±9 ml after 3.5 years 
follow-up (p<0.001), with an average growth rate of 6.1 ml/year. The false lumen volume 
increased from 81±7 ml to 106±12 ml (p=0.018) with an average growth rate of 2.8 ml/year. 
The true lumen changed only slightly from 59±4 ml to 65±8 ml (p=0.205). The 5-year freedom 
from descending thoracic aorta intervention was significantly lower in fast growth of the 
complete lumen (80±9%) compared to slow growth (100%; p=0.003). Similar was true for 
growth of the false lumen (fast: 74±12% vs. slow: 100%; p=0.042). 
Conclusion: Increased growth of the false lumen of the descending thoracic aorta after 
deBakey type 1 aortic dissection was associated with higher risk on secondary intervention on 
the descending thoracic aorta. 
 




Acute type A aortic dissection is a life threatening condition with an incidence of 2.9 per  
100 000 patient-years.
1
 Emergency surgery is the only option to improve the survival of 
patients with acute type A aortic dissection.
2
 One of the objectives of acute type A aortic 
dissection surgery is restoration of adequate flow in the true lumen with obliteration, if 
possible, of the false lumen in the distal aorta.
3
 This is particularly important since the 
presence of a complete patent false lumen (PFL) or only partially thrombosed false lumen 
(pTFL) is associated with worse outcome, higher reoperation rates and aneurysmal growth.
4-7
 
Aneurysmal growth has been associated with increased risk of adverse clinical events at 
follow-up and, accordingly, current guidelines recommend regular surveillance with multi-
detector row computed tomography (MDCT) to monitor potential complications and growth 
of the descending thoracic aorta, especially when the false lumen is not completely 
thrombosed.
8
 Reoperation on the descending thoracic aorta (with open surgery or 
endovascular stenting procedure) is indicated if aortic rupture or progressive aortic dilation 
are observed.
4,9
 The MDCT data can be used to plan endovascular stenting procedures.
10
 In 
order to reduce the intra- and interobserver variability of manual measurements of serial 
MDCT of the descending aorta and size of the PFL, automated algorithms to assess these 
aspects would be the preferred methodology.
11
 The present study investigated whether 
descending thoracic aorta growth can be measured reliably on MDCT data using a semi-
automated volumetric method. In addition, descending thoracic aorta growth and patency of 




Patients with acute type A aortic dissection DeBakey type 1 (dissection progressed distal from 
ascending aorta) who underwent surgical repair at the Leiden University Medical Center and 
who survived the initial hospital admission were considered eligible for this study. Fifty-eight 
patients who underwent postoperative contrast enhanced MDCT surveillance of the thoracic 
aorta (with ≥5 months elapsed between scans) were included in the present analysis. Clinical 
and surgical data were collected in the departmental Cardiology Information System (EPD-
Vision®, Leiden University Medical Center, Leiden, The Netherlands) and retrospectively 
analyzed. Critical preoperative state was defined as suffering from ventricular tachycardia or 
ventricular fibrillation or aborted sudden death, preoperative cardiac massage, preoperative 
ventilation before anaesthetic room, preoperative inotropes or intra-arterial balloon pump or 
preoperative acute renal failure (anuria or oliguria <10ml/hour). The institutional ethical 
committee approved this retrospective evaluation of clinically acquired data and waived the 
need for individual written patient consent. 
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Multi-detector row computed tomography 
Contrast-enhanced MDCT studies were performed to evaluate the postoperative status of the 
thoracic aorta with a 16-, 64-, or 320-slice MDCT scanner (Aquilion, Toshiba Medical Systems, 
Tokyo, Japan). MDCT angiography data acquisition extended from above the aortic arch to the 
diaphragm, including the entire thoracic aorta. Data analysis was performed by 2 independent 
observers. First, the false lumen of the descending thoracic aorta was identified and qualified 
as completely thrombosed (TFL, which was defined as no contrast enhancement of the entire 
false lumen), partially thrombosed (pTFL, which was defined as part of the false lumen 
thrombosed and part of the false lumen contrast enhanced) or completely patent (PFL, which 
was defined as the entire false lumen contrast enhanced).  
Figure 1. Volumetric measurement of the descending thoracic aorta. 
A stretched multiplanar reformation of the aorta is automatically constructed by the software. A: The 
part of interest (between the left subclavian artery and the aorta at the level of the apex of the heart as 
assessed on the axial images) is selected for the volumetric analysis. B: The centerline is manually 
adjusted when necessary. C&D: Along the centerline, cross sections of the aorta every 0.5 mm along the 
length of the centerline were manually adjusted if the lumen was not correctly defined by the automated 
software. 
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The endovascular stent planning module from the post-processing software (Vitrea FX 1.0; 
Vital Images, Minnetonka, MN) was used to perform the quantitative measurements as 
displayed in Figure 1. The software was able to recognize the thoracic aorta and reconstruct a 
stretched multiplanar reformation of the aorta. The descending thoracic aorta was selected 
for analysis from the left subclavian artery until the level of the apex of the heart (on the axial 
images). A centerline was drawn automatically through the aorta which could be adjusted 
manually when necessary. Along the centerline, every 0.5 mm cross sections through the aorta 
were performed and the contrast-enhanced lumen circumference was defined automatically. 
When the lumen was not correctly defined by the software, the cross sectional circumferences 
of the lumen could be manually adjusted. In patients with a PFL, the false and true lumen were 
both included in the complete lumen volumetric analysis. In patients with pTFL, the true 
lumen and the contrast-enhanced part of the false lumen were included in the complete 
lumen volumetric analysis. The volume of the lumen of the descending thoracic aorta was 
measured distal from the left subclavian artery until the level of the apex of the heart. In 
addition for patients with a PFL or pTFL, the volume of the true lumen was measured similarly 
and the (contrast-enhanced) false lumen volume was calculated by subtracting the true lumen 
volume from the complete lumen volume. Furthermore, the minimum and maximum aortic 
diameters of the aorta at the level of the left subclavian artery (proximal descending thoracic 
aorta) and at the level of the apex of the heart (distal descending thoracic aorta) were 
automatically obtained.  
 
Surgical repair 
After median sternotomy, arterial cannulation of the subclavian or femoral artery was 
performed in the majority of patients. In the remaining cases, cannulation was performed in 
the distal ascending aorta. Effort was made to identify and resect the primary entry tear. 
Valve-sparing root replacement, supracoronary ascending aorta replacement or aortic valve 
and root replacement were performed as previously described. 12-16 In every patient the 
distal ascending aorta and arch were inspected under deep hypothermic circulatory arrest. If a 
(re)entry tear was present in the arch, concomitant (hemi-)arch replacement was performed. 
 
Statistical analysis 
All data analyses were performed using the SPSS software (Version 20.0. Armonk, NY: IBM 
Corp). Categorical variables were reported as frequencies and percentages. Continuous 
variables were displayed as mean ± standard deviation if normally distributed and as median 
and interquartile range if non-normally distributed. Patients with TFL, PFL and pTFL were 
compared using chi-square test for categorical variables and ANOVA test or Kruskall Wallis test 
for normally and non-normally distributed continuous variables, respectively.  
Chapter 12 │ 
184 
 
Change in descending thoracic aorta volume and diameter over time was assessed with 
repeated measures analysis of variance. Follow-up duration in years was incorporated in the 
model as covariate. Estimated marginal means ± standard error of the mean for the aortic root 
diameters were reported directly postoperatively and during follow-up. Regression analysis 
was used to assess the descending thoracic aorta growth rate in ml/year following the 
previously described instrumental variables approach.17 Assuming that descending thoracic 
aorta growth is linear, the estimate of the association between difference in descending 
thoracic aorta volume (in ml) and the follow-up duration (in years) was obtained by linear 
regression analysis without including an intercept. This estimate was used as a cut-off and 
patients were divided into two groups according to the growth of their aorta; slow growth 
(growth < estimate) were compared to fast growth (growth ≥ estimate). Kaplan Meier analysis 
was performed to assess freedom from secondary intervention on the distal descending 
thoracic aorta. Log-rank test was used to compare groups. In order to assess inter- and intra-
observer variability, 23 scans were measured by both observers and repeatedly by one 
observer, respectively and coefficients of variation were calculated. All statistical tests were 
two-sided. A p-value <0.05 was considered statistically significant. 
 
Results 
The clinical characteristics of the 51 included patients (mean age 58±11 years, 61% male) are 
presented in Table 1.  
 
Table 1. Baseline characteristics  







Age (years) 63±10 52±11 59±11 0.020 
Male 8 (40%) 11 (79%) 12 (71%) 0.046 
Body surface area (m
2
) 1.86±0.21 2.06±0.18 2.00±0.20 0.019 
Connective tissue disease 0 (0%) 3 (21%) 2 (12%) 0.112 
Hypertension 8 (40%) 4 (29%) 8 (47%) 0.574 
Critical preoperative state 3 (15%) 0 (0%) 1 (6%) 0.259 
EuroSCORE II (%) 6.1 (4.4-13.6) 4.4 (3.9-6.0) 5.5 (4.1-9.0) 0.124 
CPB time (min) 238±55 205±44 246±66 0.211 
AoX time (min) 168±44 149±44 194±59 0.123 
Aortic arch replacement    0.187 
 Hemi-arch 7 (35%) 5 (36%) 4 (24%)  
 Total arch 6 (30%) 0 (0%) 5 (29%)  
Data are presented as mean ± standard deviation or median (interquartile range) or as number 
(percentage). AoX time: Aortic cross clamp time. CPB time: Cardiopulmonary Bypass time. EuroSCORE II: 
European System for Cardiac Operative Risk Evaluation. PFL: Patent false lumen. pTFL: Partially 
thrombosed false lumen. TFL: Thrombosed false lumen.  
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The median duration between surgery and the post-operative MDCT was 9 days and in the 
majority of patients, the post-operative MDCT was performed within the first month after 
surgery. On the post-operative MDCT, 20 (39%) patients had a TFL, 14 (28%) patients had a PFL 
and 17 (33%) patients had a pTFL. Patients with PFL were younger compared to patients with 
TFL and pTFL. Patients with TFL were more often female and had less often connective tissue 
disease, a smaller body surface area and a higher EuroSCORE II compared with patients with 
PFL and pTFL. 
 
MDCT measurements of the descending thoracic aorta 
Table 2 shows the MDCT measurements of the descending thoracic aorta post-operatively and 
at follow-up.  
 
Table 2: Change in descending thoracic aorta measurements  
 Post-
operative 
Follow-up p-value Growth rate 
per year 
Volume complete descending thoracic 
aorta (ml) 
133±8 163±9 <0.001 6.1±1.6 
Volume false lumen descending thoracic 
aorta (ml) (n=31) 
81±7 106±12 0.018 2.8±2.4 
Volume true lumen descending thoracic 
aorta (ml) (n=31) 
59±4 65±8 0.205 2.1±1.1 
Minimum diameter proximal descending 
thoracic aorta (mm) 
25.6±0.6 26.6±0.7 0.046 0.24±0.11 
Maximum diameter proximal descending 
thoracic aorta (mm) 
30.2±0.6 31.2±0.7 0.052 0.07±0.11 
Minimum diameter distal descending 
thoracic aorta (mm) 
26.0±0.7 26.9±0.8 0.205 0.16±0.15 
Maximum diameter distal descending 
thoracic aorta (mm) 
29.6±0.7 32.0±0.9 <0.001 0.45±0.13 
Data are displayed as estimated marginal means ± standard error of the mean after a mean follow up 
duration of 3.5 years. In addition, estimated mean growth rates ± standard error of the mean in ml or mm 
per year are displayed. 
 
The volume of the complete lumen was estimated 133±8 ml directly post-operative and 
increased to 163±9 ml (p<0.001) at follow-up. In patients with a pTFL and PFL (n=31), the false 
lumen increased from 81±7ml to 106±12 ml (0.018). The true lumen volume in the patients 
with pTFL and PFL remained more or less stable (59±4 vs. 65±8 ml, p=0.205). The diameter of 
the proximal descending thoracic aorta increased significantly during follow-up. A significant 
increase was also observed in the maximum diameter of the distal descending thoracic aorta. 
 
  




Figure 2. Example of a patient with a fast growing descending thoracic aorta. 
A-D: Images of the postoperative MDCT. A: 3 dimensional image of the descending thoracic aorta. B: 
Volume of the descending thoracic aorta (125 ml). C: minimum and maximum diameter of the proximal 
descending thoracic aorta (21.3 mm and 23.8 mm). D: minimum and maximum diameter of the distal 
descending thoracic aorta (29.5 mm and 31.4 mm). E-H: Images of the follow-up MDCT, 33 months after 
postoperative MDCT. E: 3 dimensional image of the descending thoracic aorta with an aneurysm of the 
descending thoracic aorta. F: Volume of the descending thoracic aorta (284 ml). G: minimum and 
maximum diameter of the proximal descending thoracic aorta (20.4 mm and 22.9 mm). H: minimum and 
maximum diameter of the distal descending thoracic aorta (31.3 mm and 35.1 mm). 
 




Figure 3. Example of a patient with a stable descending thoracic aorta. 
A-D: Images of the postoperative MDCT. A: 3 dimensional image of the descending thoracic aorta. B: 
Volume of the descending thoracic aorta (105 ml). C: minimum and maximum diameter of the proximal 
descending thoracic aorta (25.0 mm and 30.3 mm). D: minimum and maximum diameter of the distal 
descending thoracic aorta (23.5 mm and 24.9 mm). E-H: Images of the follow-up MDCT, 132 months after 
postoperative MDCT. E: 3 dimensional image of the descending thoracic aorta at follow up. F: Volume of 
the descending thoracic aorta (111 ml). G: minimum and maximum diameter of the proximal descending 
thoracic aorta (26.3 mm and 31.8 mm). H: minimum and maximum diameter of the distal descending 
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Descending thoracic aorta growth rate 
Linear regression analysis showed significant growth of the descending thoracic aorta in 
complete lumen volume with an estimated growth rate of 6.1 ml/year. The false lumen 
volume increased with 2.8 ml/year on average. The true lumen growth was estimated 2.1 
ml/year, Patients with fast growth of the complete lumen did not differ from patients with 
slow growth in terms of gender, age and history of hypertension. The number of patients who 
used oral anticoagulants after surgery was comparable between the fast and slow growth rate 
groups.  
Figure 2 shows an example of a patient with fast growth rate. The volume of the descending 
thoracic aorta was 125 ml directly post-operatively. After 33 months of follow-up, the volume 
increased to 284 ml. This patient underwent distal secondary intervention of the aneurysm of 
the descending thoracic aorta. Figure 3 shows an example of a patient with slow growth rate. 
The volume of the descending thoracic aorta was 105 ml post-operatively and 111 ml after 11 
years of follow-up. 
 
Freedom from secondary aortic intervention during follow-up 
Secondary intervention on the descending thoracic aorta during follow-up was performed in 6 
patients. Endovascular repair was performed in 1 patient because of anastomotic leakage. 
Open repair on the descending thoracic aorta was performed in the other 5 patients because 
of descending thoracic aorta aneurysm formation >6.0 cm. Fast growth of the descending 
thoracic aorta was not per se an indication for secondary intervention. The freedom from 
secondary intervention on the descending thoracic aorta after 5 years follow-up was 80±9% in 
the group with complete lumen fast growth rate compared to 100% in the complete lumen 
slow growth rate group (log-rank p=0.003). In particular, patients with pTFL had significantly 
worse 5 year freedom from secondary intervention (75±11%) compared to patients with TFL 
and PFL (both 100%; p=0.008). In the patients with pTFL and PFL, the false lumen fast growth 
was associated with worse freedom from secondary intervention after 5 years (74±12%) 
compared to false lumen slow growth (100%; p=0.042). On the contrary, the growth rate of 
the true lumen was not associated with secondary intervention. Kaplan Meier curves are 
provided in Figure 4. In addition, patients who underwent secondary intervention had a 
significantly larger complete lumen descending thoracic aorta growth rate with compared to in 
patients without secondary intervention (25.6 ml/year vs. 5.6 ml/year, respectively; p=0.041). 




Figure 4: Kaplan Meier freedom from reoperation  
A: Freedom from distal reoperation for complete lumen slow growth compared to fast growth. B: 
Freedom from distal reoperation for type of false lumen. TFL: thrombosed false lumen, PFL: patent false 
lumen, pTFL: partially thrombosed false lumen.C: Freedom from distal reoperation for false lumen slow 
growth compared to fast growth. D: Freedom from distal reoperation for true lumen slow growth 
compared to fast growth. 
 
Inter- and intra-observer variability 
The intra-observer variability, calculated as 1.96 standard deviation of the mean difference, 
was 4.7 ml for the volumetric measurement. The variability for the maximum diameter 
measurement was 2.7 mm for the proximal descending thoracic aorta and 1.6 mm for the 
distal descending thoracic aorta. This resulted in a coefficient of variation of 1.1% for the 
volume and 3.0 and 1.9% for the measurement of the maximum diameter of the proximal and 
distal descending thoracic aorta, respectively. Inter-observer variability was 27.0 ml for the 
volumetric measurement with a coefficient of variation of 6.5%. The inter-observer variability 
of the measurement of the proximal and distal maximum diameter of the descending thoracic 
aorta was 6.9 and 5.5 mm, respectively, with a coefficient of variation of 7.4 and 6.5%, 
respectively. 
  




The main findings of the present study can be summarized as follows: in survivors of acute 
type A aortic dissection undergoing emergent surgery, fast growth rate of the descending 
thoracic aorta, especially of the false lumen when patent or only partially thrombosed, was 
associated with higher rates of secondary intervention of the descending thoracic aorta. The 
present MDCT-based software provides an automated and reproducible measure of the 
growth rate of the descending thoracic aorta with low intra-observer variability. In addition, 
distinction between the false and true lumen volume can be made and this study shows that 
in particular increase in false lumen is associated with a higher risk on secondary intervention. 
Survivors of an acute type A aortic dissection require regular surveillance with non-invasive 
imaging techniques of the native descending thoracic aorta to identify potential complications 
such as further progression of the dissection and aortic rupture or aneurysm formation.
4,5,8
 
Current guidelines recommend performing this measurement in stretched views along a 
center line of the descending thoracic aorta to provide the true cross sectional area.
8
 The 
change in diameter of the descending thoracic aorta over time is approximately 1 mm/year.
4-7
 
Besides the underlying aortopathy (i.e. Marfan syndrome) and cardiovascular risk factors (i.e. 
hypertension), the status of the false lumen plays an important role in the growth of the 
descending thoracic aorta.
4,6,7
 Kimura et al. showed a significant difference in growth rate of 
the proximal descending thoracic aorta between PFL (1.9±3.8 mm/year) and TFL (-0.7±2.8 
mm/year; p<0.001).
6
 Similar results were described by Fattouch et al. with a significant higher 
growth rate in PFL (2.8±0.4 mm/year) compared to TFL (1.1±0.2 mm/year; p=0.001).
4
 
However, these studies did not differentiate between complete thrombosis or partial 
thrombosis of the false lumen. According to Song et al., the descending thoracic aorta growth 
rate was largest in pTFL (5.5±9.1 mm/year) compared to PFL and TFL (3.8±5.6 mm/year and -
0.9±3.9 mm/year, respectively; p=0.005).
7
 The present study shows in addition that it is in 
particular the false lumen that enlarges during follow-up in patients with a PFL of pTFL in 
contrast to the true lumen volume which remains more or less stable. 
Patients with faster growth rate of the descending thoracic aorta are more frequently referred 
for secondary intervention on the descending thoracic aorta to prevent aortic rupture, as we 
show in the present study. The status of the false lumen plays an important role in the growth 
rate of the descending thoracic aorta and therefore affects the need for secondary 
intervention. Patients with PFL had significantly worse 5-year freedom from secondary 
intervention on the descending thoracic aorta (72±3%) compared to TFL (97±1%; p<0.001).
4
 
Secondary interventions on the descending thoracic aorta, whether it was an open or 
endovascular procedure, were most often performed in pTFL compared to PFL and TFL.
7
 In the 
present study, faster growth of the false lumen was associated with higher need for secondary 
aortic intervention.  




Current guidelines recommend regular follow-up in patients after acute type A aortic 
dissection: 1 month after the treatment, after 6 months, 12 months and then yearly.
8
 If a 
stable course has been documented in the first postoperative year, less-strict imaging intervals 
may be sufficient. However fixed criteria for a stable course have not been proposed in the 
current guidelines. The present study shows that there is an increased need for secondary 
intervention on the descending thoracic aorta in patients with fast aortic growth (≥6.1 
ml/year). Especially in patients with accelerated growth of the false lumen of ≥ 2.8 ml/year, 
secondary intervention might be needed in the future. This may be used after the first year of 
follow-up as a cut off to determine the timing of follow-up and may help physicians to 
individualize surveillance of patients with a faster growth rate (needing more frequently CT 
evaluation) and patients with slow growth rate (preventing unnecessary radiation). The effects 
of this approach should be evaluated in future prospective studies.  
 
Study limitations 
The study was limited by its retrospective nature and small sample size. Only patients who 
survived the initial postoperative period and underwent MDCT at follow-up were included in 
the study, this might have introduced selection bias. Secondary intervention was performed in 
1 patient with anastomotic leakage and in 5 patients with aneurysm formation with a 
diameter exceeding 6.0 cm. The growth rate itself was not taken into account in decision 
making whether a secondary intervention was needed. However, MDCT follow-up schemes 
may already have been adapted in patients with a faster growth rate. To eliminate this 
potential bias, strict predefined follow-up schemes should be used in future studies. In 
addition, the present study identified a cut-off of 6.1 ml/year to define fast growth of the 
complete lumen; this should be validated. The small sample size of the present study 
hampered multivariable analysis to identify factors associated with faster growth. 
Furthermore, whether early secondary intervention in patients with fast growth will improve 
survival should be evaluated in future long term follow-up studies. 
The present method did not evaluate aortic arch growth rate; however, there were 2 patients 
with isolated aortic arch dilation during follow-up who underwent secondary intervention on 
the aortic arch. These secondary interventions were not included in the present analysis. 
Lastly, the semi-automated method to measure the descending thoracic aorta volume is more 
time-consuming compared to measuring aortic diameters. In some patients, only very small 
adjustments were needed and the volume was obtained in an almost entirely automated 
fashion. In some patients (particularly the patients with pTFL), it was difficult to define the 
precise delineation of the aortic lumen and manual adjustments were needed resulting in 
longer analysis times. 




Survivors of acute type A aortic dissection should be closely monitored with MDCT to evaluate 
complications and annual growth rate of the native descending thoracic aorta. Volumetric 
measurement of the descending thoracic aorta seems a reliable method with low intra-
observer variability. The present study showed that increased growth of the complete lumen 
and in particular of the false lumen of the descending thoracic aorta after deBakey type 1 
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Summary and future perspectives 
 
  




The present thesis described the additional value of cardiac imaging in the selection and 
evaluation of patients with aortic regurgitation and/or aortopathy undergoing aortic valve and 
root surgery. In the general introduction (Chapter 1), an overview was provided on aortic valve 
and root pathology, the indications for surgery, different valve-sparing surgical techniques and 
the role of multimodality imaging in the selection of patients for valve-sparing aortic root 
replacement. 
 
Part I: preoperative evaluation of patients with aortic regurgitation and/or aortopathy 
Part I focused on imaging performed in the preoperative period to evaluate the progression of 
disease and to identify patients who may be candidates for valve-sparing procedures. Chapter 
2 evaluated the effect of aortic root dilation on the aortic valve geometry using 3-dimensional 
transesophageal echocardiography. There was an increase in aortic valve leaflet size in 
patients with aortic root dilation compared to patients with normal aortic roots. However, this 
adaptive mechanism seemed insufficient to compensate for the increased aortic root area, 
especially in patients with central aortic regurgitation. In addition, in eccentric aortic 
regurgitation, there was relative excessive leaflet tissue in relation to the aortic root area 
resulting in prolapse. In Chapter 3, the effect of aortic regurgitation on the mitral valve 
geometry was discussed. Aortic regurgitation is associated with left ventricular volume 
overload and thereby left ventricular dilation and eventually reduction in left ventricular 
ejection fraction. This may lead to an increased tethering of the mitral leaflets due to papillary 
muscle displacement on one hand and a decrease in closing forces on the other hand. The 
mitral valve adapts to the left ventricular dilation by increased leaflet length. However, when 
compensatory mechanisms fail, significant mitral regurgitation can develop, which occurred in 
23% of aortic regurgitation patients. Factors independently associated with significant mitral 
regurgitation in patients with aortic regurgitation were a larger left atrial volume and a lower 
left ventricular ejection fraction. Chapter 4 investigated the effect of statin therapy in reducing 
the progression of aortopathy in bicuspid aortic valve patients. Patients on statin therapy were 
compared to non-users of this medication. Patients who used statins had smaller aortic root 
diameters at baseline and after a median follow-up period of 4.7 years even after adjusting for 
coronary artery disease, age and medication use compared with non-users. The average 
annual aortic root dilation rates were 0.08 mm/year for aortoventricular junction, 0.16 
mm/year for the sinus of Valsalva, 0.12 mm/year for the sinotubular junction, 0.45 mm/year 
for the ascending aorta. The use of statins had no effect on the aortic root dilation rate.  
Chapter 5 described the use of multidetector row computed tomography of the aortic valve 
and thoracic aorta in 61 patients considered for valve-sparing root replacement. The aortic 
valve was successfully repaired in 36 patients whereas repair was not feasible or not 
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successful in 25 patients. Patients with a reparable aortic valve had less often bicuspid aortic 
valve anatomy, less annular calcification and less commissural calcification compared to their 
non-reparable counterparts. The information provided by multidetector row computed 
tomography on valve morphology and calcification grade may be helpful in the preoperative 
assessment of aortic valve reparability. In Chapter 6, the additional value of transthoracic 
echocardiography in determining the right graft size used during the David reimplantation 
technique was evaluated. In 30 patients, undergoing valve-sparing root replacement with the 
reimplantation technique without additional leaflet repair, the average leaflet height, leaflet 
length and the total leaflet area were measured on echocardiography. Leaflet height 
(diameter = 1.1 • ((2 • 2/3 • leaflet height) + 2)), length (diameter = (2 • 2/3 • length) + 2) and 
area (diameter = 0.8 • ((2 • √(total leaflet area / π)) + 2)) were calculated based on 
transthoracic echocardiography formulas. Patients who received a smaller graft size than 
calculated with the formulas (undersized), had less often residual mild aortic regurgitation 
compared to patients who received an oversized graft. However, prospective validation of the 
formulas is needed before application in daily clinical practice. 
 
Part II: postoperative evaluation of patients after aortic valve and root surgery 
Part II focused on the role of imaging after aortic valve and root surgery. In Chapters 7 and 8 
the postoperative left ventricular reverse remodeling after aortic valve and root surgery was 
evaluated. Chapter 7 evaluated the differences in postoperative left ventricular reverse 
remodeling in patients with acute and chronic aortic regurgitation. Both in patients with acute 
and chronic aortic regurgitation, there was significant left ventricular reverse remodeling. 
However, after aortic valve and root surgery for acute aortic regurgitation, the left ventricular 
end-diastolic volume was more reduced and global longitudinal strain indexed for the left 
ventricular end-diastolic volume was more preserved in comparison to those observed in 
patients with chronic aortic regurgitation. Furthermore, patients who underwent a valve-
sparing procedure were compared to patients who underwent aortic valve and root 
replacement with a biological prosthesis in Chapter 8. Patients undergoing aortic valve and 
root replacement had significant larger left ventricular volumes before surgery as compared 
with their counterparts. Postoperatively, after a median follow-up of 46 months, both groups 
of patients showed a significant and sustained reduction in LV volumes, with a larger reduction 
in patients undergoing aortic valve and root replacement. The recurrence of significant aortic 
regurgitation during follow up was about 7-8% and not significantly different between repair 
and replacement techniques. Chapter 9 evaluated the postoperative change in left ventricular 
volumes and function in 97 patients with acute type A aortic dissection who survived the initial 
surgery. In this chapter, 3 different procedures were compared; valve-sparing root 
replacement (with the remodeling or reimplantation technique), supracoronary ascending 
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aorta replacement, and aortic valve and root replacement (with a biological or mechanical 
prosthesis).  During follow-up, aortic regurgitation grade ≥2 was significantly more often 
observed in supracoronary ascending aorta replacement and valve-sparing root replacement 
compared to aortic valve and root replacement. Left ventricular volumes remained stable in 
valve-sparing root replacement and aortic valve and root replacement whereas in 
supracoronary ascending aorta replacement, left ventricular volumes significantly increased 
over time. In addition, among patients with recurrent aortic regurgitation grade ≥2 at follow-
up, left ventricular volumes increased significantly over time whereas patients without 
recurrent aortic regurgitation did not show significant left ventricular dilation. In Chapter 10, 
the effect of aortic valve replacement on the conduction system was evaluated. Patients who 
underwent sutureless, transcatheter and conventional stented biological aortic valve 
replacement were compared. Patients who underwent sutureless and transcatheter aortic 
valve replacement developed more often new-onset complete left bundle branch block 
directly after aortic valve replacement in comparison to conventional aortic valve 
replacement.  
Chapters 11 and 12 focused on the postoperative changes in aortic diameter. In bicuspid aortic 
valves, the aortic root growth rate has been described to be faster compared to that of 
patients with tricuspid aortic valves due to an underlying genetic substrate and/or altered 
hemodynamics. In Chapter 11 the aortic root dilation rate in patients with bicuspid aortic valve 
anatomy was compared to patients with tricuspid aortic valve anatomy before and after aortic 
valve replacement to obtain better insight in the mechanisms of aortic root dilation in bicuspid 
aortopathy. The preoperative aortic root dilation rate was significantly faster in patients with 
bicuspid valve compared to patients with tricuspid valve whereas after surgery, the aortic root 
dilation rate was comparable between groups, indicating that hemodynamics play an 
important role in the increased aortic dilation in bicuspid aortopathy. 
Chapter 12 investigated the growth rate of the descending thoracic aorta in patients operated 
for acute type A aortic dissection. The growth rate was assessed using a volumetric 
measurement of the descending thoracic aorta on multidetector row computed tomography. 
Increased growth of the complete lumen and in particular of the false lumen of the descending 
thoracic aorta after aortic dissection was associated with higher risk on secondary intervention 
on the descending thoracic aorta. 
 
Conclusion and future perspectives 
Alongside with increasing life expectancy in the general population, the prevalence of aortic 
valve disease increases; hence there is a need for aortic valve surgery with long durability and 
low complication rate. Mechanical and biological (including transcatheter) prosthesis and 
aortic valve repair are the available approaches for patients with aortic valve disease. The 
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need for reoperation (aortic valve repair and biological valves) should be balanced against the 
risk on thromboembolic and bleeding complications (mechanical valves that need lifelong 
anticoagulation). In addition, patient’s preference in this era of shared decision making is an 
important factor. Aortic valve preservation has shown promising results, however at present 
there are many different surgical techniques and modifications and the success of these 
techniques are largely operator-dependent. In the coming years, we may witness 
standardization of surgical repair techniques and development of durable and less invasive 
prostheses and these may be possible with the help of developments in 3-dimensional imaging 
techniques and postprocessing softwares that allow 3-dimensional printing and simulation. 
Currently, thorough evaluation of the aortic root dimensions and mechanism of aortic 
regurgitation with echocardiography is mandatory prior to surgery. Transesophageal 
echocardiography provides better visualization of the aortic root and characteristics of the 
aortic cusps than transthoracic echocardiography.  In addition, 3-dimensional 
echocardiographic techniques have shown to be more accurate in grading aortic regurgitation 
than 2-dimensional echocardiography. The ascending aorta is better visualized with 
multidetector row computed tomography or cardiac magnetic resonance. These 3-
dimensional imaging techniques permit reconstruction of the aortic root complex and with 
specific software, the structure can be printed out in three dimensions allowing the surgeon to 
tailor the surgical approach. Ongoing research has led to important advances in finite element 
analyses that provide cardiac models and simulations of the aortic root reproducing the 
mechanism of aortic regurgitation and evaluating the effects of the surgical technique on the 
wall stress.  This cardiac modelling will permit in the near future personalization of the aortic 
valve repair, probably resulting in better durability of the repair and competence of the aortic 
valve.  In addition, patients should be discussed at the heart team meeting preparatory to 
surgery taking into account all information obtained by preoperative cardiac imaging to 
determine the most appropriate surgical technique for that particular patient. This may 
require centralization of care with valve-preserving procedures only executed in high volume 
centers with dedicated surgeons and dedicated cardiologists working together to provide the 
optimal care. At present, the aortic valve insufficiency and ascending aorta aneurysm 
international registry (AVIATOR) is ongoing, chaired by Dr. Lansac. The aims of the AVIATOR 
registry comprise optimized multidisciplinary patient care, uniform scientific reporting and 
assessment of quality of care. This international multicenter study will play a key role in the 
coming years to establish the place of repair in aortic valve and root surgery which might 











Samenvatting en toekomstperspectieven 
  




Dit proefschrift beschreef de toegevoegde waarde van beeldvormende technieken bij de 
selectie en evaluatie van patiënten met aortaklepinsufficiëntie en/of aorta-pathologie die 
aortaklep en –wortelchirurgie ondergaan. De algemene introductie in hoofdstuk 1 gaf een 
overzicht over aortaklep- en aortawortelpathologie, de operatie-indicatie, de verschillende 
klepsparende chirurgische technieken en de rol die beeldvorming speelt in de selectie van 
patiënten voor een klepsparende aortawortelvervanging.  
 
Deel I: preoperatieve evaluatie van patiënten met aortaklepinsufficiëntie en/of aorta-
pathologie 
Deel I richtte zich op de beeldvorming in de preoperatieve fase om progressie van de ziekte te 
evalueren en om patiënten die mogelijk geschikt zijn voor een klepsparende operatie te 
identificeren. In hoofdstuk 2 werd het effect van aortaworteldilatatie op de geometrie van de 
aortaklep geëvalueerd met behulp van 3-dimensionale echocardiografie. De klepgrootte nam 
significant toe bij patiënten met een gedilateerde aortawortel in vergelijking tot normale 
aortawortels. Echter, deze aanpassing leek onvoldoende om te compenseren voor de 
toegenomen aortawortelgrootte, voornamelijk bij patiënten met centrale 
aortaklepinsufficiëntie. Bij patiënten met excentrische aortaklepinsufficiëntie was er een 
relatief overschot aan klepweefsel vergeleken met de aortawortelgrootte wat resulteerde in 
prolaps. In hoofdstuk 3 werd gekeken naar het effect van aortaklepinsufficiëntie op de 
mitralisklep. Aortaklepinsufficiëntie is geassocieerd met volume-overbelasting en daarmee 
dilatatie van de linker ventrikel en uiteindelijk achteruitgang in linker ventrikelfunctie. Dit kan 
leiden tot een verhoogde spanning op de mitralisklepblaadjes door verplaatsing van de 
papillairspieren aan de ene kant en een verminderde mitralisklepsluiting aan de andere kant. 
De mitralisklep past zich aan, aan de linker ventrikeldilatatie, met een verlenging van de 
klepblaadjes. Als deze compensatoire mechanismen tekort schieten, dan kan er 
mitralisklepinsufficiëntie ontstaan, wat gebeurde in 23% van de patiënten met 
aortaklepinsufficiëntie. Een groter linkeratriumvolume en een lagere linker ventrikel 
ejectiefractie waren onafhankelijk geassocieerd met mitralisklepinsufficiëntie bij patiënten 
met aortaklepinsufficiëntie. In hoofdstuk 4 werd het effect van statines ter vermindering van 
progressie van aortadilatatie bij patiënten met een bicuspide aortaklep onderzocht. Patiënten 
die statines gebruikten werden vergeleken met patiënten die geen statines gebruikten. 
Statine-gebruikers hadden kleinere aortaworteldiameters bij aanvang van de studie en na een 
mediane duur van 4.7 jaar, zelfs na correctie voor coronairlijden, leeftijd en gebruik van 
andere medicatie. De gemiddelde jaarlijkse aortawortelgroeisnelheid was 0.08 mm/jaar voor 
de aortoventriculaire overgang, 0.16 mm/jaar voor de sinus van Valsalva, 0.12 mm/jaar voor 
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de sinotubulaire overgang en 0.45 mm/jaar voor de aorta ascendens. Het gebruik van statines 
had geen effect op de aortawortelgroeisnelheid.  
Hoofdstuk 5 ging over het gebruik van computer tomografie van de aortaklep en de thoracale 
aorta in 61 patiënten bij wie een klepsparende aortawortelreconstructie werd overwogen. De 
aortaklep was succesvol gerepareerd in 36 patiënten, terwijl in de overige 25 patiënten 
reparatie niet mogelijk bleek of niet gelukt was. Patiënten met een gerepareerde klep hadden 
minder vaak een bicuspide aortaklep, minder calcificaties in de annulus en minder calcificaties 
in de commissuren vergeleken met patiënten bij wie de klep niet te repareren was. De 
informatie verkregen met behulp van computer tomografie aangaande klepmorfologie en 
mate van calcificatie kan van toegevoegde waarde zijn in de beslissing of een klep te repareren 
is. In hoofdstuk 6 werd gekeken of transthoracale echocardiografie kan bijdragen in het 
bepalen van de juiste maat buisprothese die gebruikt wordt bij de David reimplantatie 
techniek. In 30 patiënten die een klepsparende aortawortelvervanging middels de 
reimplantatie techniek ondergingen zonder aanvullende klepreparatie, werd de klephoogte, 
kleplengte en klepoppervlakte gemeten met behulp van echocardiografie. Er werden formules 
ontwikkeld op basis van de klephoogte (diameter = 1.1 • ((2 • 2/3 • gemiddelde klephoogte) + 
2)), kleplengte (diameter = (2 • 2/3 • kleplengte) + 2) en het klepoppervlakte (diameter = 0.8 • 
((2 • √(totale klepoppervlakte / π)) + 2)). Patiënten die een buisprothese kregen die kleiner 
was dan berekend met de formules, hadden minder vaak residuele milde 
aortaklepinsufficiëntie vergeleken met patiënten die een grotere buisprothese dan berekend 
kregen. Er dient nog wel prospectieve validatie van de formules plaats te vinden voordat deze 
toegepast kunnen worden in de dagelijkse praktijk. 
 
Deel II: postoperatieve evaluatie van patiënten na aortaklep- en aortawortelchirurgie 
Deel II richtte zich op de beeldvorming in de postoperatieve fase na aortaklep- en 
aortawortelchirurgie. In hoofdstuk 7 en 8 werd de postoperatieve remodelering van de linker 
ventrikel geëvalueerd. In hoofdstuk 7 werd gekeken naar het verschil in postoperatieve linker 
ventrikelremodelering bij patiënten met acute en chronische aortaklepinsufficiëntie. In beide 
groepen was er sprake van significante linker ventrikelremodelering. Echter, na aortaklep- en 
aortawortelchirurgie voor acute aortaklepinsufficiëntie was het linker ventrikel eind-
diastolisch volume meer afgenomen en de geïndexeerde globale longitudinale strain beter 
behouden in vergelijking met chronische aortaklepinsufficiëntie. Vervolgens werden patiënten 
die een klepsparende operatie ondergingen vergeleken met patiënten bij wie de aortaklep en 
aortawortel vervangen werd met een biologische prothese in hoofdstuk 8. Patiënten die een 
aortaklep- en aortawortelvervanging ondergingen hadden significant grotere linker ventrikel 
volumes voor de operatie. Na de operatie, na een mediane duur van 46 maanden, vond er in 
beide groepen een significante reductie van linker ventrikelvolumes plaats. De linker ventrikel 
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ejectie fractie daalde direct na operatie en steeg daarna in beide groepen. De terugkeer van 
significante aortaklepinsufficiëntie tijdens de studieperiode was ongeveer 7-8% en niet 
verschillend tussen reparatie en vervanging. Hoofdstuk 9 onderzocht de postoperatieve 
verandering in linker ventrikelvolumes en -functie bij 97 patiënten met een acute type A 
aortadissectie die de initiële operatie overleefd hadden. In dit hoofdstuk werden 3 
verschillende operaties met elkaar vergeleken: de klepsparende aortawortelvervanging 
(middels de remodellering techniek of de reimplantatie techniek), de supracoronaire aorta 
ascendens vervanging en de aortaklep- en aortawortelvervanging (met een biologische of 
mechanische prothese). Na de supracoronaire aorta ascendens vervanging en de klepsparende 
aortawortelvervanging werd significant vaker aortaklepinsufficiëntie graad ≥2 gezien dan na 
aortaklep- en aortawortelvervanging. De linker ventrikelvolumes bleven stabiel na 
klepsparende aortawortelvervanging en aortaklep- en aortawortelvervanging, terwijl deze 
significant toenamen na de supracoronaire aorta ascendens vervanging. Bij patiënten met 
significante aortaklepinsufficiëntie (graad ≥2) na de operatie was er een significante toename 
in linker ventrikelvolumes, terwijl er geen linker ventrikeldilatatie werd geobserveerd bij 
patiënten zonder significante aortaklepinsufficiëntie na de operatie.  
In hoofdstuk 10 werd het effect van aortaklepvervanging op het geleidingssysteem 
geëvalueerd. Patiënten die een aortaklepvervanging zonder hechtingen, via een catheter of op 
de conventionele manier ondergingen werden met elkaar vergeleken. En nieuw 
linkerbundeltakblok werd vaker geobserveerd na een aortaklepvervanging zonder hechtingen 
en via een catheter in vergelijking met de conventionele aortaklepvervanging. 
Hoofdstuk 11 en 12 legden de nadruk op de postoperatieve veranderingen in aortadiameter. 
De aortawortelgroeisnelheid is hoger bij patiënten met een bicuspide aortaklep in vergelijking 
met mensen met een tricuspide aortaklep ten gevolge van een onderliggend genetisch 
substraat en/of een veranderde hemodynamiek. In hoofdstuk 11 werd de 
aortawortelgroeisnelheid vergeleken tussen patiënten met een bicuspide aortaklep en 
patiënten met een tricuspide aortaklep voor en na aortaklepvervanging om beter inzicht te 
krijgen in de mechanismen van aortaworteldilatatie bij bicuspidie. De preoperatieve 
aortawortelgroeisnelheid was significant sneller bij bicuspide aortakleppen vergeleken met 
tricuspide aortakleppen. Terwijl na de operatie, de groeisnelheid hetzelfde was in beide 
groepen. Dit impliceert dat hemodynamiek een belangrijke rol speelt in de snellere 
aortadilatatie bij bicuspide aortakleppen.  
In hoofdstuk 12 werd gekeken naar de groei van de thoracale aorta descendens bij patiënten 
die geopereerd waren aan een acute type A aortadissectie. Groei werd bekeken met behulp 
van metingen van het volume van de thoracale aorta descendens op computer tomografie. 
Een snellere groei van het complete lumen en in het bijzonder van het false lumen na 
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aortadissectie was geassocieerd met vaker opnieuw een operatie aan de thoracale aorta 
descendens.  
 
Conclusies en toekomstperspectieven 
De levensverwachting van de algemene populatie neemt nog steeds toe, derhalve is er vraag 
naar aortaklepoperaties met een lange levensduur en weinig complicaties. Mechanische en 
biologische (inclusief transcatheter) klepprotheses en aortaklepreparatie zijn de beschikbare 
opties voor patiënten met aortakleplijden. Het risico op opnieuw een operatie (bij biologische 
klepprotheses en aortaklepreparatie) moet afgewogen worden tegen het risico op trombo-
embolische en bloedingscomplicaties (bij mechanische klepprotheses waarbij levenslang 
antistolling nodig is). Daarbij komt dat de individuele voorkeur van de patiënt tegenwoordig 
van groot belang is. Het sparen van de aortaklep heeft al veelbelovende resultaten laten zien, 
maar op dit moment zijn er veel verschillende chirurgische technieken en modificaties en is 
het succes grotendeels afhankelijk van de operateur. In de komende jaren zullen chirurgen en 
cardiologen de praktijk van aortaklepreparatie meer te standaardiseren. Daarnaast kunnen we 
verwachten dat minder invasieve technieken en protheses met langere levensduur ontwikkeld 
worden met behulp van 3-dimensionale beeldvormingstechnieken en software welke voorziet 
in 3-dimensionaal printen. 
Tegenwoordig is het noodzakelijk om de aortaworteldimensies en de mechanismen van 
aortaklepinsufficiëntie te evalueren met behulp van echocardiografie voorafgaand aan de 
operatie. Slokdarmechocardiografie geeft betere beelden van de aortaklep en -wortel dan 
transthoracale echocardiografie. Tevens is 3-dimensionale echocardiografie accurater in het 
beoordelen van de ernst van aortaklepinsufficiëntie dan 2-dimensionale echocardiografie. De 
aorta ascendens kan daarnaast beter gevisualiseerd worden met computer tomografie of 
cardiale magnetische resonantie. Door deze 3-dimensionale technieken is het mogelijk om de 
aortawortel te reconstrueren met behulp van speciale software, zodat de structuur geprint 
kan worden met behulp van een 3-dimensionale printer. Dit kan de chirurg helpen om de 
chirurgische techniek te individualiseren. Recent wetenschappelijk onderzoek heeft geleid tot 
voortgang op het gebied van finite element analyse waardoor cardiale modellen en simulaties 
van de aortawortel gebruikt kunnen worden om de mechanismen van aortaklepinsufficiëntie 
te reproduceren en om effecten van chirurgische technieken op de aortawand te evalueren. 
Cardiaal modelleren kan in de nabije toekomst personaliseren van aortaklepreparatie mogelijk 
maken wat zou kunnen resulteren in een langere levensduur van de aortaklepreparatie.  
Daarnaast is het belangrijk dat patiënten besproken worden tijdens een hart team 
bijeenkomst voorafgaand aan de operatie waarbij alle informatie verkregen middels 
preoperatieve beeldvorming in acht wordt genomen. De meest geschikte chirurgische 
techniek kan dan gekozen worden door een multidisciplinair team. Hierbij is het waarschijnlijk 
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nodig om de zorg met betrekking tot klepsparende operaties te centraliseren in hoog-volume 
centra met toegewijde chirurgen en cardiologen die samenwerken om de optimale zorg te 
leveren. Op dit moment is er een lopende registratie van klepsparende aortaworteloperaties 
waarbij het doel is om de multidisciplinaire patiëntenzorg te optimaliseren, een uniforme 
manier van rapporteren van resultaten te ontwikkelen en de zorg te beoordelen. Deze 
internationale multicenterstudie zal een sleutelrol spelen in de komende jaren om de plaats 
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